<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="00407036">선바이오</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-1424243</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="LCommon">정정신고(보고)-대표이사등의확인</FILENAME>

<CORRECTION>
<TITLE ATOC="Y" AASSOCNOTE="CORRECTION">정 정 신 고 (보고)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">2021년 10월 27일</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<P USERMARK="F-14">1. 정정대상 공시서류 : 사업보고서</P>
<P></P>
<P USERMARK="F-14">2. 정정대상 공시서류의 최초제출일 : 2021년 5월 7일</P>
<P></P>
<P USERMARK="F-14">3. 정정사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="673" BORDER="1">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="344" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정사유 </TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="344" HEIGHT="76" VALIGN="MIDDLE">I. 회사의 개요&cr;2. 회사의 연혁&cr;
<SPAN USERMARK=" B">가. 설립이후의 주요연혁</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">미기재 및&cr;기재사항 보완</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주1) 정정 전</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주1) 정정 후</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="344" HEIGHT="76" VALIGN="MIDDLE">V. 감사인의 감사의견 등&cr;
<SPAN USERMARK=" B">- 조정협의회 주요 협의내용&cr;- 전ㆍ당기 재무제표 불일치에 대한 세부정보</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">미기재</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주2) 정정 후</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="344" HEIGHT="76" VALIGN="MIDDLE">VII. 주주에 관한 사항&cr;
<SPAN USERMARK=" B">가. 최대주주 및 특수관계인의 주식소유 현황&cr;다. 소액주주 현황</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">미기재 및&cr;기재사항 보완</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주3) 정정 전</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주3) 정정 후</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-14">3-1. 정정사항 (2021년 10월 27일 정정)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="673" BORDER="1">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="344" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정사유 </TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="344" HEIGHT="76" VALIGN="MIDDLE">VII. 주주에 관한 사항&cr;
<SPAN USERMARK=" B">가. 최대주주 및 특수관계인의 주식소유 현황&cr;다. 소액주주 현황</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">미기재</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주4) 정정 전</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주4) 정정 후</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN></SPAN>
<SPAN USERMARK=" B">(</SPAN>
<SPAN USERMARK=" B">주1</SPAN>
<SPAN USERMARK=" B">) </SPAN>
<SPAN USERMARK=" B">정정 전&cr;</SPAN>
<SPAN></SPAN>
<SPAN>I. 회사의 개요&cr;2. 회사의 연혁&cr;가. 설립이후의 주요연혁</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="792">

<COLGROUP>
<COL WIDTH="56"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="669"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="114" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="678" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내 역</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1996년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>8월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국 및 미국 특허출원 8건 (뇌졸중치료제, 항암활성제, 인공혈액, 패혈증치료제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1997년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>선바이오(주) 설립 (총자본금 7억 5천만원, 국민창투 1/3)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1998년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>PEG유도체 자체개발 성공</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1998년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>8월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>선바이오(주) 연구소 설립</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1998년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>12월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국 및 미국 특허출원 10건 (PEG유도체 수건, LIPOSOME, PEG-LIPOSOME)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1999년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>PEG-SHOP 개설</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1999년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>특허등록 (항암활성제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1999년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>5월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>벤처기업으로 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1999년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>12월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>뇌졸중치료제, 항암활성제의 전임상 독성시험 (급독성시험, 약리시험, 항원성시험)완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2000년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>자본금 증자 (총자본금 14억, 이수화학(주) 지분참여)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="150" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2000년</P>
</TD>

<TD WIDTH="49" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>9월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>자본금 증자 (총자본금 15억 3천만원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>사옥구입 이전 및 연구소 확장</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>뇌졸중 치료제/인공혈액 영국에서 전임상시험 시작</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>11월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허등록 (뇌졸중치료제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>12월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>자본금 증자 (총자본금 15억 5천만원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2001년</P>
</TD>

<TD WIDTH="49" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>5월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>sunbio.com의 인터넷주소 매입</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>5억원 규모의 선바이오 전환사채를 금창창투가 인수 및 주식전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>6억원 규모의 선바이오 전환사채를 기업은행이 인수함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>11월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>Biogen사와 신약개발 공동추진</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2002년</P>
</TD>

<TD WIDTH="49" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>BioVectra사와 생체고분자 북미지역 마케팅 계약체결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>Amgen사와 신약개발 공동추진</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2003년</P>
</TD>

<TD WIDTH="49" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>11월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국특허 (#6,828,401 PEG-maleimide 제조방법)등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>인도의 INTAS PHARMA사와 PEG-GCSF, PEG-IFN 공동개발 (당사의 기술수출)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2004년</P>
</TD>

<TD WIDTH="49" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (hexa-arm PEG 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (PEG-EPO 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (PEG-interferon GCSF 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (PEG-interferon beta 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (PEG-interferon alpha 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>인도의 Serum Institute of India와 PEG-GCSF, PEG-IFN, PEG-EPO 공동개발. (당사의 기술수출)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2005년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (PEG-propionaldehyde 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>5월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국특허 (#6,858,736 hexa-arm PEG 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국특허 (#6,956,135, PEG-aldehyde 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국특허 (#6,916,962, PEG-aldehyde 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국의 BioSite 사와 공급 및 기술계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>11월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국의 CytImmun Sciences사와 공급 및 기술계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2006년</P>
</TD>

<TD WIDTH="49" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국의 Cartilix사와 공급 및 기술계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국특허 (#7,257,845, PEG-aldehyde 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>미국특허 (#7,041,855, PEG-aldehyde 제조방법) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2007년</P>
</TD>

<TD WIDTH="49" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>9월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>NEUPEG (선바이오 신약1호)이 인도 및 세계시장에서 출시 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허(모발페길레이션기술) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2012년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>12월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (구강건조 치료제 기술) 출원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2014년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>NEUPEG (PEG-GCSF) EU에서의 임상완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>NEUPEG (PEG-GCSF) 미국에서의 임상완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>7월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>PEG-인터페론 (C형 간염체료제) 인도에서의 제품승인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>12월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>NEUPEG의 미국 FDA filing 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" HEIGHT="210" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015년</P>
</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>3월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>대우스팩2호와 스팩합병 IPO심사 청구 (5월 철회)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>한국특허 (구강건조증 치료제 기술) 등록</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">SL인베스트먼트로 부터 전환상환 우선주 5만주(주당4만원)발행 -12월 보통주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">한국투자파트너스로 부터 전환상환 우선주 5만주(주당4만원) 발행-12월 보통주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">코스닥 IPO청구 (11월 보호예수동의 문제로철회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">자본금 100% 무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">코넥스 상장 신청서 (보고서) 제출 - 2016년 1월 22일 코넥스 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">2016년</TD>
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">코넥스 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 100,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">한국특허 (폴리에틸렌글리콜 수화젤 주사제) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 25,000천주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">본점 소재지 이전 (경기도 군포시 산본로 95)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">코스닥 IPO청구 (미승인 결정)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="120" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="4">2017년</TD>
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">지정자문인 및 유동성 공급계약 변경 (하나금융투자)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 68,500주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>자기주식처분 (400주, 소재불명 원소유주에게 반환)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>Intas사 PEG-filgrastim 바이오시밀러를 EMA에 MAA 파일링</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="90" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="3">2018년</TD>

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>3월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>주식매수선택권 부여 (보통주식 10,000주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>Apotex사의 Lapelga, Health Canada의 승인 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>9월</P>
</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>PELGRAZ (PEG-filgrastim)의 EU 승인 승인 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="210" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="7">2019년</TD>
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">선바이오-팬젠 바이오베터 의약품 공동개발 협약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">Apobiologix가 LapelgaTM를 캐나다에서 launching </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 35,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">2019 필라델피아 바이오 박람회참가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">Apotex사의 Lapelga, 호주 TGA의 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">구강건조증치료제 MucoPEG 미국 FDA 판매허가 획득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">MucoPEG - 아일랜드 더블린 소재 Meroven사와 MOU체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="203" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="6">2020년</TD>
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>MucoPEG - MENA 지역 판매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>인공혈액 미국특허 출원 (Novel Modified Hemoglobin as Blood Substitute / 출원번호: 63/044,579)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>

<TD WIDTH="678" HEIGHT="53" VALIGN="MIDDLE">
<P>차세대 페길레이션 기술 미국 특허 취득 (3차 알콕시 폴리에틸렌 글리콜 및 이의 유도체 (TERTIARY ALKOXY POLYETHYLENE GLYCOL AND DERIVATIVESTHEREOF))</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>구강건조증치료제 MucoPEG의 Post-approval 미국 임상시험 시작 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>MucoPEG 기술이전 계약 체결 (중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>

<TD WIDTH="678" HEIGHT="30" VALIGN="MIDDLE">
<P>BioSciences사와 MOU 체결 (PEG-filgrastim개발)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">(주1) 정정 후&cr;</SPAN>I. 회사의 개요&cr;2. 회사의 연혁&cr;가. 설립이후의 주요연혁
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="792">

<COLGROUP>
<COL WIDTH="56"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="665"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="674" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내 역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1996년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국 및 미국 특허출원 8건 (뇌졸중치료제, 항암활성제, 인공혈액, 패혈증치료제)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1997년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">선바이오(주) 설립 (총자본금 7억 5천만원, 국민창투 1/3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1998년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">PEG유도체 자체개발 성공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1998년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">선바이오(주) 연구소 설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1998년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국 및 미국 특허출원 10건 (PEG유도체 수건, LIPOSOME, PEG-LIPOSOME)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1999년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">PEG-SHOP 개설</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1999년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">특허등록 (항암활성제)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1999년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">벤처기업으로 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1999년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">뇌졸중치료제, 항암활성제의 전임상 독성시험 (급독성시험, 약리시험, 항원성시험)완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2000년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 증자 (총자본금 14억, 이수화학(주) 지분참여)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">2000년</TD>
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">9월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 증자 (총자본금 15억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">사옥구입 이전 및 연구소 확장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">뇌졸중 치료제/인공혈액 영국에서 전임상시험 시작</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허등록 (뇌졸중치료제)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 증자 (총자본금 15억 5천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">2001년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 증자 (총자본금 15억 6천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">5월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">sunbio.com의 인터넷주소 매입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">5억원 규모의 선바이오 전환사채를 금창창투가 인수 및 주식전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">6억원 규모의 선바이오 전환사채를 기업은행이 인수함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 증자 (총자본금 16억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">Biogen사와 신약개발 공동추진</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">2002년</TD>
<TD ROWSPAN="3" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">1월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">BioVectra사와 생체고분자 북미지역 마케팅 계약체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">Amgen사와 신약개발 공동추진</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 증자 (총자본금 18억 6천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">2003년</TD>
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">11월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국특허 (#6,828,401 PEG-maleimide 제조방법)등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">인도의 INTAS PHARMA사와 PEG-GCSF, PEG-IFN 공동개발 (당사의 기술수출)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">2004년</TD>
<TD ROWSPAN="6" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (hexa-arm PEG 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (PEG-EPO 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (PEG-interferon GCSF 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (PEG-interferon beta 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (PEG-interferon alpha 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">인도의 Serum Institute of India와 PEG-GCSF, PEG-IFN, PEG-EPO 공동개발. (당사의 기술수출)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">2005년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (PEG-propionaldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국특허 (#6,858,736 hexa-arm PEG 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">10월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국특허 (#6,956,135, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국특허 (#6,916,962, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국의 BioSite 사와 공급 및 기술계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국의 CytImmun Sciences사와 공급 및 기술계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">2006년</TD>
<TD ROWSPAN="3" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">4월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국의 Cartilix사와 공급 및 기술계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국특허 (#7,257,845, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">미국특허 (#7,041,855, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">2007년</TD>
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">9월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">NEUPEG (선바이오 신약1호)이 인도 및 세계시장에서 출시 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허(모발페길레이션기술) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2012년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (구강건조 치료제 기술) 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">2014년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">NEUPEG (PEG-GCSF) EU에서의 임상완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">NEUPEG (PEG-GCSF) 미국에서의 임상완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">PEG-인터페론 (C형 간염체료제) 인도에서의 제품승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">NEUPEG의 미국 FDA filing 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">2015년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">대우스팩2호와 스팩합병 IPO심사 청구 (5월 철회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (구강건조증 치료제 기술) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">SL인베스트먼트로 부터 전환상환 우선주 5만주(주당4만원)발행 -12월 보통주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국투자파트너스로 부터 전환상환 우선주 5만주(주당4만원) 발행-12월 보통주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">코스닥 IPO청구 (11월 보호예수동의 문제로철회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자본금 100% 무상증자 (총자본금 38억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">코넥스 상장 신청서 (보고서) 제출 - 2016년 1월 22일 코넥스 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">2016년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">코넥스 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">주식매수선택권 부여 (보통주식 100,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">한국특허 (폴리에틸렌글리콜 수화젤 주사제) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">주식매수선택권 부여 (보통주식 25,000천주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">본점 소재지 이전 (경기도 군포시 산본로 95)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">코스닥 IPO청구 (미승인 결정)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">2017년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">지정자문인 및 유동성 공급계약 변경 (하나금융투자)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">주식매수선택권 부여 (보통주식 68,500주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">자기주식처분 (400주, 소재불명 원소유주에게 반환)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">Intas사 PEG-filgrastim 바이오시밀러를 EMA에 MAA 파일링</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">2018년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">주식매수선택권 부여 (보통주식 10,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">Apotex사의 Lapelga, Health Canada의 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">9월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">PELGRAZ (PEG-filgrastim)의 EU 승인 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="8" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="240">2019년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">선바이오-팬젠 바이오베터 의약품 공동개발 협약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">Apobiologix가 LapelgaTM를 캐나다에서 launching </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">주식매수선택권 부여 (보통주식 35,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">주식매수선택권 19,600주 행사 (총자본금 38억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">2019 필라델피아 바이오 박람회참가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">Apotex사의 Lapelga, 호주 TGA의 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">구강건조증치료제 MucoPEG 미국 FDA 판매허가 획득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">MucoPEG - 아일랜드 더블린 소재 Meroven사와 MOU체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="203">2020년</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">MucoPEG - MENA 지역 판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">인공혈액 미국특허 출원 (Novel Modified Hemoglobin as Blood Substitute / 출원번호: 63/044,579)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">10월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="53">차세대 페길레이션 기술 미국 특허 취득 (3차 알콕시 폴리에틸렌 글리콜 및 이의 유도체 (TERTIARY ALKOXY POLYETHYLENE GLYCOL AND DERIVATIVESTHEREOF))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">구강건조증치료제 MucoPEG의 Post-approval 미국 임상시험 시작 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">MucoPEG 기술이전 계약 체결 (중국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="674" VALIGN="MIDDLE" HEIGHT="30">BioSciences사와 MOU 체결 (PEG-filgrastim개발)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">(주2) 정정 후&cr;</SPAN>
<SPAN>V. 감사인의 감사의견 등&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>조정협의회 주요 협의내용
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="629" BORDER="1">

<COLGROUP>
<COL WIDTH="26"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="489" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내 용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2">개최 일자</TD>
<TD ALIGN="CENTER" WIDTH="489" HEIGHT="30" VALIGN="MIDDLE">2021년 02월 23일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="35" HEIGHT="90" VALIGN="MIDDLE" ROWSPAN="3">참&cr;석&cr;자</TD>
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE">회사</TD>
<TD ALIGN="CENTER" WIDTH="489" HEIGHT="30" VALIGN="MIDDLE">선바이오(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE">전기 감사인</TD>
<TD ALIGN="CENTER" WIDTH="489" HEIGHT="30" VALIGN="MIDDLE">다산회계법인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE">당기 감사인</TD>
<TD ALIGN="CENTER" WIDTH="489" HEIGHT="30" VALIGN="MIDDLE">정인회계법인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2">협의대상</TD>
<TD ALIGN="CENTER" WIDTH="489" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="76" VALIGN="MIDDLE" COLSPAN="2">주요 협의내용 및&cr;의견 불합치 이유</TD>
<TD WIDTH="489" HEIGHT="76" VALIGN="MIDDLE">(1) 주식매수선택권 평가시점의 종가 입력 오류로 인해 평가금액 오류 발생, 당기손익 영향 없으나 전기 자본항목의 수정에 대한 의견 불일치&cr;(2) 기술료수입(로열티수익)의 기간귀속에 대한 의견불일치</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 당사의 전ㆍ당기 감사인은 한국공인회계사회에 설치된 전ㆍ당기 감사인간 의견불일치 조정협의회를 진행하지 않았습니다. 상기 개최일자는 의견 불일치가 제시 된 일자를 기재하였습니다.&cr;주2) 당기 감사인과 전기 감사인은 당사(유선 및 이메일)를 통해 전기 재무제표에 대한 협의를 진행하였으나 의견 불합치로 당기 비교표시 재무제표의 전기 재무제표 수정사항이 아래와 같이 발생하였습니다.&cr;</P>
<P>전ㆍ당기 재무제표 불일치에 대한 세부정보</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="597" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="297" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무제표명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기금액&cr;(A)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기 비교&cr;표시금액(B)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">불일치 금액&cr;(B-A)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">재무상태표</TD>
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="30" VALIGN="MIDDLE">매출채권 및 기타채권</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">1,403,226</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">2,165,116</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">761,890</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">재무상태표</TD>
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="30" VALIGN="MIDDLE">주식발행초과금</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">2,987,816</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">3,000,811</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">12,995</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">재무상태표</TD>
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">1,640,609</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">1,668,720</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">28,111</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">재무상태표</TD>
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="30" VALIGN="MIDDLE">미처리결손금</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">(1,638,825)</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">720,784</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">(918,041)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">손익계산서</TD>
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="30" VALIGN="MIDDLE">매출액</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">5,771,750</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">6,547,190</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">775,440</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">(주3) 정정 전&cr;</SPAN>
<SPAN>VII. 주주에 관한 사항&cr;가. 최대주주 및 특수관계인의 주식소유 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="682" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="371" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="685" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="175" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="61" VALIGN="MIDDLE">
<P>노 광</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="61" VALIGN="MIDDLE">
<P>최대주주 및&cr;대표이사</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="61">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="61" VALIGN="MIDDLE">2,503,040</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="61" VALIGN="MIDDLE">32.63</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="61" VALIGN="MIDDLE">2,111,947</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="61" VALIGN="MIDDLE">27.53</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="61" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노 완</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>제</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">117,600</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">1.53</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">118,800</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">1.55</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30" VALIGN="MIDDLE">조학수</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">90,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">1.17</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">70,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.91</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노흥덕</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">74,300</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.97</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">74,300</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.97</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노 찬</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>형</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">46,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.60</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">44,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.57</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노수덕</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">15,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.20</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">5,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.07</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>조동환</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>매형</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">12,424</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.16</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">6,300</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.08</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노성두</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>제</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">31,200</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.41</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">31,200</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.41</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>이티에스소프트</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>제의 회사</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">40,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.52</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">40,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.52</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>황은숙</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>제수</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">39,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.51</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">39,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.51</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노순남</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>누이</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">17,938</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.23</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">10,294</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.13</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>백기황</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌누이 남편</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">20,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.26</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">20,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.26</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>김판균</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>임원</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">1,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.01</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.00</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>김영옥</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>처의 올케</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">20,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.26</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">20,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.26</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>전상용</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>동서</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">15,900</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.21</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">11,826</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.15</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노경애</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌누이</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">11,500</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.15</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">11,500</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.15</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>김경숙</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>처의 누이</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">12,782</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.17</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">12,782</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.17</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>박상갑</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>처 누이남편</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">11,500</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.15</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">11,500</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.15</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>김능률</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>동서</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">10,340</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.13</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">10,340</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.13</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>정춘자</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>모</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">5,254</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.07</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">3,854</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.05</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>신명희</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>제의 처</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">8,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.10</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">8,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.10</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>김동일</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사외이사</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">5,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.07</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">5,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.07</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>박재옥</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌의 처</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">1,576</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.02</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">1,576</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.02</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노태현</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌의 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">10,888</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.14</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">10,888</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.14</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">노태민</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌의 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">16,230</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.21</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.00</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>선바이오(주)</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>자사주</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">7,997</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.10</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">7,997</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.10</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>박효경 </P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>고종사촌</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">24,402</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.32</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">24,402</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.32</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>김선기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌의 처</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">10,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.13</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">9,180</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.12</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노선애 </P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">11,965</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.16</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">11,965</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.16</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노혜진</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌의자녀</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.00</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.00</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" HEIGHT="34" VALIGN="MIDDLE">
<P>노문정</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" HEIGHT="34" VALIGN="MIDDLE">
<P>사촌의자녀</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="34">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="34" VALIGN="MIDDLE">1,500</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="34" VALIGN="MIDDLE">0.02</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="34" VALIGN="MIDDLE">1,500</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="34" VALIGN="MIDDLE">0.02</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="34" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30" VALIGN="MIDDLE">김태형</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">          880 </TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">0.01</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">880</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.01</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30" VALIGN="MIDDLE">김태오</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">          880 </TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">0.01</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">880</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.01</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30" VALIGN="MIDDLE">이성훈</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">임원</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">5,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">0.07</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.00</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30" VALIGN="MIDDLE">KIM SUN SOOK</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">처</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">38,000</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">0.50</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">38,000</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.50</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30" VALIGN="MIDDLE">김준</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">사촌의 남편</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">9,162</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">0.12</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">12,582</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.16</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="60">계</TD>
<TD ALIGN="CENTER" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">3,246,258</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">42.32</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">2,785,493</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">36.31</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL11">[ 소액주주현황 ]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소액주주</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,475</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,513</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97.48</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,828,396</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,670,540</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49.91</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;</P>

<P>
<SPAN USERMARK=" B">(주3) 정정 후&cr;</SPAN>VII. 주주에 관한 사항&cr;가. 최대주주 및 특수관계인의 주식소유 현황
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="682" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="371" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="685" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="326" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">노광</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="53" VALIGN="MIDDLE">최대주주 및 대표이사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">  2,503,040 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="53" VALIGN="MIDDLE">   32.63</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="53" VALIGN="MIDDLE">  2,111,947 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="53" VALIGN="MIDDLE">   27.53 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노완</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">    117,600 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    1.53 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">   118,800 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">   1.55 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">조학수</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     90,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    1.17 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     70,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.91 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노흥덕</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     74,300 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.97 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     74,300 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.97 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노찬</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">형</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     46,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">  0.60 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     44,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.57 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노수덕</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     15,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.20</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">조동환</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">매형</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     12,424 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.16</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       6,300 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.08 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노성두</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     31,200 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.41</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     31,200 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.41 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">이티에스소프트(주)</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제의 회사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     40,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.52 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     40,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.52 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">황은숙</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제수</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     39,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.51 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     39,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.51 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노순남</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">누이</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     17,938 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.23 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,294 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백기황</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌누이 남편</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김영옥</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처의 올케</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">전상룡</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">동서</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     15,900 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.21 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,826 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노경애</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌누이</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.15</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김경숙</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처의 누이</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     12,782 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.17 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     12,782 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.17 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박상갑</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 누이남편</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김능율</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">동서</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,340 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.13 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,340 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">정춘자</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">모</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       5,254 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.07 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       3,854 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">신명희</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       8,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.10 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       8,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김동일</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사외이사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박재옥</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       1,576 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       1,576 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노태현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,888 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.14 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,888 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.14 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">선바이오(주)</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">자사주</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       7,997 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       7,997 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박효경</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">고종사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     24,402 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.32 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     24,402 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.32 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김선기</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       9,180 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.12 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노선애</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,965 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.16 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,965 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.16 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노문정</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       1,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">  0.02 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       1,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김태형</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김태오</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.01 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김준</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 남편</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       9,162 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.12 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     12,582 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.16 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백성현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       4,399 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.06 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       4,399 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.06 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백준현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       4,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       4,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">KIM SUN SOOK</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">배우자</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     38,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.50</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     38,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.50 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="256" HEIGHT="60">계</TD>
<TD ALIGN="CENTER" WIDTH="55" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">  3,232,427 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">42.14</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">  2,793,892 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">36.42</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="55" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;[ 소액주주현황 ]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소액주주</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,473</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,513</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97.35</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,819,997</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,670,540</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49.801</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-14">3-1. 정정사항 (2021년 10월 27일 정정)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="673" BORDER="1">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="344" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정사유 </TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="344" HEIGHT="76" VALIGN="MIDDLE">VII. 주주에 관한 사항&cr;
<SPAN USERMARK=" B">가. 최대주주 및 특수관계인의 주식소유 현황&cr;다. 소액주주 현황</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">미기재 및&cr;기재사항 보완</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주4) 정정 전</TD>
<TD WIDTH="108" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">(주4) 정정 후</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK=" B">(주4) 정정 전&cr;</SPAN>VII. 주주에 관한 사항&cr;가. 최대주주 및 특수관계인의 주식소유 현황
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="682" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="371" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="685" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="326" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">노광</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="53" VALIGN="MIDDLE">최대주주 및 대표이사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">  2,503,040 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="53" VALIGN="MIDDLE">   32.63</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="53" VALIGN="MIDDLE">  2,111,947 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="53" VALIGN="MIDDLE">   27.53 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노완</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">    117,600 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    1.53 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">   118,800 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">   1.55 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">조학수</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     90,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    1.17 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     70,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.91 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노흥덕</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     74,300 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.97 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     74,300 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.97 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노찬</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">형</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     46,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">  0.60 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     44,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.57 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노수덕</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     15,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.20</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">조동환</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">매형</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     12,424 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.16</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       6,300 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.08 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노성두</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     31,200 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.41</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     31,200 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.41 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">이티에스소프트(주)</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제의 회사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     40,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.52 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     40,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.52 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">황은숙</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제수</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     39,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.51 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     39,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.51 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노순남</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">누이</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     17,938 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.23 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,294 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백기황</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌누이 남편</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김영옥</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처의 올케</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">전상룡</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">동서</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     15,900 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.21 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,826 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노경애</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌누이</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.15</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김경숙</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처의 누이</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     12,782 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.17 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     12,782 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.17 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박상갑</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 누이남편</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김능율</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">동서</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,340 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.13 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,340 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">정춘자</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">모</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       5,254 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.07 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       3,854 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">신명희</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       8,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.10 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       8,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김동일</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사외이사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박재옥</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       1,576 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       1,576 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노태현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,888 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.14 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,888 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.14 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">선바이오(주)</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">자사주</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       7,997 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       7,997 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박효경</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">고종사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     24,402 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.32 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     24,402 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.32 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김선기</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       9,180 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.12 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노선애</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,965 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.16 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,965 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.16 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노문정</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       1,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">  0.02 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       1,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김태형</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김태오</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.01 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김준</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 남편</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       9,162 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.12 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     12,582 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.16 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백성현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       4,399 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.06 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       4,399 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.06 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백준현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       4,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       4,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">KIM SUN SOOK</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">배우자</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     38,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.50</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     38,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.50 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="256" HEIGHT="60">계</TD>
<TD ALIGN="CENTER" WIDTH="55" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">  3,232,427 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">42.14</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">  2,793,892 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">36.42</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="55" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;[ 소액주주현황 ]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소액주주</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,473</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,513</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97.35</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,819,997</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,670,540</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49.801</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK=" B">(주4) 정정 후&cr;</SPAN>VII. 주주에 관한 사항&cr;가. 최대주주 및 특수관계인의 주식소유 현황
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="682" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="371" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="685" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="326" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">노광</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="53" VALIGN="MIDDLE">최대주주 및 대표이사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">  2,503,040 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="53" VALIGN="MIDDLE">   32.63</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="53" VALIGN="MIDDLE">  2,111,947 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="53" VALIGN="MIDDLE">   27.53 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노완</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">    117,600 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    1.53 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">   118,800 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">   1.55 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">조학수</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     90,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    1.17 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     70,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.91 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노흥덕</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     74,300 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.97 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     74,300 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.97 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노찬</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">형</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     46,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">  0.60 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     44,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.57 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노수덕</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     15,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.20</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">조동환</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">매형</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     12,424 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.16</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       6,300 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.08 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노성두</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     31,200 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.41</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     31,200 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.41 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">이티에스소프트(주)</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제의 회사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     40,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.52 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     40,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.52 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">황은숙</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제수</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     39,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.51 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     39,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.51 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노순남</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">누이</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     17,938 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.23 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,294 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백기황</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌누이 남편</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김영옥</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처의 올케</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     20,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.26 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">전상룡</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">동서</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     15,900 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.21 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,826 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노경애</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌누이</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.15</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김경숙</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처의 누이</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     12,782 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.17 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     12,782 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.17 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박상갑</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 누이남편</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.15 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김능율</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">동서</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,340 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.13 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,340 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">정춘자</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">모</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       5,254 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.07 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       3,854 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">신명희</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">제의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       8,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.10 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       8,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김동일</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사외이사</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       5,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.07 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박재옥</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       1,576 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       1,576 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노태현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,888 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.14 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     10,888 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.14 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">선바이오(주)</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">자사주</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       7,997 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       7,997 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.10 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박효경</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">고종사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     24,402 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.32 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     24,402 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.32 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김선기</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 처</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     10,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.13 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       9,180 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.12 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노선애</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     11,965 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.16 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     11,965 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.16 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">노문정</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       1,500 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">  0.02 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       1,500 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.02 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김태형</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김태오</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">처 조카</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.01 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">         880 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.01 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">김준</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 남편</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       9,162 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.12 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     12,582 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.16 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백성현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       4,399 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">   0.06 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       4,399 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.06 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">백준현</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">사촌의 자녀</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       4,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       4,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.05 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">KIM SUN SOOK</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">배우자</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">
<P>보통주</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">     38,000 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">     0.50</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">     38,000 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">    0.50 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">박재순</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">관계회사 임원</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">       8,890 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">0.12 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">       8,980 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">0.12</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="256" HEIGHT="60">계</TD>
<TD ALIGN="CENTER" WIDTH="55" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">  3,241,317 </TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">42.26 </TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">  2,802,872 </TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">36.54 </TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="55" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="65" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="66" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;[ 소액주주현황 ]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소액주주</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,472</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,513</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97.29</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,811,017</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,670,540</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49.68</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>&cr;</P>
<PGBRK></PGBRK>
</CORRECTION>

<SECTION-1 AID="CEO-CERT-COR" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT_COR">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">확인서_1.jpg</IMG>
<IMG-CAPTION ATOC="N">확인서_1</IMG-CAPTION>
</IMAGE>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">확인서.jpg</IMG>
<IMG-CAPTION ATOC="N">확인서</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>
</LIBRARY>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;</P>
<P USERMARK="F-16">                                    (제 24기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021 년    5 월   7 일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">선바이오 주식회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">노 광</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">경기도 군포시 산본로 95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 031-423-5467</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.sunbio.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 이사                  (성  명) 이성훈</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 031-423-5467</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P></P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">대표이사 등의 확인서.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사 등의 확인서</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>

<P>&cr;
<SPAN USERMARK=" B">1. 연결대상 종속회사 개황</SPAN>&cr;보고서 작성기준일 현재 해당사항이 없습니다.&cr;&cr;
<SPAN USERMARK=" B">2. 회사의 법적, 상업적 명칭&cr;</SPAN>당사의 명칭은 선바이오 주식회사라 칭하고, 영문명으로는 SunBio,Inc.라 표기합니다. 단, 약식으로 표기할 경우에는 선바이오(주)라고 표기합니다.&cr;&cr;
<SPAN USERMARK=" B">3. 설립일자 및 존속기간&cr;</SPAN>당사는 1997년 7월 설립되어 현재까지 사업을 영위하고 있습니다.&cr;&cr;
<SPAN USERMARK=" B">4. 본사의 주소, 전화번호, 홈페이지 주소.&cr;</SPAN>(1) 주소 : 경기도 군포시 산본로 95&cr;(2) 전화번호 : 031-423-5467&cr;(3) 홈페이지 : http://www.sunbio.com&cr;&cr;
<SPAN USERMARK=" B">5. 중소기업 해당여부&cr;</SPAN>보고서 작성 기준일 현재 중소기업기본법 제2조 및 중소기업기본법 시행령 규칙 제3조제1항2호에 의거 중소기업에 해당합니다.
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">6. 벤처기업해당여부</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="594" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" USERMARK=" BC0XBEBEBE">구분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30" USERMARK=" BC0XBEBEBE">당사현황</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" USERMARK=" BC0XBEBEBE">발행번호</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" USERMARK=" BC0XBEBEBE">벤처기업지정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60">연구개발기업</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">확인일자 : 2021.02.22</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="60">제 20210101543호</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="60">기술보증기금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">유효일자 : 2023.02.21</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B">7. 주요사업의 내용 및 향후 추진하려는 신규사업&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>(1) 의약품 연구개발 생산 및 판매</SPAN>
</P>

<P>
<SPAN>(2) 의약품 개발관련 임상실험&cr;(3) 생체고분자유도체 사업&cr;상세한 내용은 본 보고서의 II.사업의 내용을 참조하시기 바랍니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">8. 공시서류 작성기준일 현재 계열회사의 총수, 주요계열회사의 명칭 및 상장여부&cr;</SPAN>
<SPAN>보고서 작성기준일 현재 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK=" B">&cr;9. 신용평가에 관한 사항&cr;</SPAN>
<SPAN>보고서 작성기준일 현재 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>
<P USERMARK=" B">10. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">코넥스상장</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="20160122">2016년 01월 22일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">부</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">해당사항없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>

<P>&cr;
<SPAN USERMARK=" B">가. 설립이후의 주요연혁</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="792">

<COLGROUP>
<COL WIDTH="56"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="665"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="674" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내 역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1996년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국 및 미국 특허출원 8건 (뇌졸중치료제, 항암활성제, 인공혈액, 패혈증치료제)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1997년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">선바이오(주) 설립 (총자본금 7억 5천만원, 국민창투 1/3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1998년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">PEG유도체 자체개발 성공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1998년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">선바이오(주) 연구소 설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1998년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국 및 미국 특허출원 10건 (PEG유도체 수건, LIPOSOME, PEG-LIPOSOME)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1999년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">PEG-SHOP 개설</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1999년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">특허등록 (항암활성제)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1999년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">벤처기업으로 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1999년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">뇌졸중치료제, 항암활성제의 전임상 독성시험 (급독성시험, 약리시험, 항원성시험)완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2000년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (총자본금 14억, 이수화학(주) 지분참여)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="150" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">2000년</TD>
<TD WIDTH="53" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">9월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (총자본금 15억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">사옥구입 이전 및 연구소 확장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">뇌졸중 치료제/인공혈액 영국에서 전임상시험 시작</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허등록 (뇌졸중치료제)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (총자본금 15억 5천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">2001년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (총자본금 15억 6천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">5월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">sunbio.com의 인터넷주소 매입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">5억원 규모의 선바이오 전환사채를 금창창투가 인수 및 주식전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">6억원 규모의 선바이오 전환사채를 기업은행이 인수함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (총자본금 16억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">Biogen사와 신약개발 공동추진</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">2002년</TD>
<TD WIDTH="53" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">BioVectra사와 생체고분자 북미지역 마케팅 계약체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">Amgen사와 신약개발 공동추진</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 (총자본금 18억 6천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">2003년</TD>
<TD WIDTH="53" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국특허 (#6,828,401 PEG-maleimide 제조방법)등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">인도의 INTAS PHARMA사와 PEG-GCSF, PEG-IFN 공동개발 (당사의 기술수출)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">2004년</TD>
<TD WIDTH="53" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (hexa-arm PEG 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (PEG-EPO 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (PEG-interferon GCSF 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (PEG-interferon beta 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (PEG-interferon alpha 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">인도의 Serum Institute of India와 PEG-GCSF, PEG-IFN, PEG-EPO 공동개발. (당사의 기술수출)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">2005년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (PEG-propionaldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국특허 (#6,858,736 hexa-arm PEG 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국특허 (#6,956,135, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국특허 (#6,916,962, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국의 BioSite 사와 공급 및 기술계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국의 CytImmun Sciences사와 공급 및 기술계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">2006년</TD>
<TD WIDTH="53" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">4월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국의 Cartilix사와 공급 및 기술계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국특허 (#7,257,845, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">미국특허 (#7,041,855, PEG-aldehyde 제조방법) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">2007년</TD>
<TD WIDTH="53" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">9월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">NEUPEG (선바이오 신약1호)이 인도 및 세계시장에서 출시 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허(모발페길레이션기술) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2012년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (구강건조 치료제 기술) 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">2014년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">NEUPEG (PEG-GCSF) EU에서의 임상완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">NEUPEG (PEG-GCSF) 미국에서의 임상완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">PEG-인터페론 (C형 간염체료제) 인도에서의 제품승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">NEUPEG의 미국 FDA filing 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="210" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">2015년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">대우스팩2호와 스팩합병 IPO심사 청구 (5월 철회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (구강건조증 치료제 기술) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">SL인베스트먼트로 부터 전환상환 우선주 5만주(주당4만원)발행 -12월 보통주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국투자파트너스로 부터 전환상환 우선주 5만주(주당4만원) 발행-12월 보통주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">코스닥 IPO청구 (11월 보호예수동의 문제로철회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자본금 100% 무상증자 (총자본금 38억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">코넥스 상장 신청서 (보고서) 제출 - 2016년 1월 22일 코넥스 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">2016년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">코넥스 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 100,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">한국특허 (폴리에틸렌글리콜 수화젤 주사제) 등록</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 25,000천주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">본점 소재지 이전 (경기도 군포시 산본로 95)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">코스닥 IPO청구 (미승인 결정)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">2017년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">지정자문인 및 유동성 공급계약 변경 (하나금융투자)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 68,500주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">자기주식처분 (400주, 소재불명 원소유주에게 반환)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">Intas사 PEG-filgrastim 바이오시밀러를 EMA에 MAA 파일링</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">2018년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 10,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">Apotex사의 Lapelga, Health Canada의 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">9월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">PELGRAZ (PEG-filgrastim)의 EU 승인 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="240" ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE">2019년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">선바이오-팬젠 바이오베터 의약품 공동개발 협약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">Apobiologix가 LapelgaTM를 캐나다에서 launching </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 부여 (보통주식 35,000주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권 19,600주 행사 (총자본금 38억)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">2019 필라델피아 바이오 박람회참가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">Apotex사의 Lapelga, 호주 TGA의 승인 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">구강건조증치료제 MucoPEG 미국 FDA 판매허가 획득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">MucoPEG - 아일랜드 더블린 소재 Meroven사와 MOU체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="65" HEIGHT="203" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">2020년</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">MucoPEG - MENA 지역 판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">인공혈액 미국특허 출원 (Novel Modified Hemoglobin as Blood Substitute / 출원번호: 63/044,579)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">10월</TD>
<TD WIDTH="674" HEIGHT="53" VALIGN="MIDDLE">차세대 페길레이션 기술 미국 특허 취득 (3차 알콕시 폴리에틸렌 글리콜 및 이의 유도체 (TERTIARY ALKOXY POLYETHYLENE GLYCOL AND DERIVATIVESTHEREOF))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">구강건조증치료제 MucoPEG의 Post-approval 미국 임상시험 시작 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">MucoPEG 기술이전 계약 체결 (중국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월</TD>
<TD WIDTH="674" HEIGHT="30" VALIGN="MIDDLE">BioSciences사와 MOU 체결 (PEG-filgrastim개발)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">나. 경영진의 변동사항</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="698">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="225"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="92" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="186" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>변경 전</P>
</TH>

<TH WIDTH="186" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>변경 후</P>
</TH>

<TH WIDTH="234" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비 고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>대표</P>
<P>이사</P>
</TH>

<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>이 사</P>
</TH>

<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>감 사</P>
</TH>

<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>대표</P>
<P>이사</P>
</TH>

<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>이 사</P>
</TH>

<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>감 사</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.07.02</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>노 광</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김동일</P>
<P>정동준</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김형빈</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>노 광</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김동일</P>
<P>정동준</P>
<P>김판균</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김형빈</P>
</TD>

<TD WIDTH="234" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김판균 사내이사 취임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2018.03.21</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>노 광</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김동일</P>
<P>정동준</P>
<P>김판균</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김형빈</P>
</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노 광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김동일&cr;김판균</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="234" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정동준 사외이사 퇴임&cr;김형빈 감사 퇴임&cr;정유근 감사 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2019.01.03</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노 광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김동일&cr;김판균</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노 광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김동일&cr;김판균&cr;주우식</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="234" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">주우식 사외이사 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.31</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노 광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김동일&cr;김판균&cr;주우식</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노 광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김동일&cr;주우식</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="234" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김판균 사내이사 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2021.03.29</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노 광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">김동일&cr;주우식</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">노광</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">안응호&cr;이성훈&cr;주우식</TD>
<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">정유근</TD>
<TD WIDTH="234" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">안응호 사내이사 취임&cr;이성훈 사내이사 취임&cr;정유근 감사 재선임</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>

<P>&cr;
<SPAN USERMARK=" B">가. 증자(감자)현황</SPAN>
</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="623" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="317"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="326" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="623" BORDER="1">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="423" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="81" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" AUNIT="INC_DT" AUNITVALUE="20190517">2019.05.17</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="53" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="53" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="66" HEIGHT="53" ACODE="INC_CNT">19,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="81" HEIGHT="53" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACODE="INC_SL_AMT">16,130</TE>
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ALIGN="CENTER">주식매수선택권 행사</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">나. 미상환 전환사채 발행현황</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">2_미상환전환사채발행현황</FILENAME>

<TABLE-GROUP ACLASS="CB" ADELETETABLE="N">
<TITLE ATOC="N">미상환 전환사채 발행현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1103" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="797"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="806" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1105" BORDER="1">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="73"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="125" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">종류＼구분</TH>
<TH WIDTH="65" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">회차</TH>
<TH WIDTH="91" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">발행일</TH>
<TH WIDTH="91" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">만기일</TH>
<TH WIDTH="112" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="89" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환대상&cr;주식의 종류</TH>
<TH WIDTH="100" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환청구가능기간</TH>
<TH WIDTH="163" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환조건</TH>
<TH WIDTH="187" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">미상환사채</TH>
<TH WIDTH="82" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환비율&cr;(%)</TH>
<TH WIDTH="85" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가액</TH>
<TH WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="70" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="125" HEIGHT="76" ACODE="CB_KND" ALIGN="CENTER" VALIGN="MIDDLE">무기명식 이권부 사모 전환사채</TE>
<TE WIDTH="65" HEIGHT="76" ACODE="CB_SEQ" ALIGN="CENTER" VALIGN="MIDDLE">제3회</TE>
<TU WIDTH="91" HEIGHT="76" AUNIT="CB_DT" AUNITVALUE="20190513" ALIGN="CENTER" VALIGN="MIDDLE">2019.05.13</TU>
<TU WIDTH="91" HEIGHT="76" AUNIT="CB_FDT" AUNITVALUE="20220513" ALIGN="CENTER" VALIGN="MIDDLE">2022.05.13</TU>
<TE WIDTH="112" HEIGHT="76" ACODE="CB_EN" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000</TE>
<TE WIDTH="89" HEIGHT="76" ACODE="CB_KN" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TE>
<TE WIDTH="100" HEIGHT="76" ACODE="CB_PE" ALIGN="CENTER" VALIGN="MIDDLE">2020.05.14&cr;~&cr;2022.05.04</TE>
<TE WIDTH="78" HEIGHT="76" ACODE="CB_RAT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="85" HEIGHT="76" ACODE="CB_PR" ALIGN="RIGHT" VALIGN="MIDDLE">22,200</TE>
<TE WIDTH="117" HEIGHT="76" ACODE="CB_AMN" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000</TE>
<TE WIDTH="70" HEIGHT="76" ACODE="CB_CN" ALIGN="RIGHT" VALIGN="MIDDLE">90,090</TE>
<TE WIDTH="82" HEIGHT="76" ACODE="NOTE" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">합 계</TD>
<TD WIDTH="65" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="91" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="91" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="112" HEIGHT="30" ACODE="CB_ENT" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000</TE>
<TE WIDTH="89" HEIGHT="30" ACODE="CB_KNT" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
<TD WIDTH="100" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="78" HEIGHT="30" ACODE="CB_RATT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="85" HEIGHT="30" ACODE="CB_PRT" ALIGN="RIGHT" VALIGN="MIDDLE">22,200</TE>
<TE WIDTH="117" HEIGHT="30" ACODE="CB_AMNT" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000</TE>
<TE WIDTH="70" HEIGHT="30" ACODE="CB_CNT" ALIGN="RIGHT" VALIGN="MIDDLE">90,090</TE>
<TE WIDTH="82" HEIGHT="30" ACODE="NOTET" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P USERMARK=" B">가. 주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="635" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="297" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="636" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">-</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">50,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_ISU_STK1">50,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">7,670,540</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_ISU_STK2">7,670,540</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">7,670,540</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_ISU_STK3">7,670,540</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">7,997</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_TRS_STK">7,997</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">7,662,543</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30" ACODE="SUM_FLT_STK">7,662,543</TE>
<TE VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">나. 자기주식 취득 및 처분현황&cr;</SPAN>보고서 작성 기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">다. 종류주식(명칭) 발행현황&cr;</SPAN>보고서 작성 기준일 현재 해당사항 없습니다.&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">7,670,540</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="83" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="53" ACODE="ISN_STK">7,997</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="53" ACODE="VOT_NOTE1">상법 제369조 2항 자기주식</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">7,662,543</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>

<P>&cr;
<SPAN USERMARK=" B">가. 배당에 관련한 정관 기재사항&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="904">제11조의3(신주의 배당기산일)&cr;이 회사가 유상증자, 무상증자 및 주식배당에 의하여 신주를 발행하는 경우 신주에 대한 이익의 배당에 관하여는 신주를 발행한 때가 속하는 영업년도의 직전영업년도말에 발행된 것으로 본다.&cr;&cr;제44조(이익금의 처분)&cr;이 회사는 매사업년도의 처분전리익잉여금을 다음과 같이 처분한다.&cr;1. 이익준비금&cr;2. 기타의 법정적립금&cr;3. 배당금&cr;4. 임의적립금&cr;5. 기타의 이익잉여금처분액&cr;&cr;제45조(이익배당)&cr;①이익의 배당은 금전, 주식 및 기타의 재산으로 할 수 있다. &cr;②제1항의 배당은 매결산기말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게 지급한다. &cr;&cr;제45조의2(중간배당)&cr;①회사는 이사회의 결의로 6월30일 24시 현재의 주주에게 상법에서 정한 중간배당을 할 수 있다.&cr;②제1항의 중간배당은 이사회의 결의로 하되, 그 결의는 제1항의 기준일 이후 45일 내에 하여야 한다.&cr;③중간배당은 직전결산기의 대차대조표상의 순재산액에서 다음 각 호의 금액을 공제한 액을 한도로 한다.&cr;1. 직전결산기의 자본의 액&cr;2. 직전결산기까지 적립된 자본준비금과 이익준비금의 합계액&cr;3. 상법시행령에서 정하는 미실현이익&cr;4. 직전결산기의 정기주주총회에서 이익배당하기로 정한 금액&cr;5. 직전결산기까지 정관의 규정 또는 주주총회의 결의에 의하여 특정목적을 위해 적립한 임의 준비금&cr;6. 중간배당에 따라 당해 결산기에 적립하여야 할 이익준비금&cr;④사업년도개시일 이후 제1항의 기준일 이전에 신주를 발행한 경우(준비금의 자본 전입, 주식배당, 전환사채의 전환 청구, 신주인수권부사채의 신주인수권 행사에 의한 경우를 포함한다)에는 중간배당에 관해서는 당해 신주는 직전사업년도말에 발행된 것으로 본다.&cr;&cr;제46조(배당금지급청구권의 소멸시효)&cr;①배당금의 지급청구권은 5연간 이를 행사하지 아니하면 소멸시효가 완성한다.&cr;②제1항의 시효의 완성으로 인한 배당금은 이 회사에 귀속한다.</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P USERMARK=" B">나. 주요배당지표&cr;
<SPAN USERMARK=" !B">당사는 사업보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제24기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제23기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제22기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">48_과거배당이력</FILENAME>
<P USERMARK=" B">다. 과거 배당 이력</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK=" B">가. 정관 변경 이력&cr;</SPAN>당사는 공시대상기간중 정관 변경 이력이 없습니다.
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-16 B">1. 사업의 개요</SPAN>
<SPAN USERMARK="F-16"></SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">가. </SPAN>
<SPAN USERMARK=" B">업계 현황 및 전망</SPAN>
</P>
<P>&cr;(1) 시장의 특성</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(가) 바이오시</SPAN>
<SPAN>밀러의 구분</SPAN>
</P>

<P>
<SPAN>  </SPAN>
<SPAN>바이오의약품이란 사람이나 다른 생물체에서 유래하는 세포, 단백질, 유전자 등을 그 원료 또는 재료로 하여 제조한 생물학적 제제, 유전자재조합 의약품 및 세포배양 의약품, 그리고 세포치료제와 유전자 치료제 등을 포함하는 의약품으로 정의할 수 있습니다. 바이오시밀러는 "이미 제조판매·수입품목 허가를 받은 바이오의약품 품목(Reference Drug; 오리지널 의약품)과 품질 및 비임상/임상적 비교동등성(Comparability)이 입증된 생물의약품”으로 식품의약품안전처에서 정의하고 있습니다. 일반 화학적 합성 복제의약품(Generic)은 원료와 제조방법에 상관없이 오리지널 합성의약품과 같은 효능을 가지므로 임상시험이 필요 없어 저렴한 비용에 개발이 가능하지만, 바이오시밀러는 살아있는 세포를 이용하여 단백질을 추출, 의약품을 생산하기 때문</SPAN>
<SPAN>에 사용하는 세포, 배양조건, 정제방법 등에 따라 효능이 달라질 가능성이 높습니다. 따라서 임상시험을 통해 오리지널 바이오의약품과의 동등성(similarity)을 증명하는 것이 가장 중요합니다. </SPAN>
</P>
<P>  </P>
<P>(나) 바이오시밀러 시장의 특성</P>

<P>
<SPAN>  바이오시밀러는 일반적으로는 세포 배양 혹은 유전자 재조합을 통해 생산되는 단백질이나 호르몬 등의 형태입니다. 그리고, 바이오신약에 비해 상대적으로 개발비용 및 개발기간을 절감할 수 있고, 제품 가격이 바이오신약의 약 70% 수준이며, 이미 검증된 제품을 생산하기 때문에 단기간에 성장이 가능하다는 장점이 있습니다.  또한 세계 각국이 의료비 재정부담을 축소하고, 의약품에 대한 환자 접근성 개선 등을 위해&cr;아태 시장을 중심으로 신약 의약품 대비 저렴한 복제약 사용을 장려할 것으로 보여 바이오시밀러 시장이 급격히 확대될 전망입니다.&cr;의</SPAN>
<SPAN>료비 지출 비중 및 바이오 의약품 소비액이 가장 높은 미국도 의료 재정 절감을 위해 바이오시밀러의 사용을 권장하는 추세이며, FTC(연방거래위원회)는 바이오시밀러가 2020년까지 11개의 블록버스터 특허 만료로 약 0.3조달러를 절약할 수 있다고 전망 한 봐 있습니다. 현재 미국의 바이오시밀러 침투율이 유럽과 비교하여 상당히 낮지만 꾸준한 지원으로 침투율이 서서히 상승하고 있습니다. &cr;</SPAN>
<SPAN>  </SPAN>
<SPAN></SPAN>
</P>
<P>(다) PEG 유도체 시장의 특성  </P>

<P>
<SPAN>PEG 유도체 시장에서 미국의 Nectar 사, 일본의 NOF사, 중국의 Jenkem사 등이 </SPAN>
<SPAN>당사의 경쟁업체입니다. PEG 유도체의 품질은 당사가  우수하며, 많은 회사들이 당사의 제품을 스탠다드로 사용하고 있기도 합니다. </SPAN>
</P>
<P>PEG 유도체의 활용분야는 매우 넓으며 다양합니다. 신약 및 바이오시밀러와 같은 의약품 분야에서부터 의료용 봉합제 및 성형 필러와 같은 의료용 제품 그리고 PEG 유도체의 결합기술을 이용한 바이오칩 및 ELISA와 같은 진단기기 등에도 사용됩니다.</P>
<P>당사는 PEG 유도체 개발 및 생산에 관한 특허를 보유하고 있으며 이에 따른 기술 우위를 확보하고 있으며 부가가치가 매우 높습니다. 당사의 PEG 유도체 사업은 신약개발(의약품개발) 및 바이오시밀러 의약품 개발과 긴밀하게 연결되어 있는 특징을 가지고 있으며 타 산업에 비해 연구 개발 비중이 높은 차별성을 보유하고 있습니다.</P>
<P>  </P>
<P>(2) 시장 규모 및 전망</P>

<P>
<SPAN>  </SPAN>
<SPAN></SPAN>
</P>
<P>(가) 바이오시밀러 시장 현황 및 전망</P>

<P>
<SPAN> </SPAN>
<SPAN>세계 바이오시밀러 시장은 2017~2023년 연평균 30.6%로 고성장하여 2017년 97억 달러에서 2023년 481억 달러에 이를 전망이라고 합니다. 세계 바이오의약품 시장이 2017년 2,300억 달러에서 연평균 8.4%로 성장하여, 2023년 3,700억 달러로 확대하는 가운데, 전체 바이오의약품 중 바이오시밀러 비중은 2017년 4.2%에서 2023년 12.9%로 급증할 것으로 전망하고 있습니다. (Frost & Sullivan, 2019)&cr;</SPAN>
<SPAN>전체 바이오의약품 시장의 약 74%를 바이오의약품 매출 상위 10대 기업이 차지하고 있으며, 바이오신약 개발사인 다국적 제약업체 뿐 아니라 합성의약품을 제조하는 대형업체(Pfizer, Merck등), 제네릭 선두업체들(Teva, Sandoz 등)도 M&A 등을 통해 적극적으로 바이오시밀러 시장에 진입하고 있습니다. 즉, 바이오시밀러 시장 전망에 따라 기업간 경쟁이 매우 심화될 전망입니다. 관계 당국은 시장이 더 경쟁적으로 되면 바이오시밀러 제품 가격이 떨어져 환자 접근성이 더 높아질 것으로 기대합니다.&cr;미국 FDA도 의료비 비용 절감을  위해 2018년 7월 출범한 Biosimilar Action Plan을 통해 바이오시밀러의 시장 출시 기간을 단축하고 승인 절차를 가속화하고 있습니다(EvaluatePharma, 2018).  주요 오리지널 바이오 의약품들의 특허 만료를 앞둔 시점에 바이오시밀러는 오리지널 제약사들에게는 위험 요인이자 그 외 제약사들에게는 기회가 될 것입니다. 2022년까지 주요 오리지널 바이오 의약품 약 28개의 특허 만료가 예상되며, 향후 5년 동안 약 10개의 주요 바이오 의약품(약 1,590억달러 규모)의 특허 만료를 앞두고 있어 바이오시밀러 시장은 더욱 급속히 확대될 것으로 전망됩니다. </SPAN>
</P>
<P>  </P>
<P>(나) PEG 유도체 시장 규모 및 전망</P>
<P>  </P>
<P>1) PEG 유도체 시장 규모</P>

<P>
<SPAN>  </SPAN>
<SPAN>PEG 유도체 시장 매출 규모를 추정하기 위해 PEG 유도체를 연구개발 및 생산판매하고 있는 Nektar Therapeutics(미국)와 NOF Corp.(일본)의 연간 보고서(annual Report), PEG 유도체 후발주자인 Tianjin Jenkem Technology Co. ltd.(중국)의 매출 관련 기사들을 요약하여 추산하면</SPAN>
<SPAN> 약 1,360억원 정도의 시장을 형성 할 수 있을 것으로 예상하고 있습니다.</SPAN>
</P>
<P>  </P>
<P>2) PEG 유도체 사업 전망</P>

<P>
<SPAN>  </SPAN>
<SPAN>중국시장의 성장과 기존 신약의 특허가 만료됨에 따라 </SPAN>
<SPAN> PEG 유도체를 이용한 바이오시밀러 제품의 출시 및 </SPAN>
<SPAN>시장점유율이 증가함에 따라 PEG 유도체 시장은 점점 상승할 것으로 예상 할 수 있습니다.&cr;</SPAN>
</P>
<P USERMARK=" B">나. 회사의 현황</P>

<P>
<SPAN>&cr;(1) 사업 분야&cr;</SPAN>
<SPAN>당사는 "PEG(Poly Ethylene Glycol)"라고 하는 안전한 생체적합 고분자를 의약품 또는 기타 목표물의 표면에 화학적 공유결합으로 부착시키는 기술 즉, "PEGylation"  기술을 활용하여 바이오시밀러 의약품 및 신약개발을 통한 로열티와 기술이전(라이센싱 아웃)사업, 그리고 PEG 유도체 생산 및 합성을 통한 PEG 유도체 판매 사업을 진행하고 있습니다.</SPAN>
</P>

<TABLE WIDTH="630" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="244"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">사 업 분 야</P>
</TH>

<TH WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">내 용</P>
</TH>

<TH WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">현 황</P>
</TH>

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">수 익 구 조</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>바이오시밀러 사업</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="99">

<P>
<SPAN>PEG-GCSF, (</SPAN>
<SPAN>Lapelga™,Pelgraz™)&cr;</SPAN>
</P>
<P>PEG-interferon alpha</P>
<P>PEG-EPO </P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">

<P>
<SPAN>유럽, 캐나다, &cr;</SPAN>
<SPAN>제3시장 판매 </SPAN>
</P>
<P>인도허가 </P>
<P>/연구개발</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>기술 수익료 &cr; 및 로열티</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>신약 개발사업</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="99">
<P>인공혈액 SB1 개발</P>

<P USERMARK="F-12 0X1814FF">
<SPAN USERMARK="F-11 0X000000">연골 활액 충진제 개발</SPAN>
<SPAN USERMARK="F-11 0X000000"> &cr;</SPAN>
<SPAN USERMARK="F-11 0X000000">구강건조증 치료제 개발</SPAN>
<SPAN USERMARK="F-11 0X000000">*</SPAN>
</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">

<P>
<SPAN>비임상 및 &cr; 임상진행 중&cr;</SPAN>
<SPAN>*</SPAN>
<SPAN>FDA 510(k) 판매허가 획득</SPAN>
</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">

<P>기술 수익료 &cr; 및 로열티,&cr;
<SPAN></SPAN>
<SPAN></SPAN>제품매출
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>PEG 유도체 사업</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" HEIGHT="30">
<P>PEG 유도체 생산·판매 사업</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판매</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 매출</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="286" ALIGN="CENTER" HSPACE="0">pegylation 융합기술 기반 파이프라인.jpg</IMG>
<IMG-CAPTION ATOC="N">PEGylation 융합기술 기반 파이프라인</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>당사의 핵심기술인 PEGylation 기술은 </SPAN>
<SPAN>당사</SPAN>
<SPAN>의 창업 당시인 1997년에는 국내에서 생소한 기술이었습니다. 하지만 노광 대표이사는 향후 PEGylation 기술이 신약개발과 바이오시밀러 분야의 핵심 기술이 될 것을 예견하고, PEG 유도체 제조 기술 및 십 년 이상 PEGylation 기술을 연구 개발하며 쌓아온 기술력을 바탕으로 1997년 선바이오㈜를 창업하게 되었습니다.</SPAN>
</P>
<P>  </P>

<P>
<SPAN>1999년부터 수익 사업인 PEG 유도체 생산판매 사업을 시작하였고, 소량 다품종 사업으로서 현재 세계 50여 곳의 거래처에 공급하고 있습니다. 대부분의 거래처는 신약, 의료기기, 성형 제품의 개발에 </SPAN>
<SPAN>당사</SPAN>
<SPAN>의 PEG 유도체를 사용하고 있으며, 많은 거래처들은 임상을 진행하고 있습니다. 그들의 임상이 성공적으로 완료되고 시장에 제품을 출시하게 되면 </SPAN>
<SPAN>당사</SPAN>
<SPAN>의 PEG 유도체 매출도 더불어 증가할 것으로 예상합니다.</SPAN>
</P>

<P>
<SPAN>  &cr;</SPAN>
<SPAN>당사의 핵심기술인 PEGylation (페길레이션)의 파급효과는 신약, 바이오시밀러, 의료기기, 진단기기, 분석기기, 성형제품 등을 아우릅니다. 당사는 20여년간 이 분야에 집중한 꾸준한 연구개발을 통하여 다수의 바이오의약품을 세계시장에 출시하였고, 더불어 다수의 바이오의약품 파이프라인을 보유하고 있습니다. 당사는 앞서가는 PEGylation 기술개발, 제형의 완성, 특허 등록에 힘쓰고, 임상 등 제품까지의 개발은 제휴업체를 통하여 완성하는, 그러한 기술이전 라이센싱을 통한 비용의 효율화와 전문성의 극대화를 추구하여 다수 제품화(바이오시밀러, 의료기기)에 성공하였습니다.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="324" ALIGN="CENTER" HSPACE="0">peg 의약품의 full spectrum 상품화 능력.jpg</IMG>
<IMG-CAPTION ATOC="N">PEG 의약품의 full spectrum 상품화 능력</IMG-CAPTION>
</IMAGE>
<P></P>

<P>
<SPAN>기술 이전(라이센싱 아웃) 수익을 위한 바이오시밀러에 대한 꾸준한 연구개발로 2003년 동사의 기술력으로 개발하여 기술 이전 한 PEG-filgrastim의 바이오시밀러 Neupeg™은 2007년 인도 판매승인 후, 2018년 4월 5일 Lapelga(Apotex; Apobiologix)의 캐나다 품목 승인을 획득하였습니다. 또한, 2018년 9월에는 동일제품이 유럽의약품청(EMA)로부터 Pelgraz(Intas Pharmaceuticals 제조; Accord Healthcare 판매)'의 상품명으로 판매 허가승인을 획득하였습니다. &cr;또한, 2019년 11월 동사의 구강건조증 치료제인 MucoPEG™이 FDA 510(k)로 판매승인을 획득하여 추후 기술이전 및 제품 매출을 기대하고 있습니다. &cr;바이오시밀러 사업의 성공에 기인하여 동사는 향후 큰 폭의 수익을 기대할 수 있게 되었고, 이에 힘입어 동사가 원천기술을 보유하고 있는 인공혈액과 뇌졸중 응급처치제, 연골활액 충진제 등 다양한 신약 개발을 진행하고 있습니다. </SPAN>
</P>
<P>&cr;(2) 제품 설명  </P>
<P>(가) 바이오시밀러 사업; 로열티 및 기술이전 제품</P>

<TABLE WIDTH="629" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="26"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="264"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="35" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">No.</P>
</TH>

<TH WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">품 목</P>
</TH>

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">기능 / 용도</P>
</TH>

<TH WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">특징</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">세계시장 &cr;규모(조원)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="35" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>1</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" HEIGHT="191">
<P>PEG-&cr;filgrastim</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="191">
<P>호중구감소증 치료제</P>
<P>;고형암 및 악성림프종에 대한 세포독성화학요법을 투여 받는 환자</P>
</TD>

<TD WIDTH="273" VALIGN="MIDDLE" HEIGHT="191">
<P>PEG-filgrastim 바이오시밀러</P>
<P>인도 Intas 사에 기술이전 및 라이센싱 아웃</P>
<P>2007년 인도 의약품 승인</P>

<P USERMARK="F-12">
<SPAN USERMARK="F-11">2014년 유럽 및 미국 임상완료&cr;2014년12월 미국FDA filing&cr;</SPAN>
<SPAN USERMARK="F-11">2</SPAN>
<SPAN USERMARK="F-11">0</SPAN>
<SPAN USERMARK="F-11">18년 4월 5일 Lapelga 캐나다 승인&cr;2018년 9월27일 Pelgraz EU 승인</SPAN>
</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>5*</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="35" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" HEIGHT="76">
<P>PEG-&cr;interferon&cr;alpha</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="76">
<P>B, C형 간염 치료제</P>
</TD>

<TD WIDTH="273" VALIGN="MIDDLE" HEIGHT="76">
<P>PEG-interferon alpha 바이오시밀러</P>
<P>2014년 인도 의약품 승인</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P><1</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>* Amgen 사 </SPAN>
<SPAN>2016</SPAN>
<SPAN> Annual report&cr;&cr;</SPAN>
<SPAN>당사가 개발에 성공한 바이오시밀러 중 대표적인 제품인 PEG-filgrastim은 항암 치료 시 사용되는 호중구감소증 치료제(백혈구생성촉진제)로, 오리지널 의약품 제조사인 암젠에 따른 세계 시장규모는</SPAN>
<SPAN> 5조원</SPAN>
<SPAN>(2016년 Amgen 사 Annual report; $</SPAN>
<SPAN>4,648백만)이나,</SPAN>
<SPAN>  </SPAN>
<SPAN>Credence Research, Inc.의 시장보고서에 따르면 2016년 약 8조 7천억원(US$ 7.71십억)이며, 2017년부터 2025년까지 연평균5.6%로 성장하여 2025년까지 약 14조원(US$ 12.56십억)에 이를 것으로 예상합니다. &cr;</SPAN>
<SPAN>여러 형태의 암 발생률이 증가하기 때문에 화학요법으로 유발되는 호중구 감소증 치료제 시장은 상당한 성장을 보일 것으로 예측하며, 호중구감소증 치료제 중 filgrastim을 기반으로 한 제품이 가장 큰 시장을 형성하며, 또한 전체 위험도가 높은 화학요법 환자들을 대상으로 filgrastim의 예방 치료법이 권고되어, filgrastim의 시장은 더욱 성장 할 것으로 예측합니다.</SPAN>
<SPAN> 바이오시밀러 제품은 오리지널 신약의 복제품으로 임상시험을 통해 오리지널과의 생물학적 효능</SPAN>
<SPAN>의 동등성 및 안전성을 입증하고 미국 FDA 등 관련 기관의 품목허가 승인을 획득하여야 시장에 출시할 수 있습니다.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="156" ALIGN="CENTER" HSPACE="0">pegfilgrastim.jpg</IMG>
<IMG-CAPTION ATOC="N">Pegfilgrastim 바이오시밀러</IMG-CAPTION>
</IMAGE>
<P></P>

<P USERMARK=" 0X54AF00"> 
<SPAN USERMARK=" 0X000000">Neupeg™의 제조 관련 기술은 동사가 2003년 인도의 Intas 사에 기술이전 하였으며, Intas 사는 미국 및 유럽 선진시장에 진출하기 위하여 캐나다의 Apotex 사와 제휴를 맺고, 2014년 중반에 유럽과 미국에서의 임상을 완료하였습니다. 이후, 2018년 4월 5일Lapelga(Apotex; Apobiologix)의 캐나다 품목 승인, 2018년 9월 27일 유럽의약품청(EMA)으로부터 Pelgraz(Intas;Accord Health)'의 허가 승인을 획득한 상태입니다.  미국 FDA에는 filing 후 현재 심사 중입니다.</SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>PEG-filgrastim의 바이오시밀러인 Neupeg™(Pelgraz, Lapelga)은 독일을 시작으로2018년10월부터 유럽에 출시 판매되고 있습니다. 당사의 PEG-filgrastim 제품이 EU에서 승인받은 최초의 바이오시밀러였으나, 그후 6개의 제품이 더 EU에서 승인을 획득하여 현재 EU시장에서는 7개의 PEG-filgrastim 바이오시밀러가 오리지널과 함께 경쟁중입니다. 또한 당사가 승인을 기다리고 있는 미국시장에서는 현재 4개의 PEG-filgrastim 바이오시밀러가 승인을 받았습니다. 그중 Coherus사의 Udenyca가 시장의 20%를 차지하였다고 최근 발표되었습니다. &cr;&cr;</SPAN>(나) 신약개발 사업- 신약  및  의료용 제품 개발사업
</P>

<TABLE WIDTH="608" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="343"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">개별품목 </P>
</TH>

<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">사용처</P>
</TH>

<TH WIDTH="352" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">세계 시장규모 및 전망</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127">
<P USERMARK="F-12">SB 프로젝트</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127">
<P USERMARK="F-12">산소운반체;&cr;인공혈액,</P>
<P USERMARK="F-12">뇌졸중응급처치제등 허혈부위의 용이한 산소공급 용도</P>
</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="127">
<P USERMARK="F-12">세계 헌혈액 및 적혈구 기반 연구개발 제품 기준으로 인공혈액 시장규모를 산출, 뇌졸중 응급처치제 및 장기보존액 시장을 합산하여 약 200~500조 원으로 추정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="223">

<P USERMARK="F-12">
<SPAN>SynoGel</SPAN>
<SPAN></SPAN>
</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="223">
<P USERMARK="F-12">연골 활액 충진제</P>
</TD>
<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="223" USERMARK="F-12">2017년 세계 연골활액 충진제 시장은 3.4조원으로 골관절염 치료제시장(2017년 5.7조 원)의 59% 규모로 추정. 세계 골관절염 치료제 시장의 CAGR 6.8%, 국내는15.6%로 국내의 빠른 성장률을 전망.(출처: Hyaluronic acid products Market, Transparency Market Research, Polaris Market research 2017, Acute Market Reports 2017, Business wire 2017)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="295">
<P USERMARK="F-12">MucoPEG™</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="295">
<P USERMARK="F-12">구강건조증 치료제</P>
</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="295">
<P USERMARK="F-12">고령화 및 항암치료를 포함한 방사선 치료 등으로 인해 구강건조 환자가 증가하고 있으며, 따라서 암환자와 구강건조 환자 수는 비례적으로 증가하고 있음.</P>
<P USERMARK="F-12">전 세계 구강 건조증 치료제 시장규모는 2018년에 6억 2,530만($625.3 백만) 달러로 추정되었으며, 2019년부터 2026년까지 연평균 3.6% 성장할 것으로 예상함(출처: Xerostomia (Dry Mouth) Therapeutics Market Size, Share, Trends, & Industry Analysis Report, By Product ; By Distribution Channel; By Regions: Segment Forecast, 2019 - 2026).</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;1) SB프로젝트 (산소운반체/인공혈액)&cr;인간의 혈액은 인체 체중의 7~8 %에 해당하는 특수한 체액이며, 혈액은 산소와 영양소를 체세포로 운반하고 이산화탄소, 암모니아 및 기타 노폐물을 세포에서 다시 운반하는 중요한 기능을 수행합니다. 인간 혈액의 산소 운반 능력은 가장 중요한 적혈구 (RBC)에 기인하며, 인공 혈액 대체물(인공혈액)이 산소 운반 능력을 위해 RBC를 대체하는 대안으로 연구 및 개발하고 있습니다.&cr;인공혈액, 뇌졸중 응급치료제, 항암 활성제, 장기 보존액, 기타 허혈성 치료제로서 적용이 가능한 산소운반체는 인류 복지와 수명연장에 혁명적인 역할을 할 것으로 기대됩니다.</SPAN>
<SPAN USERMARK=" U"></SPAN>
<SPAN> 일반적인 인간의 혈액은 보관 수명이 42 일에 불과하므로 사용기간이 제한되기 때문에, 더 오랜 기간 동안 저장 될 수 있는 혈액 대체물의 개발이 필요하며, 또한 세포의 산소 부족으로 조직에 영구적인 손상을 가하여 환자의 생존에 영향을 미치는 부상 및 사고로 인한 급성 및 만성 출혈에도 매우 필요합니다.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="451" HEIGHT="332" ALIGN="CENTER" HSPACE="0">기존 헌혈액과 인공혈액.jpg</IMG>
<IMG-CAPTION ATOC="N">헌혈액과 인공혈액(적혈구 대체제, 인공산소운반체)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>흔히 일반인의 이해를 쉽게 하기 위한 목적으로서 이를 인공혈액(Artificial Blood) 또는 대체혈액(Blood Substitute)이라 명명하고 있습니다. 물론 혈액 대체용으로서, 즉  수술 시 수혈을 대체할 수 있는 용도의 시장이 가장 큽니다. 그리고 구급일선에서, 예를 들어 출혈이 심한 환자를 이송하는 경우 수혈용 전혈을 주입하는 것이 아니라, 혈액형에 관계없이 주사할 수 있는 인공혈액을 주입해주면 골든타임 동안의 손상을 예방할 수 있습니다. 미국 육군의 추산에 의하면, 응급일선에서 이런 용액이 있었다면 베트남 전쟁에서 사망한 병사 65,000명 중 35,000명은 살릴 수 있었을 것이라는 보고서가 있으며, 이후 미 육군은 인공혈액의 개발에 있어서 개발사들에게 많은 후원을 하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>즉, 인공혈액의 개발이 완료된다면, 혈액형 타입에 상관없이 빠른 수혈을 제공 받으며, 수혈로 인한 감염의 위험 없이 안전한 적용이 가능해짐, 대량 생산이 가능해지면서 혈액 수급 문제를 해결하며, 오랜 기간 저장 보관이 가능해 질 것으로 예상합니다. 응급 수혈을 위한 인공혈액 및 산소 운반체(뇌졸중 응급치료제, 항암 활성제, 장기 보존액, 기타 허혈성 치료제)의 적용은 인류 복지와 수명연장에 혁명적인 역할을 할 것으로 기대합니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>당사는 1997~2002년의 기간 동안 한 차례 인공혈액의 비임상을 완료하고 식약처에 IND 신청까지 한 경험이 있습니다. 따라서 이 프로젝트는 당사가 효율적으로 (재)개발을 진행할 수 있습니다. 그러나 1980년대부터 현재까지 세계적으로 10여 개에 가까운 개발사들이 인공혈액 개발을 시도하였고, 몇몇 개발사들은 임상 3상까지 진행되었으나, 아직 성공한 개발사는 없습니다</SPAN>
<SPAN>. </SPAN>
<SPAN>&cr;인공혈액 개발에 참여했던 회사로서는 Sangart, Northfield, Biopure, Baxter, Somatogen, Hemosol, Prolong Pharma. 사 등이 있습니다. 이 중 Sangart, Biopure, Northfield가 임상 3상까지, Prolong Pharma가 2상 까지 진행하였지만, 현재 이들 개발 업체들 가운데 Biopure사만이</SPAN>
<SPAN> 남아공과 러시아에서 승인을 받았고, 그외 선진시장에서 승인 및 상용화에 성공한 경우는 없습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사의 산소운반체 PEG-Hb; 인공혈액, 뇌졸중 응급처치제는 다음과 같은 특장점을 가집니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="543"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="552" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>장점</P>
</TD>

<TD WIDTH="552" VALIGN="MIDDLE" HEIGHT="99">
<P>▶ 분자규모의 산소운반체로 적혈구가 갈 수 없는 곳까지 산소 운반</P>
<P>▶ 정상세포로의 산소공급은 최소화하고 저산소상태의 뇌세포로의 산소공급량을</P>
<P>최대화하여 치료 후 회복율을 향상(p50값 : 10±2 mmHg)</P>
<P>▶ 일회투여로 지속적인 효과(비글견의 경우 체내 반감기 47～68시간)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특징</P>
</TD>

<TD WIDTH="552" VALIGN="MIDDLE" HEIGHT="53">
<P>바이오시밀러 의약품 개발에 사용되는 PEGylation 기술을 hemoglobin 유래 산소전달체에 적용</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>즉, 바이오시밀러 의약품 개발에 사용되는 PEGylation 기술을 헤모글로빈(hemoglobin)에 적용하여, 인공혈액, 뇌졸중 응급치료제, 항암 활성제 등 기타 허혈성 치료제로서 적용이 가능한 산소 운반체로 개발되고 있습니다. 거대분자인 적혈구와 달리 분자규모의 산소운반체로 적혈구가 갈 수 없는 곳까지 산소를 운반하는 것을 목표로 합니다. &cr;산소운반체의 가능성은 크나, 인공혈액이라는 큰 범위의 임상시험을 위한 대규모 투자에 앞서서, 일단 비교적 소규모이지만 임상의 실시와 결과가 보다 명확히 규정되는 뇌졸중응급처치 개발에 초점을 두고 있습니다. &cr;</P>

<IMAGE>
<IMG WIDTH="324" HEIGHT="263" ALIGN="CENTER" HSPACE="0">emb000027182255.jpg</IMG>
<IMG-CAPTION ATOC="N">[PEG헤모글로빈 산소운반체의 모식도]</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>(그림 설명: 혈전이나 경색으로 혈관이 좁아져 적혈구가 들어갈 수 없는 상황에서도 인공혈액은 쉽사리 통과하여 산소를 공급할 수 있습니다.)&cr;</SPAN>
<SPAN>&cr;혈전이나 출혈 등 원인에 관계없이, 사고 직후 투여하여, 사고 후 처치까지의 3~4 시간 동안 피가 안 통하는 혈전부위 뇌세포에 산소를 전달하는 것이 시험 프로토콜이며, 혈전뇌졸중의 경우에 혈전부위 뇌세포를 정상적으로 유지하는 것이 시험을 통해 확인되었습니다. 현</SPAN>
<SPAN>재, 지금까지 개발된 인공 혈액의 문제점을 개선하고자 헤모글로빈에 PEGylation 유도체 접합 외에 특수링커를 통한 헤모글로빈의 표면을 변형시킨 HBOC를 개발하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>2) SynoGel</SPAN>
<SPAN>™</SPAN>
<SPAN> (연골활액충진제)&cr;</SPAN>
</P>

<P>
<SPAN>골관절염(Osteoarthritis)은 뼈의 관절 면을 감싸고 있는 연골의 손상이나 퇴행성 변화로 관절 주변의 활액막(synovial membrane)에 염증이 생겨 통증이 유발되는 질환입니다. 고령의 연령층에서 흔히 볼 수 있는 질환이며 전 세계적인 고령화 추세에 따라 점차 증가하고 있습니다.  </SPAN>
<SPAN>현재까지 이러한 골관절염 치료는 </SPAN>
<SPAN>관절의 구조적 손상을 회복시켜주는 방향이 아닌, 증상 완화에 초점을 맞추어 통증을 줄이고 질병 심각도를 지연시킴으로써 관절의 기능을 유지시키는 </SPAN>
<SPAN>데 있었습니다. </SPAN>
<SPAN>&cr; </SPAN>
</P>

<P>
<SPAN>현재, 시판되고 있는 히알루론산 주사 제품들은 히알루론산 자체로 이루어진 제품과 가교된 히알루론산 젤로 나눠집니다. 히알루론산나트륨 수용액 제품인 Hyalgan?, Artz?, Euflexxa? 그리고, Orthovisc? 등은 분자량이 약 500,000～3,600,000 Da로 한번에 2 ml 씩 3회 반복 투여 시 또는 약 3개월, 5회 반복 투여 시 6개월의 통증완화 효과를 나타낸다고 합니다. 가교화된 히알루론산 형태의 시판 제품은 Synvisc?, Synvisc-one?, Durolane?, Gel-One? 그리고 가장 최근 미국FDA에서 승인된 Monovisc? 등이 있습니다.&cr;&cr;당사의 연골 활액 충진제 </SPAN>
<SPAN>SynoGel</SPAN>
<SPAN>™</SPAN>
<SPAN>의 특장점은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="543"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="552" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>장점</P>
</TD>

<TD WIDTH="552" VALIGN="MIDDLE" HEIGHT="99">
<P>▶ 무독성의 생체 폴리머</P>
<P>▶ PEG 분자의 보습성 및 점탄성</P>
<P>▶ 교차결합을 통한 하이드로젤 형성</P>
<P>▶ 기존 제품보다 연골 보호 효과의 지속성 증가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특징</P>
</TD>

<TD WIDTH="552" VALIGN="MIDDLE" HEIGHT="53">
<P>의료용 제품 및 나노테크놀로지 개발에 사용되는 PEGylation 기술을 연골 활액 충진제에 적용</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>SynoGel</SPAN>
<SPAN>™</SPAN>
<SPAN>은 생체 친화적인 고분자로 이루어진 하이드로젤로, 아민기를 갖는 PEG 유도체, 그리고 이 아민기와 반응하여 펩티드 결합을 형성할 수 있는 반응기를 갖는 PEG 유도체로 하이드로젤 제조 방법을 개발, 이를 국내특허등록(제10-2001-0028654)한 바 있고, 외과용 혈관 봉합제인 CoSeal?과 유사한 기술에 관절염 주사액에 사용되는 히알루론산 나트륨을 함유하여 하이드로젤의 유연성을 증가시킨 하이드로젤 관련 제품입니다. </SPAN>
</P>
<P>  </P>

<P>
<SPAN>하이드로젤은 수용액을 흡수하고 내포할 수 있어 생체조직과 유사하고, 산소, 영양분, 대사물질 같은 저분자 물질들에 대해 투과성을 가집니다. 또한, 팽윤된 하이드로젤의 표면은 부드러워서 생체 내에서 주위의 세포나 조직들과 마찰로 인한 자극을 줄일 수 있습니다. 이러한 하이드로젤에 반감기가 낮은 히알루론산을 포함시켜 생체 내에서 오래 지속되는 관절염 주사제로 개발하여, 관절에 1회 투여 시 분해되지 않고, 장시간 지속되어 오랜 진통효과(long-lasting analgesic effect)와 연골 보호효과를 얻을 수 있습니다.</SPAN>
<SPAN>&cr;  </SPAN>
</P>

<P>
<SPAN>또한, 기존 제품의 높은 점도에 따른 생체 내 투입 시 높은 투여압력 의한 통증을 감소시키기 위해, 하이드로젤의 가교화 시간을 조절하여 투입 시 낮은 점도로 투여가 용이하도록 하였으며, 투여 후 두 종류의 PEG 유도체가 반응하여 서서히 펩티드 결합을 형성하여 히알루론산을 포함한 점탄성이 우수한 하이드로젤을 형성하게 하였습니다. 이상과 같이 높은 생체적합성과 생체지속성을 나타내는 조성물을 관절 내 1회 주사하여 관절염 질환에 의해 유발된 통증 억제용 조성물, 또는 활막 염증 억제용 주사액 조성물을 완성하였습니다. </SPAN>
<SPAN>이 조성물과 관련하여 국내특허등록(10-1637883; 폴리에틸렌 글리콜 수화젤 주사제) 및 국제 PCT, 미국과 유럽에 출원을 완료하였습니다.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="515" HEIGHT="270" ALIGN="CENTER" HSPACE="0">synogel의 적용 모식도.jpg</IMG>
<IMG-CAPTION ATOC="N">[SynoGel의 적용 모식도]</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0X54AF00"></SPAN>
<SPAN>3.8조 원 규모의 연골 치료 시장 중 연골충진제(viscosupplementation) 시장이 1.7조 원(44%)이며, 매년 10% 이상의 성장이 예상됩니다. 골관절염은 전 세계적으로 매년 6천만 명 정도의 환자가 발생하고 있으며, 현재까지 완치를 위한 의약품이 개발되어 있지 않아 환자의 지속적인 증가와 혁신적인 치료제 개발 시 급성장이 예상되는 분야입니다. 다회 (3～5회) 투여로 인하여 환자의 치료 순응도가 낮아 지속시간을 연장하기 위한 다양한 연구개발 시도가 진행되고 있는데, 당사의 Synogel™에 의한 1회 투여로 기존 3～5회 투여 시의 효과 및 그 이상의 지속효과를 나타낸다면 환자의 순응도가 높아질 것이며, 그에 따라 과거 관절 치료를 적용할 수 없었던 환자에게도 적용이 가능해지고, 전체적으로 관절강 내 주사제 치료를 받는 환자 수가 증가하는 등의 효과를 보일 것입니다. Synogel 원료 PEG유도체에 방사성동위원소를 부착한 후 반감기(Half Life)시험을 완료하였으며, 비임상시험-생체적합성 시험(Biocompatibility test)을 해외 CRO 업체와 함께 일부 항목의 시험을 완료하였습니다. 비임상시험 일부 항목은 중소기업청 혁신과제의 지원을 받아 진행하였습니다. </SPAN>
<SPAN>&cr;</SPAN>
<SPAN> &cr; </SPAN>
<SPAN>3) MucoPEG</SPAN>
<SPAN>™ </SPAN>
<SPAN>(구강건조증치료제)&cr;</SPAN>
<SPAN>구강건조증(xerostomia)은 노화 또는 기타 질병 등과 같은 여러 가지 원인에 의하여 타액의 분비량 이 감소되어 구강 점막이 건조화 되거나, 항암 치료 시 수반하는 부작용으로서 점막이 파괴되어 발생하는 질환입니다. 타액은 구강의 주요기능을 원활하게 유지하고 구강 점막을 보호하는 중요한 역할을 하므로 타액 분비량이 감소되어 구강 건조증이 생기면 심한 구취와 충치가 발생하며, 정도에 따라 구강 점막의 작열감 또는 구강 점막의 궤양 등으로 심한 고통을 겪게 됩니다.</SPAN>
</P>
<P>노인성 구강건조증은 대체로 만성적인 타액 분비량 감소 및 여러 약물복용에 의한 현상으로 나타나는데, 노인의 구강 건강과 건조로 예민해진 구강 점막에 자극적이지 않은 제품의 개발로 노년기 삶의 질을 향상시켜야 합니다. 또한, 인구 고령화, 암 진단기술 발달, 생활습관의 변화 등 여러 원인으로 암 발생이 증가하여 이들의 항암 및 방사선 치료과정에서 합병증 및 구강건조증이 증가하고 있습니다. 이외에도 고혈압, 당뇨 등 노인성 질환에 치료제로 사용되는 약 1,800개 약물의 부작용이 구강건조증을 유발한다는 보고도 있습니다.</P>
<P>따라서 기존의 처방이나 관리법에 의한 단시간의 보습효과 제품이 아닌 손상된 점막에 자극 없이 오랫동안 보습을 유지하고, 구강 내 세균 증식을 억제하여 구내염 및 구강건조증을 완화하는 제품의 개발이 필요합니다.</P>
<P>구강건조증의 치료에는 부교감신경 흥분성 약제(parasympathomimetic drugs) 중 콜린성 약재(pilocarpine(Salagen, MGI Pharmaceuticals., Minneapolis), Cevimeline(Evoxac); 하루 3～4회 식후복용, 약효지속은 2～4 시간)를 사용하여 타액의 분비를 촉진시키는 방법이 있습니다. 하지만 콜린성 약재는 신체의 다른 부위에도 영향을 미쳐 눈물이나 콧물의 분비를 증가시키거나 땀의 분비가 증가할 수 있습니다.</P>
<P>현재 국내에서는 인공타액(드라이문트-동아제약, Taliva액-한림제약)을 포함하여 구강건조증에 대한 다양한 치료법들이 제공되고 있으나, 제품의 만족도 및 처방 후 지속사용률이 낮다고 합니다.</P>

<P>
<SPAN>&cr;당사의 구강건조증 치료제 MucoPEG</SPAN>
<SPAN>™</SPAN>
<SPAN>의 특장점은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="544"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="553" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>장점</P>
</TD>

<TD WIDTH="553" VALIGN="MIDDLE" HEIGHT="99">
<P>▶ 무독성의 생체 폴리머</P>
<P>▶ PEG 분자의 흡수성과 보습성</P>
<P>▶ 구강점막의 아민 기(amine group)와 공유결합</P>
<P>▶ 구강점막에 공유결합 후 세포탈락 주기까지 지속</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특징</P>
</TD>

<TD WIDTH="553" VALIGN="MIDDLE" HEIGHT="53">
<P>바이오시밀러 의약품 개발에 사용되는 PEGylation 기술을 구강건조 환자의 구강점막에 적용</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<IMAGE>
<IMG WIDTH="419" HEIGHT="543" ALIGN="CENTER" HSPACE="0">구강건조증 치료제의 작용.jpg</IMG>
<IMG-CAPTION ATOC="N">[구강건조증 치료제의 작용]</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>현재, </SPAN>
<SPAN>MucoPEG</SPAN>
<SPAN>™</SPAN>
<SPAN>은 미국 비임상전문 GLP 인증업체에서 안전성(생체적합성)시험을 완료하고, 미국내 의료기기 등록 및 판매신고 510(k)를 제출 후, 2019년 11월 5일 판매허가 (Market Clearance Letter)를  FDA로부터 받았습니다. 미국 시장을 목표로 하여 구강제품 경험이 있는 미국 또는 글로벌 회사로의  기술이전을 통한 로열티 수익창출 및 PEG 유도체 공급을 계획하고 있습니다. </SPAN>
</P>

<P>
<SPAN USERMARK=" 0X54AF00"></SPAN>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="443" HEIGHT="228" ALIGN="CENTER" HSPACE="0">muco.jpg</IMG>
<IMG-CAPTION ATOC="N">MucoPEG-FDA 510(k) 획득</IMG-CAPTION>
</IMAGE>
<P></P>
<P>2020년 12월, 당사는 Guangzhou Bairui (No.51-4 East Xingang Road, Haizhu District, Guangzhou, China) 사와 공동으로 중국 광저우에서 소규모 예비적 임상시험을 진행하였습니다. 임상시험은 두경부암 방사선치료 후 발생한 구강건조증의 증상 및 통증을 호소하는 다수의 환자들을 상대로 진행하였으며, 3일간 MucoPEG™을 1일 1회 사용 후 구강건조증 증상의 변화를 환자 설문을 통해 확인하였습니다. 설문 문항에 대하여 1(poor), 2(fair), 3(good), 4(better), 5(best) 다섯 단계의 등급으로 스코어를 표시하였으며, 모니터링 항목으로써는 구강 내의 보습 효과, 보습효과의 지속성, 구강 내 통증의 정도, 말 할 때 통증의 정도, 식음료 섭취 시 통증의 정도, 취침 시 구강 건조증으로 인한 수면 장애의 여부 등 14개 항목에 대한 환자의 의견을 기록하였습니다. 그 결과 MucoPEG™ 사용 후 1일(1회) 경과 시점에는 대부분의 설문 항목에서 1~3의 스코어를 기록하였으나, 사용 후 2일 및 3일 경과 시점에서는 3~5의 스코어를 기록하여, 구강건조증 치료제 MucoPEG™의 우수한 효능을 입증하였습니다.</P>
<P>중국 예비임상 결과를 바탕으로 원활한 기술이전이 이루어졌으며, 중국내 MucoPEG™ 판매를 위한 허가를 준비하고 있습니다.   </P>
<P>또한, 미국 임상 CRO 업체인 NAMSA와 계약 체결 후, 구강 건조증 환자 40여명을 대상으로 GSK 사의 Biotene 가글 제품과 당사 MucoPEG™의 구강건조 완화 효과에 대한 비교 임상을 진행하고 있습니다. 특히 이번 미국 비교 임상시험은 기술이전을 위해 여러 글로벌 업체와 논의하던 중 업체의 요구사항으로 510(k) 판매허가 후에 추가적으로 진행되는 사항이며, 이 시험결과는 기술이전 시 당사 MucoPEG™의 효능 검증면에서 기술의 가치를 상승시킬 수 있는 중요한 시험이라 할 수 있습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(다) PEG 유도체 제품&cr;PEG유도체는 약리활성이 없는 생체 고분자로서 친수성과 소수성 특징(양친매성)을 동시에 가지기 때문에 물과의 친화력이 낮은 의약품과 단백질의 수용성 향상에 활용할 수 있고 의약품의 체내 반감기 증가 및 면역원성 조절에 효과적입니다.</SPAN>
</P>

<TABLE WIDTH="630" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="27"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="36" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">No.</P>
</TH>

<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">품 목</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">기능·용도</P>
</TH>

<TH WIDTH="341" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">특 징</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="36" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="82">
<P>1</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="82">
<P>mPEG</P>
<P>유도체</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="82">
<P>의약품, 바이오시밀러 제품, 진단기기</P>
</TD>

<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="82">
<P>-한 개의 작용기를 갖는 유도체</P>
<P>-신약개발 및 진단기기에 사용되어지는 중간체 물질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="36" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>2</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>PEG-di</P>
<P>유도체</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>성형 dermal filler</P>
<P>Drug Delivery System&cr;(약물전달시스템)</P>
</TD>

<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="103">
<P>-두 개의 작용기를 갖는 유도체 </P>
<P>-약물전달시스템, 성형필러 등에 사용되는 중간체 물질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="36" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>3</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>4-arm &cr;PEG &cr;유도체</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>의료기기 sealant&cr;(봉합사)</P>
<P>nanotechnology&cr;(나노기술)</P>
</TD>

<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="103">
<P>-4 개의 작용기를 갖는 유도체</P>
<P>-의료기기, 인공 봉합사, 나노기술에 사용되는 중간체 물질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="36" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>4</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>6-arm &cr;PEG &cr;유도체</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>Hydrogel&cr;(하이드로젤)</P>
<P>nanotechnology&cr;(나노기술)</P>
</TD>

<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="103">
<P>-6 개의 작용기를 갖는 유도체</P>
<P>-하이드로젤, 나노기술에 사용되어지는 중간체 물질</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>PEG 유도체는 일반적인 PEG 고분자의 말단부분에 의약품이나 단백질 등과 같은 목표물과 화학적 결합을 할 수 있도록 반응기를 합성하여 붙인 형태를 말합니다. PEG에 여러 종류의 반응기(amine, maleimide 등)를 붙여 다양한 종류, 다양한 분자량의 PEG 유도체를 생산하여 제품화하고 있습니다.&cr;&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>PEG 유도체 판매를 위해 홈페이지에 PEG-SHOP을 운영하고 있으며, PEG-SHOP에는 최고 품질과 다양한 종류의 PEG 유도체를 판매하고 있습니다. 국내외 수십 여 거래처에 판매되고 있으며, 기존 거래처와의 매출은 안정적이라고 할 수 있습니다. 또한, 거래처의 임상 진행 정도와 제품 출시 여부에 따라 매출 및 공급물량이 증가하거나 감소할 수 있습니다.&cr;&cr;PEG 유도체는 크게 두 종류로 구분할 수 있으며, 하나는 Generic PEG 유도체이고, 다른 하나는 당사 특허보유 PEG 유도체입니다. 지속적인 연구개발을 통해 새로운 PEG 유도체를 개발하고 있습니다. 2019년 4월 새로운 제형의 PEG 유도체를 생산, 연구 개발하여 미국특허를 출원하여, 2020.10월 특허등록결정(16/381,499: Tertiary alkoxy polyethylene glycol and derivatives thereof)을 통보받았습니다. 이렇게 꾸준히  새로운 PEG 유도체들을 특허화하고, 차세대 PEGylation 기술에 이용하여 향후 바이오베터 또는 신약 개발에 적용할 계획입니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="52"></COL>
<COL WIDTH="228"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>  </P>
</TH>

<TH WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>종 류</P>
</TH>

<TH WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>분자량</P>
</TH>

<TH WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>구 조 식</P>
</TH>

<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>기능 및 용도</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="207">
<P>mPEG</P>
<P>유도체</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="53">
<P>mPEG-amine</P>
</TD>

<TD ROWSPAN="6" WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="207">
<P>2k</P>
<P>5k</P>
<P>10k</P>
<P>12k</P>
<P>20k</P>
<P>30k</P>
</TD>

<TD ROWSPAN="6" WIDTH="157" VALIGN="MIDDLE" HEIGHT="207" ALIGN="CENTER">
<P></P>

<IMAGE>
<IMG WIDTH="133" HEIGHT="133" ALIGN="CENTER" HSPACE="0">emb00002718229f.jpg</IMG>
<IMG-CAPTION ATOC="N">mPEG</IMG-CAPTION>
</IMAGE>
</TD>

<TD ROWSPAN="6" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="207">
<P>의약품</P>
<P>바이오시밀러 </P>
<P>진단기기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>mPEG-maleimide</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>mPEG-propionaldehyde</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>mPEG-succinimidylsuccinate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>mPEG-nitrophenylcarbonate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="34">
<P>등 50여 가지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="207">
<P>di-PEG</P>
<P>유도체</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>PEG-diamine</P>
</TD>

<TD ROWSPAN="6" WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="207">
<P>2k</P>
<P>5k</P>
<P> 10k</P>
<P>12k</P>
<P>20k</P>
<P>30k</P>
</TD>

<TD ROWSPAN="6" WIDTH="157" VALIGN="MIDDLE" HEIGHT="207">
<P></P>

<IMAGE>
<IMG WIDTH="133" HEIGHT="133" ALIGN="CENTER" HSPACE="0">emb0000271822a0.jpg</IMG>
<IMG-CAPTION ATOC="N">di-PEG</IMG-CAPTION>
</IMAGE>
</TD>

<TD ROWSPAN="6" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="207">
<P>성형 dermal filler</P>
<P>Drug delivery&cr;System</P>
<P>(DDS;약물전달 시스템)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>PEG-dimaleimide</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>PEG-dipropionaldehyde</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>PEG-succinimidylsuccinate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>PEG-dinitrophenylcarbonate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="57">
<P>등 50여 가지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="206">
<P>4-arm</P>
<P>PEG</P>
<P>유도체</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>4-arm-PEG-amine</P>
</TD>

<TD ROWSPAN="4" WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="206">
<P>10k</P>
<P> 13k&cr;15k</P>
<P> 17k </P>
<P>20k</P>
</TD>

<TD ROWSPAN="4" WIDTH="157" VALIGN="MIDDLE" HEIGHT="206">
<P></P>

<IMAGE>
<IMG WIDTH="133" HEIGHT="132" ALIGN="CENTER" HSPACE="0">emb0000271822a1.jpg</IMG>
<IMG-CAPTION ATOC="N">4-arm PEG</IMG-CAPTION>
</IMAGE>
</TD>

<TD ROWSPAN="4" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="206">
<P>의료기기 sealant&cr;(봉합사)</P>
<P>nanotechnology</P>
<P>(나노기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>4-arm-PEG-succinimidylsuccinate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>4-arm-PEG-succinimidylglutarate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="116">
<P>등 30여 가지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="211">
<P>6-arm</P>
<P>PEG</P>
<P>유도체</P>
</TD>

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>6-arm-PEG-amine</P>
</TD>

<TD ROWSPAN="4" WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="211">
<P>10k</P>
<P>13k</P>
<P>15k</P>
<P>17k</P>
<P>20k</P>
</TD>

<TD ROWSPAN="4" WIDTH="157" VALIGN="MIDDLE" HEIGHT="211">
<P></P>

<IMAGE>
<IMG WIDTH="134" HEIGHT="134" ALIGN="CENTER" HSPACE="0">emb0000271822a2.jpg</IMG>
<IMG-CAPTION ATOC="N">6-arm PEG</IMG-CAPTION>
</IMAGE>
</TD>

<TD ROWSPAN="4" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="211">
<P>Hydrogel&cr;(하이드로젤)</P>
<P>Nanotechnology</P>
<P>(나노기술)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>6-arm-PEG-succinimidylsuccinate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="30">
<P>6-arm-PEG-succinimidylglutarate</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="237" VALIGN="MIDDLE" HEIGHT="121">
<P>등 30여 가지</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN> &cr;</SPAN>
<SPAN></SPAN>
<SPAN>다. 경영상 중요계약</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="817">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="414"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약성격</P>
</TH>

<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약 제품 </P>
<P>또는 기술</P>
</TH>

<TH WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약일 &cr;및 기간</P>
</TH>

<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약상대&cr;(국가)</P>
</TH>

<TH WIDTH="423" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약의 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">PEG-GCSF</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'03. 11. 5 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Intas Pharmaceuticals Ltd.</P>
<P USERMARK="F-10">(India)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">PEG-GCSF의 개발을 위한 기술이전 및 PEG유도체 공급 계약. PEG-GCSF는 항암치료 시 사용되는 백혈구 생성 촉진제이며, 본 계약은 INTAS에서 생산한 GCSF의약품에 당사의 PEG유도체를 당사의 페길레이션 기술로 부착하는 제조공정 기술이전에 관한 것임. 이 제조기술을 Intas의 연구진들이 당사를 3개월 방문체류하여 기술 습득함 </P>
<P USERMARK="F-10">계약금 :USD150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약 </P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">PEG-인터페론</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'03. 11. 5 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Intas Pharmaceuticals Ltd.</P>
<P USERMARK="F-10">(India)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">PEG-인터페론의 개발을 위한 기술이전 및 PEG유도체 공급 계약. PEG-인터페론은C형 간염치료제이며, 본 계약은 INTAS에서 생산한 인터페론 의약품에 당사의 PEG유도체를 당사의 페길레이션 기술로 부착하는 제조공정 기술이전에 관한 것임. 이 제조기술을 Intas의 연구진들이 당사를 3개월 방문체류하며, 기술 습득함 </P>
<P USERMARK="F-10">계약금 USD150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">PEG-GCSF,</P>
<P USERMARK="F-10">PEG-인터페론,</P>
<P USERMARK="F-10">PEG-EPO</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">'04. 6. 21 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">Serum Institute of India, Ltd.</P>
<P USERMARK="F-10">(India)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">PEG-GCSF, PEG-인터페론, PEG-EPO의 개발을 위한 기술이전 및 PEG유도체 공급 계약. 본 계약은 Serum에서 생산한 GCSF, 인터페론, EPO 의약품에 당사의 PEG유도체를 당사의 페길레이션 기술로 부착하는 제조공정 기술이전에 관한 것임. &cr;계약금 USD420,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">공동개발 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">Adamantane&cr;-PEG-Lactose</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'05. 8. 15 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Calando Pharmaceuticals Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Adamantane-PEG-Lactose의 개발을 위한 공동개발 및 PEG유도체 공급 계약. 당사가 제공하는 PEG유도체에 한쪽은 Adamantane을 부착하고, 다른 한쪽은 Lactose를 부착하여 만드는 항암제 캐리어이며, 이의 개발을 위하여 당사가 기술 개발을 하고 시료를 생산하여 Calando에 기술 이전함. </P>
<P USERMARK="F-10">계약금 USD150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">P1SH-2</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'05. 11. 3 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">BioSite, Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">P1SH-2의 제조기술이전 및 공급계약. 이 PEG제품은 당사가 제조하여 Biosite에 공급하는 것이며, 이 제품의 제조공정 및 분석방법에 관한 기술을 이전하고, 공급계약을 체결. 이 제품은 Biosite에서 마약검출 등 의료진단기기의 제조에 사용됨. </P>
<P USERMARK="F-10">Signing Fee USD140,000</P>
<P USERMARK="F-10">Extra Fee (DMF Filing) USD100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">P1MAL-5</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'05. 11 .3 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Quidel.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">P1MAL-5 의 제조기술이전 및 공급계약. 이 PEG제품은 당사의 특허품목이며, 당사가 제조하여 Biosite에 공급하는 것이며, 이 제품의 제조공정 및 분석방법에 관한 기술을 이전하고, 공급계약을 체결. 이 제품은 Biosite에서 혈액 진단 등 의료진단기기의 제조에 사용 </P>
<P USERMARK="F-10">Signing Fee USD140,000</P>
<P USERMARK="F-10">Extra Fee (DMF Filing) USD100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">공동개발 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">Transferrin-PEG-Adamantane</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'05. 12. 7 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Calando Pharmaceuticals Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Transferrin-PEG-Adamantane의 개발을 위한 공동개발 및 PEG유도체 공급 계약. 당사가 제공하는 PEG유도체에 한쪽은 Adamantane을 부착하고, 다른 한쪽은 Transferrin을 부착하여 만드는 항암제 캐리어이며, 이의 개발을 위하여 당사가 기술 개발을 하고 시료를 생산하여 Calando에 기술 이전 </P>
<P USERMARK="F-10">계약금 USD 175,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">공급 및</P>
<P USERMARK="F-10">기술계약</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">P2AC-3</P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">'06. 4. 10 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">Cartilix, Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">P2AC-3의 제조기술이전 및 공급계약. 당사가 제조하여 공급하는 이 PEG 제품은 Cartilix에서 성형용dermal filler의 개발에 사용되는 주성분이며, 본 제품의 제조기술 및 분석기술을 기술 이전 &cr;Signing Fee USD200,000</P>
<P USERMARK="F-10">Extra Fee (DMF Filing) USD100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
<P USERMARK="F-10">(변경계약) </P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">PEG-GCSF </P>
</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">'13. 8. 7 ~</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">Intas </P>
<P USERMARK="F-10">Pharmaceuticals Ltd.</P>
<P USERMARK="F-10">(India) </P>
</TD>

<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">PEG-GCSF의 개발을 위한 기술이전 및 PEG유도체 공급계약(2003년 원 계약)의 수정계약. 2003년 원 계약의 수정계약으로서, 시장의 범위를 제3시장에서 전세계 시장으로 확대. </P>
<P USERMARK="F-10">-On signing of this Amending Agreement USD300,000 </P>
<P USERMARK="F-10">-After Granting of marketing authorization in EU USD200,000 </P>
<P USERMARK="F-10">-After getting product approval in USA USD250,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">P1SC-20</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">2014.11</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="70">
<P USERMARK="F-10">PharmaEssentia Corp</P>
<P USERMARK="F-10">(Taiwan) </P>
</TD>
<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10">Methoxy PEG -SC 20K 제조기술 이전&cr;USD100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">중국 판권</P>
</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">MucoPEG</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2020.12</TD>

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">PharmaSolution</P>
<P USERMARK="F-10">(Guangzhou Bairui사의 자회사, Hong Kong, China)</P>
</TD>
<TD WIDTH="423" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10">MucoPEG™ 구강건조증치료제의 제조기술의 이전 및 동 제품의 중국시장 판권의 부여&cr;USD350,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-16"></SPAN>
</P>

<P>
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>라. </SPAN>
<SPAN>사</SPAN>
<SPAN>업부문별 재</SPAN>
<SPAN>무정보</SPAN>
<SPAN USERMARK=" 0X54AF00"> </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="165"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">구분</TH>
<TH COLSPAN="3" WIDTH="524" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매출구분</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="186" HEIGHT="53">바이오시밀러&cr;(로열티 및 기술이전 제품)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="164" HEIGHT="53">PEG유도체</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="174" HEIGHT="53">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">매출액</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="186" HEIGHT="30">2,049,857</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="164" HEIGHT="30">3,408,672</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="174" HEIGHT="30">5,458,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">매출액 비중</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="186" HEIGHT="30">37.55%</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="164" HEIGHT="30">62.45%</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="174" HEIGHT="30">100%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">영업이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="186" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="164" HEIGHT="30">1,679,026</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="174" HEIGHT="30">
<SPAN USERMARK=" BC0X31FFFF">1,679,026</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;&cr;</SPAN>
<SPAN USERMARK="F-16 B">2</SPAN>
<SPAN USERMARK="F-16 B">. 주요 제품 등에 관한 사항</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>가. 주요 제품의 현황</SPAN>
</P>
<P>  </P>

<P>
<SPAN>당사</SPAN>
<SPAN>의 제품은 크게 2가지의 제품군으로 분류할 수 있습니다</SPAN>
</P>

<TABLE WIDTH="630" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="255"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">구 분</P>
</TH>

<TH WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">제 품</P>
</TH>

<TH WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">수익구조</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>로열티 및 기술이전 제품</P>

<P USERMARK="F-12 0X54AF00">
<SPAN USERMARK="F-11 0X000000">(바이오시밀러, </SPAN>
<SPAN USERMARK="F-11 0X000000">MucoPEG</SPAN>
<SPAN USERMARK="F-11 0X000000">)</SPAN>
</P>
</TD>

<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="103">

<P USERMARK="F-12">
<SPAN USERMARK="F-11">PEG-GCSF (Neupeg™/</SPAN>
<SPAN USERMARK="F-11">Lapelga™,&cr;Pelgraz™</SPAN>
<SPAN USERMARK="F-11">)</SPAN>
</P>

<P USERMARK="F-12 0X54AF00">
<SPAN USERMARK="F-11 0X000000">PEG-interferon alpha&cr;</SPAN>
<SPAN USERMARK="F-11 0X000000">MucoPEG™</SPAN>
</P>
</TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P>로열티 및 기술이전</P>
<P>PEG 원료 판매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>PEG 유도체 제품</P>
</TD>

<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="31">
<P>PEG 유도체 생산판매 사업</P>
</TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>PEG 유도체 판매</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>

<P>(1) 로열티 및 기술이전 제품; 바이
<SPAN>오시밀러 & </SPAN>
<SPAN>MucoPEG™</SPAN>
</P>

<P>
<SPAN>  </SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>당사</SPAN>
<SPAN>가 개발에 성공하여 시장에 출시한 바이오시밀러는 두 품목이며, 이는 PEG-filgrastim과 PEG-interferon alpha입니다. PEG-filgrastim은 항암 치료 시 사용되는 호중구감소증 치료제(백혈구생성촉진제)로</SPAN>
<SPAN> 오리지널 Amgen의 Neulasta 제품의 바이오시밀러이며</SPAN>
<SPAN>, 2007년 인도 및 제 3시장 승인, 2018년 캐나다와 유럽의 승인을 획득하여, 출시 후 판매되고 있습니다. PEG-interferon alpha는 2014년 인도승인을 획득하였으나, 2015년 Gilead사의 Sovaldi(간염완치제)의 출시로 시장이 감소한 상태입니다. &cr;&cr;구강건조증 치료제 MucoPEG 제품은 2019년 11월 미국 FDA 510(k) 판매허가를 획득 한 후, 중국 </SPAN>PharmaSolution(Guangzhou Bairui사의 자회사, Hong Kong, China)사에 기술이전 및 중국내 판권이전으로 기술료 및 제품판매 매출이 발생하였습니다. 추후, 중국 및 미국등의 기술이전을 통한 매출의 증가를 기대하고 있습니다.&cr;
</P>
<P>(2) PEG 유도체(polyethylene glycol 유도체) 제품</P>
<P>  </P>

<P>PEG 유도체는 크게 두 종류로 구분할 수 있습니다. 하나는 generic PEG 유도체이고, 다른 하나는 당사가 특허보유 하고 있는 신규한 PEG 유도체입니다. &cr;Generic PEG 유도체 중 Pegfilgrastim 바이오시밀러의 원료인 Methoxy Polyethylene Glycol Propionaldehyde 20,000 (mPEG-PAL-20k)이 당사의 대표 PEG 유도체라 할수 있으며, 주로 Intas 사에 판매되고 있습니다. 그리고 당사가 특허를 보유하고 있는 신규한 PEG 유도체는 지속적인 연구개발을 통해 새롭게 PEG 유도체를 합성, 개발하는 것이며, 기존의 PEG 유도체가 나타내는 부작용 등의 단점을 보완하기 위함입니다. 이렇게 새로운 PEG유도체를 연구 개발하여 당사의 지적재산권으로 특허화하고, 차세대 PEGylation 기술에 이용하여 향후 바이오베터 또는 신약으로서의 개발에 적용할 계획입니다. 이러한 신규한 PEG 유도체들은 신약 등의 연구개발을 위해 기본적인 Rat을 이용한 동물 독성시험 등의 안전성 시험을 확인하며, 안정성 및 면역원성 등의 추가 연구를 진행하며 차세대 PEGylation 기술에 이용하기 위한 준비과정을 거치게 됩니다.&cr;
<SPAN>&cr;나. 주요제품 매출 현황&cr;(1) 로열티 매출</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위:천원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="599">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="303"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>품 목</P>
</TH>

<TH COLSPAN="2" WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출액(비율)</P>
</TH>

<TH ROWSPAN="2" WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>제 품 설 명</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>2019년</P>
</TH>

<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" 0X54AF00">
<P>2020년</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>바이오시밀러</P>
<P>(PEG-filgrastim)</P>
</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">1,056,037&cr;(16.13)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2,049,857&cr;(37.55)</TD>

<TD WIDTH="312" VALIGN="MIDDLE" HEIGHT="53">
<SPAN>Intas사의 </SPAN>
<SPAN>Neupeg™ </SPAN>
<SPAN>매출에 대한 런닝로열티</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>(2) PEG유도체 제품 매출 </SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위:천원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="608">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="343"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매출액(비율)</P>
</TH>

<TH ROWSPAN="2" WIDTH="352" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품 설명</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1PAL-20</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">4,643,729&cr;(70.93)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2,451,237&cr;(44.91)</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="53">

<P>
<SPAN>- Intas(인도) 사에서 항암제인 </SPAN>
<SPAN>PEG-filgrastim </SPAN>
<SPAN USERMARK=" U"></SPAN>
<SPAN USERMARK=" U"></SPAN>
</P>

<P>
<SPAN USERMARK=" U"></SPAN>
<SPAN USERMARK=" U"></SPAN>
<SPAN>제품 원료로 사용 </SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1MAL-5</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">130,976&cr;(2.00)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">175,899&cr;(3.22)</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="53">
<P>- Quidel Cardiovascular, Inc.(미국) 사에서 진단기기에 사용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1AM-5</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">76,966&cr;(1.18)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">177,868&cr;(3.26)</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="53">
<P>- Applied Biosystems(미) 사에서 진단기기에 사용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">639,481&cr;(9.77)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">603,668&cr;(11.06)</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="53">
<P>- 신약개발 및 진단기기</P>
<P>- 나노기술 및 외과수술용 접착제 등에 사용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>합계</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">5,491,153&cr;(83.87)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3,408,672&cr;(62.45)</TD>

<TD WIDTH="352" VALIGN="MIDDLE" HEIGHT="53">
<P>  </P>
<P>  </P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-16 B">3. 매입에 관한 사항</SPAN>
<SPAN USERMARK="F-16"></SPAN>
</P>
<P>&cr;가. 매입 현황 &cr;&cr;(1) 원재료 매입현황</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원, 달러) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>P1OH-20</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">490,703</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,434,330</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">308,434</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>P1OH-5</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2,795</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>P1OH-30</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">18,157</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">82,601</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>P1OH-2</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">500</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P2OH-5</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P4OH-10</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,000</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P6OH-20</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P6OH-40</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">527,155</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,434,330</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">394,285</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 부재료 매입현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="91"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>염화메틸렌</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">42,041</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">44,619</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">16,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에틸에테르</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">30,868</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">45,766</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">25,408</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>다이옥산</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">21,225</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">43,788</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">13,833</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100,741</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">194,438</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">150,390</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">194,875</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">328,611</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">206,291</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 원부재료 매입총계 (단위: 천원, 달러)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="598">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">722,030</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1,762,941</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">600,576</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;나. 주요 원재료의 제품별 비중</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업연도</P>
</TH>

<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 제품명</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>원재료명</P>
</TH>

<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>원재료 비중(%)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="300" ROWSPAN="10">제 2018년도</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">P1PAL-20</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 20,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">78.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,4-Dioxane</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7.36</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">P1AM-2</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 2,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">27.63</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">72.37</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">P1MAL-5</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 5,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.58</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PFP-TFA</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">44.8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">51.62</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">P1AM-5</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 5,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">31.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">68.81</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="240" ROWSPAN="8">제 2019년도</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">P1PAL-20</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 20,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">80.27</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,4-Dioxane</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12.3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">P1MAL-5</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 5,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.85</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PFP-TFA</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">45.95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">P1AM-5</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">50.2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 5,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">40.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">59.57</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="240" ROWSPAN="8">제 2020년도</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">P1PAL-20</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 20,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">56.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,4-Dioxane</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5.26</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">38.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">P1MAL-5</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 5,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.81</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PFP-TFA</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">47.75</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">P1AM-5</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">48.44</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">mPEG-OH 5,000</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">44.73</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">55.27</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;다. 주요 원부재료 가격변동추이</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="603">

<COLGROUP>
<COL WIDTH="594"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="603" HEIGHT="30" ALIGN="RIGHT">(단위: 원, 달러) </TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>  품목</P>
</TH>

<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년도</P>
</TH>

<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년도</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년도</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1OH-20(주1)</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">5,590,500&cr;($5,000)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">5,234,780&cr;($4,500)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">4,712,600&cr;($4,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>P1OH-5</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">700,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1OH-30</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">9,078,400&cr;($8,000)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">8,318,300&cr;($8,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>P1OH-2</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">500,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P2OH-5</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P4OH-10</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">500,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P6OH-20</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">P6OH-40</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">750,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>염화메틸렌(A)</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">40,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">28,000</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">28,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에틸에테르(B)</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">78,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64,000</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>다이옥산(C)</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">270,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">106,000</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">95,000</TD>
</TR>
</TBODY>
</TABLE>
<P>참고1. 원료의 가격산출기준은 단가(원/kg)로 기입하였습니다.</P>
<P>참고2. (A)의 가격산출기준은 단가(원/24kg)로 기입하였습니다.</P>
<P>참고3. (B)의 가격산출기준은 단가(원/18L)로 기입하였습니다.</P>

<P>참고4. (C)의 가격산출기준은 단가(원/2L)로 기입하였습니다.&cr;
<SPAN></SPAN>
<SPAN>(주1) 해당 원재료는 대량구매로 인한 단가 변동입니다.&cr;(주2) 원부재료 단가변동 원인은 직거래로 인한 단가변동 입니다.&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-16 B">4. 생산 및 생산설비에 관한 사항</SPAN>
</P>
<P>&cr;가. 생산능력 및 생산실적</P>
<P>  </P>
<P>(1) 로열티 및 기술이전 사업</P>

<P>
<SPAN> </SPAN>
<SPAN>1) Pegfilgrastim 바이오시밀러</SPAN>
</P>

<P>
<SPAN>당사</SPAN>
<SPAN>의 로열티 및 기술이전 제품인 Pegfilgrastim 바이오시밀러 제품은 관련 기술의 연구개발을 완료하여 제휴업체에 기술이전을 통하여 생산 및 분석기술을 이전한 후 제휴업체에서 생산하는 방식입니다. 따라서 기술이전 및 로열티 사업의 생산 및 설비에 관한 내용은 해당사항이 없습니다. 즉, 바이오시밀러 의약품인 </SPAN>
<SPAN>PEG-filgrastim </SPAN>
<SPAN>Lapelga</SPAN>
<SPAN>(Pelgraz, Neupeg)</SPAN>
<SPAN>™</SPAN>
<SPAN>은 인도 Intas 사에서 생산이 이루어지고 있습니다.</SPAN>
</P>
<P>&cr;2) 구강건조증 치료제 MucoPEG&cr;MucoPEG™의 FDA 510(k) 판매허가를 위해, GMP 생산 설비 및 장비, 원료 및 중간제품, 완제품 분석장비 등 모든 장비를 GMP 기준에 따라 구입, 관리하며 MucoPEG™을 자체 생산하고 있습니다. 현재 MucoPEG™ 생산 규모가 batch당 1kg(980~ packet) 으로 작으나, 최근 중국 업체로의 기술이전 및 판매, 중국내 MucoPEG™ 허가를 위한 자료준비, 중국내 예비 임상 등 MucoPEG™ 수요가 증가하여, 생산규모를 증대하기 위한 생산 설비 및 인력을 충원하고 있습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="213"></COL>
<COL WIDTH="383"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>품질</P>
</TH>

<TH WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>GMP</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>작업장</P>
</TD>

<TD WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>3층</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>작업 모드(Work mode)</P>
</TD>

<TD WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Semi-automated</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산규모(Batch size)</P>
</TD>

<TD WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1 kg/batch (batch scale-up 예정)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산기간(Batch Run Time)</P>
</TD>

<TD WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1.5 주/batch</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연간 생산규모</P>
</TD>

<TD WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>건물</P>
</TD>

<TD WIDTH="392" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 5층, 3700 m2</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(2) PEG 유도체 사업 &cr;
<SPAN></SPAN>
<SPAN>당사의 다양한 PEG 유도체는 1999년 PEG-SHOP을 시작으로 가장 빠른 제품화로 국내외 많은 거래처에 판매하며 그 품질을 인정받고 있습니다. 그러나 더욱더 다양한 PEG 유도체의 품질 개선 및 대량생산을 위해 생산 설비 및 해당인력 충원, 분석 장비 등을 확대/구축하고 있으며, 2016년 7월 현재의 군포 신사옥을 임차하여 생산시설 증대 및 GMP 시설을 완료하였습니다. 해당 시설로 연간 100kg 이상의 PEG 유도체 생산 능력을 갖추었으며, 2018년 2월 EU EMA 실사를 완료 하였습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="620" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="620" HEIGHT="30">(단위: Kg, 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="621" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">구 분</P>
</TH>

<TH COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2018년도 </P>
</TH>

<TH COLSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2019년도 </P>
</TH>

<TH COLSPAN="2" WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2020년도 </P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">수량</P>
</TH>

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">금액</P>
</TH>

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">수량</P>
</TH>

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">금액</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">수량</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">생산능력</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">250Kg</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">-</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">250Kg</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">250Kg</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">생산실적</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">126.10Kg</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">3,835</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">158.74Kg</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">5,491</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">122.85Kg</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-12">3,409</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>나. 생산설비에 관한 사항</P>
<P>당기 중, 생산설비 관련 유형자산의 장부금액의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="824" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="815"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="824" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="827">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체 등</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">기계장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">419,545</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(66,995)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">352,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">차량운반구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">공구와기구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,890</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(4,346)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">12,544</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">비품</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">230,190</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">77,837</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(90,841)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">217,186</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">시설장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">373,007</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(128,579)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">244,428</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">구축설비자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,108,980</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">37,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(272,887)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,873,093</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,800</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">임차자산개량권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">35,774</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(35,774)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">사용권자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,852,393</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(266,761)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">59,567</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,645,199</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">5,053,580</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">114,837</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(830,409)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">23,793</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">4,361,801</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;당사는 당기 중에 생산능력, 품질능력 및 연구개발능력 확충을 신규 설비 투자를 진행하였으며 이중 주요한 내역은 다음과 같습니다.</SPAN>
<SPAN> </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="749">

<COLGROUP>
<COL WIDTH="740"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="749" HEIGHT="30" ALIGN="RIGHT">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="752" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>설비자산명</P>
</TH>

<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득가액</P>
</TH>

<TH WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득사유</P>
</TH>

<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>용도</P>
</TH>

<TH WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득처</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">단백질정제장비</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">56,500</TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구시설</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">글로벌라이프사이언스솔루션코리아(유)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">56,500</TD>

<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>다. PEG유도체 생산공정</P>
<P>PEG유도체를 생산하는 공정과 각 공정에 대한 설명은 다음과 같습니다.</P>

<IMAGE>
<IMG WIDTH="405" HEIGHT="426" ALIGN="CENTER" HSPACE="0">공정.jpg</IMG>
<IMG-CAPTION ATOC="N">[그림] PEG유도체 생산공정도</IMG-CAPTION>
</IMAGE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="538"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="547" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>상 세 설 명</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>원료, 자재&cr;입고 </P>
<P>및 &cr;시험</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="283">
<P>① 원료 자재 입고</P>
<P>제품 생산에 필요한 원료 및 자재를 입고하는 과정입니다. 원료는 PEG 유도체를 생산 하는 주성분 원료와 제품 품질에 직접적으로 영향을 미치는 반응용매, 첨가시약 등으로 구성됩니다. 자재는 용기 및 포장에 필요한 자재로 구성됩니다.</P>
<P>② 원료, 자재 시험</P>
<P>입고된 원료 및 자재에 대한 시험 및 검사가 이뤄지는 과정입니다. 원료, 자재의 외관상태 확인 검사와 품질관리 시험으로 구성됩니다. 외관 상태 확인 검사는 포장의 파손, 원료의 혼입, 이물질의 혼입 여부, 라벨의 표시상태 등을 검사합니다. 품질관리 시험에서는 설정된 품질관리 기준 적합 여부를 다양한 분석시험을 통해 확인합니다. 원료, 자재의 검사 및 시험결과를 토대로 품질관리(보증)책임자의 적합(사용) 승인이 이뤄지며 승인 이후부터 제조공정으로 투입이 가능해집니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>원료&cr;칭량</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="76">
<P>제조공정에 적합 승인이 완료된 원료를 투입하여 제품을 생산하기 위해 원료를 칭량하는 과정입니다. 제조관리책임자의 제조에 대한 지시가 이뤄진 후 해당 제품의 설정된 원료약품 및 분량에 맞게 원료를 칭량하고 제조공정에 투입됩니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>반응, 추출</P>
<P>및</P>
<P>농축, &cr;고형화, &cr;건조</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="283">
<P>① 반응</P>
<P>칭량이 완료된 원료를 제조 방법에 따라 반응용매에 투입하고 교반하여 반응을 진행하는 과정입니다. </P>
<P>② 추출 및 농축</P>
<P>추출은 반응이 완료된 물질을 물에 녹여 불순물을 제거하고 유기용매로 생산품을 용해하여 분리하는 과정이고, 생산품을 얻기 위해 유기용매를 제거하는 것을 농축이라 합니다.</P>
<P>③ 고형화</P>
<P>액체 상태로 농축된 제품을 고체화 할 수 있는 용매를 넣어 고체 상태로 변형하는 과정을 고형화 라고 합니다.</P>
<P>④ 건조</P>
<P>고형화된 제품은 진공 감압 상태에서 상온에서 건조되어집니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>분석</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="76">
<P>생산이 완료된 제품의 일정량을 취하여 최종 분석을 진행하는 과정입니다. 주로 PEG 유도체 말단의 반응성과 폴리머의 분자량 및 분포를 확인하여 적합 판정 시품질관리(보증)책임자가 출하 승인합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>분말화, &cr;포장</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="168">
<P>①분말화</P>
<P>균일하지 않은 고형화된 제품을 일정 틀에 넣고 분말형태로 균일화 하는 과정입니다. 고체 덩어리로 생성된 것은 파쇄작업을 하여 분말화을 진행합니다.</P>
<P>②포장</P>
<P>분말 작업이 완료된 제품을 용기 내에 일정수량 씩 소분하여 밀봉하는 과정입니다. 제품의 포장을 통해 제품의 파손을 예방하며 제품명 및 제조번호 등을 확인할 수 있도록 표시사항을 확인합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출하</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="30">
<P>출하 승인이 완료된 제품에 한하여 사용자에게 발송하는 과정입니다.</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>라. 외주생산에 관한 사항</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당사</SPAN>
<SPAN>의 생산설비 용량을 초과하는 생산이 필요하지 않아 외주가공을 진행한 내역은 없습니다.</SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-16 B">5. 매출에 관한 사항&cr;</SPAN>
</P>
<P>가. 매출실적&cr;(1) 로열티 및 기술이전 제품</P>

<TABLE ACLASS="NORMAL" WIDTH="630" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="621"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="630" HEIGHT="30">(단위: 천원, 달러)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="627" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="59"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>매출</P>
<P>유형</P>
</TH>

<TH COLSPAN="2" ROWSPAN="2" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>품 목</P>
</TH>

<TH COLSPAN="3" WIDTH="346" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금액</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>2018년도</P>
</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2019년도</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2020년도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="129">
<P>기술료 &cr;및</P>
<P>로열티</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>Intas Pharma.</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>기술료</P>

<P>
<SPAN>(</SPAN>
<SPAN></SPAN>
<SPAN>Pelgraz™,&cr;Neupeg™</SPAN>
<SPAN>)</SPAN>
</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">337,140&cr;($300,000)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Intas Pharma.</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>로열티</P>
<P>(Neupeg™)</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,505&cr;($2,231)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,056,037&cr;($908,824)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,049,857&cr;($1,743,728)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>합계</P>
</TD>

<TD COLSPAN="2" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기술료 및 로열티 합계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">339,645&cr;($302,231)</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<SPAN>1,056,037&cr;($908,824)</SPAN>
</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,049,857&cr;($1,743,728)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(2) PEG 유도체 제품</SPAN>
<SPAN USERMARK=" B"> </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT">(단위: 천원, 달러)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="625" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매출</P>
<P>유형</P>
</TH>

<TH COLSPAN="2" ROWSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품 목</P>
</TH>

<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년도</P>
</TH>

<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년도</P>
</TH>

<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년도</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="15" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="657">
<P>제품</P>
</TD>

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136">
<P>P1PAL-20</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,643,165&cr;($1,473,500)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,643,366&cr;($3,960,000)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,451,237&cr;($2,073,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내수</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">363</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소계</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,643,165&cr;($1,473,500)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,643,729&cr;($3,960,000)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,451,237&cr;($2,073,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136">P1AM-2</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,449,208&cr;($1,323,750)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내수</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,484</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,243</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,186</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소계</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,451,692&cr;($1,323,750)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">5,243</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,186</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136">
<P>P1MAL-5</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">82,984&cr;($76,000)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">130,361&cr;($112,500)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">175,489&cr;($150,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내수</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">615</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">410</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소계</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">82,984&cr;($76,000)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">130,976&cr;($112,500)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">175,899&cr;($150,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136">
<P>P1AM-5</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">64,657&cr;($59,400)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">68,674&cr;($59,400)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">175,024&cr;($148,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내수</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,795</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,292</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,844</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소계</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">67,452&cr;($59,400)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">76,966&cr;($59,400)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">177,868&cr;($148,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">
<P>기타유도체</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">539,150&cr;($489,050)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">607,483&cr;($519,400)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">576,424&cr;($495,570)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내수</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,423</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,755</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,058</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">589,573</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">634,238</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">
<P>합계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,779,164&cr;($3,421,700)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">5,449,885&cr;($4,651,300)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,378,174&cr;($2,867,070)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내수</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,702</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,268</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,498</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,834,866</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,491,153</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,408,672</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(3) 주요 매출처 및 매출처별 판매비중 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원, 달러)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="624" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업년도</TH>
<TH ALIGN="CENTER" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출구분</TH>
<TH ALIGN="CENTER" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출처</TH>
<TH ALIGN="CENTER" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ALIGN="CENTER" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH ALIGN="CENTER" WIDTH="102" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비중</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="272" ROWSPAN="6" VALIGN="MIDDLE">2020년&cr;(24기)</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="212" ROWSPAN="4" VALIGN="MIDDLE">수출</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53">A</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">인도</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">4,629,760&cr;($3,929,028)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">84.82%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53">B</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">중국</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">414,924&cr;($355,870)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">7.60%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53">C</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">미국</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">351,700&cr;($299,500)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">6.44%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53">기타</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">이스라엘 외</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">31,646&cr;(26,400)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">0.58%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">내수</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="30">D외</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="30">국내</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30" VALIGN="MIDDLE">30,498</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">0.56%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">합계</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30" VALIGN="MIDDLE">5,458,529</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">100%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="272" ROWSPAN="6" VALIGN="MIDDLE">2019년&cr;(23기)</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="212" ROWSPAN="4" VALIGN="MIDDLE">수출</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">A</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">인도</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">5,673,633&cr;($4,847,824)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">86.66%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">B</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">중국</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">500,985&cr;($428,700)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">7.65%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">C</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">미국</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">235,327&cr;($201,900)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">3.059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">기타</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">타이완 외</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">95,977&cr;($81,700)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">1.47%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">내수</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">D외</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="30" VALIGN="MIDDLE">국내</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30" VALIGN="MIDDLE">41,268</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">0.63%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">합계</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30" VALIGN="MIDDLE">6,547,190</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">100%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="295" ROWSPAN="6" VALIGN="MIDDLE">2018년&cr;(22기)</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="212" ROWSPAN="4" VALIGN="MIDDLE">수출</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">A</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">인도</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">1,987,176&cr;($1,779,731)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">47.60%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">B</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">미국</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">1,607,276&cr;($1,468,400)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">38.50%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">C</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">중국</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">309,633&cr;($278,000)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">7.42%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">기타</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">홍콩 외</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">214,724&cr;($197,800)</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">5.14%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">내수</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">D외</TD>
<TD ALIGN="CENTER" WIDTH="100" HEIGHT="53" VALIGN="MIDDLE">국내</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="53" VALIGN="MIDDLE">55,702</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="53" VALIGN="MIDDLE">1.33%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">합계</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30" VALIGN="MIDDLE">4,174,512</TD>
<TD ALIGN="CENTER" WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">100%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;나. 수출 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="692">

<COLGROUP>
<COL WIDTH="683"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="692" HEIGHT="30" ALIGN="RIGHT">(단위: 천원, 달러)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="690" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매출</P>
<P>유형</P>
</TH>

<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품 목</P>
</TH>

<TH COLSPAN="2" WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년도</P>
</TH>

<TH COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년도</P>
</TH>
<TH COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년도</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수출국</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수출액</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수출국</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수출액</P>
</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"></TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"></TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="159">
<P>로열티</P>
<P>및</P>
<P>기술이전</P>
<P>제품</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기술료</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">337,140&cr;($300,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>로열티</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,505&cr;($2,231)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<SPAN USERMARK=" BC0X31FFFF">1,056,037&cr;($908,824)</SPAN>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,049,857&cr;($1,743,728)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소계</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">339,645&cr;($302,231)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<SPAN USERMARK=" BC0X31FFFF">1,056,037&cr;($908,824)</SPAN>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,049,857&cr;($1,743,728)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="11" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="583">
<P>PEG</P>
<P>유도체</P>
<P>제 품</P>
</TD>

<TD ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="106">
<P>P1PAL-20</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,640,907&cr;($1,471,500)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,607,075&cr;($3,930,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">인도</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,451,237&cr;($2,073,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이탈리아</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,258&cr;($2,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">36,291&cr;($30,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="106" ROWSPAN="2">P1AM-2</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,438,294&cr;($1,313,500)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">타이완</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">10,914&cr;($10,250)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1MAL-5</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">82,984&cr;($76,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">130,361&cr;($112,500)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">175,489&cr;($150,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1AM-5</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">64,657&cr;($59,400)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">68,674&cr;($59,400)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">175,024&cr;($148,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P1BTC-20</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이집트</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">19,408&cr;($18,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>P2SP-3</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">중국</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,851&cr;($2,500)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">P1SP-5</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">홍콩</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">45,028&cr;($40,000)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타유도체</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">474,714&cr;($431,050)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">604,632&cr;($516,900)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">576,424&cr;($495,570)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소계</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,779,164&cr;($3,421,700)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">5,449,885&cr;($4,651,300)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,378,174&cr;($2,867,070)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>합계</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,118,809&cr;($3,723,931)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">6,505,922&cr;($5,660,124)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,378,174&cr;($2,867,070)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>  </P>
<P>다. 수주현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="749">

<COLGROUP>
<COL WIDTH="740"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="749" HEIGHT="30" ALIGN="RIGHT">(단위: 천원, 달러)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="749" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>발주처</P>
</TH>

<TH ROWSPAN="2" WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품 목</P>
</TH>

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수주일자</P>
</TH>

<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>납 기</P>
</TH>

<TH COLSPAN="2" WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수주총액</P>
</TH>

<TH COLSPAN="2" WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수주잔고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수 량</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금 액</P>
</TH>

<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수 량</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금 액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Intas&cr;Pharmaceuticals, Ltd.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">P1PAL-20</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.11</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.12&cr;~2021.12</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">74Kg</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,106,112&cr;($3,774,000)</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">49Kg</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,718,912 &cr;($2,499,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="4" ROWSPAN="2" WIDTH="417" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>합 계</P>
</TD>
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,106,112</TD>
<TD ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,718,912 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">($3,774,000)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">($2,499,000)</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 보고서 기준일(2020.12.31) 환율을 적용하였습니다. ($1,088.00)&cr;(*) 수주잔고는 제출일 현재 기준으로 작성하였습니다.&cr;</P>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-16 B">6. 판매에 관한 사항</SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16">&cr;</SPAN>
</P>
<P>가. 판매조직&cr;회사의 모든 제품에 대해서 국내외 영업은 당사 생체고분자 사업부에서 담당하고 있습니다. 해외영업은 주로 고객사 방문, 해외 학술회의 참석, 인적네트워크를 통한 이메일, 유선을 통한 PEG-SHOP 홍보로 제품을 판매를 하고 있습니다.&cr;&cr;국내영업은 당사 홈페이지(www.sunbio.com)의 PEG-SHOP을 통해 주문을 받고 있으며 별도의 영업부서는 없으며 생체고분자 사업부 내에 마케팅 업무 담당자가 주문 수주 및 제품발송을 담당하고 있습니다. &cr;</P>

<P>나. 판매경로
<SPAN>&cr;당사의 PEG 유도체 제품은 </SPAN>
<SPAN>중국 중간 도매상을 제외하고,</SPAN>
<SPAN> 직접 국내외의 </SPAN>최종 고객에게 판매하고 있습니다. 
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위:천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="599" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="54" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연도</TH>
<TH ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출유형</TH>
<TH ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH ALIGN="CENTER" WIDTH="76" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" WIDTH="90" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매경로</TH>
<TH ALIGN="CENTER" WIDTH="208" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매경로별 매출액(비중)</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="54" HEIGHT="60">'19년</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60">제품</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60">PEG유도체</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="30">수출</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">직접판매</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">5,449,885 (99.25%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="30">국내</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">직접판매</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">41,268 (0.75%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="54" HEIGHT="60">'20년</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60">제품</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60">PEG유도체</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="30">수출</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">직접판매</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">3,378,174 (99.11%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="30">국내</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">직접판매</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">30,498 (0.89%)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN>다. 판매전략</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="240"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="397" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판 매 제 품</P>
</TH>

<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>사업모델</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>PEG 유도체 소재</P>
</TD>

<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">
<P>200여종의 PEG 유도체 </P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>주문생산, 직접 판매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">
<P>제조 기술이전 PEG 유도체</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>공급계약 판매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>PEGylation 기술 </P>
<P>응용 제품</P>
</TD>

<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">
<P>Pegfilgrastim 바이오시밀러</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기술이전 및 로열티</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">
<P>MucoPEG™ 구강건조증 치료제</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기술이전 및 직접 판매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">
<P>파이프라인 연구개발 제품</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기술이전</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X54AF00"></SPAN>
</P>
<P>(1) PEG 유도체 소재</P>
<P>당사는 홈페이지(www.sunbio.com)의 PEG-SHOP 카테고리에 PEG 유도체 및 PEGylation 기술을 통한 신약개발, 전략적 제휴, 제품 홍보를 통해 영업을 하고 있습니다. PEG 유도체 소재는 PEG-SHOP을 통한 주문 및 직접 주문에 따라 고객의 요구에 맞추어 소량(g) 다품종 및 대량생산(kg), 그리고 cGMP 수준의 대량 생산을 통해 고품질의 제품을 판매를 하고 있습니다. 200여 종의 PEG 유도체는 합성 방법과 분리정제 공정 등에 따라 판매가는 상이합니다. </P>
<P>바이오/제약 등, 바이오의약품의 확대에 따른 PEG 유도체 소재의 사용이 증가할 것으로 예상하며, 특히 2019년 코로나-19 펜데믹 상황의 백신을 위한 mRNA 전달체 원료로 당사의 PEG 유도체가 판매되며 당사의 PEG 유도체 생산 및 품질 수준이 한 번 더 검증 되었으며, 이에 맞추어 PEG 유도체 영업을 활발히 하고 있습니다.</P>

<P>
<SPAN>&cr;1) 미</SPAN>
<SPAN>국 및 유럽지역 영업전략&cr;해외 학술회의 및 박람회(2019년 필라델피아 바이오 박람회; Bio USA 2019) 등을 통하여 PEG 유도체 및 당사의 PEGylation 기술 제품(Pegfilgrastim 바이오시밀러, MucoPEG), 그리고 당사를 홍보하였습니다. 앞으로도 박람회 및 전시회의 참여로 당사의 생체고분자 PEG 유도체 소재들에 대한 홍보 및 PEGylation 기술 관련 업계의 최신동향을 파악하여 경쟁력 있는 새로운 PEG 유도체의 합성 및 PEGylation 기술 응용 신제품 개발로 영업을 확대 할 계획입니다.</SPAN>
</P>
<P>  </P>
<P>2) 중국 및 동남아 제 3세계 시장 영업전략</P>
<P>중국 내 의약품 관련 영업망을 구축하고 있는 광저우 바이루이와 중국내 당사 PEG 제품의 영업을 진행하고 있으며, 이 회사를 통하여 동남아 및 제 3세계 시장 진출도 병행하여 진행하면서 적극적으로 영업망을 확대하고 있습니다. 광저우 바이루이사를 통한 중국내 매출이 연간 4억원 정도이며, 현재는 중국의 End user들이 임상을 진행하고 있어서 판매량이 많지 않으나, 점차 End user들의 임상이 성공하여 시장에 최종의약품이나 의료기기가 출시되면 판매량이 기하급수적으로 증가할 것을 예상합니다.</P>
<P>  </P>
<P>3) 국내시장 영업 전략</P>
<P>국내 제약회사 및 대학 기관과 공동 연구 및 기술제휴를 통하여 새로운 매출을 창출할 수 있도록 추진하며, 국내 학술회의 및 박람회 참석으로 현재 시장동향 및 기술동향을 파악하여 이에 부응 할 수 있는 새로운 제품 설계 및 개발을 진행 할 것입니다. </P>
<P>  </P>
<P>4) 새로운 PEG 유도체 소재 및 PEGylation 기술 적용 제품 개발</P>
<P>당사는 (ISO 9001의 규정에 따라) 매년 1건 이상의 제품 품질 개선 및 새로운 PEG 유도체 소재의 신제품 개발을 시행하고, 관련 제품을 특허화 하고 있습니다. 이는 국내외 저널 및 관련 뉴스들을 통하여 최신 기술 동향을 파악하고 신제품을 개발함으로써 매출을 향상시켜 나갈 것입니다. </P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>(2) PEGylation 기술 응용 제품</P>
<P>  </P>
<P>1) Pegfilgrastim 바이오시밀러</P>
<P>캐나다 시장에서 Pegfilgrastim 바이오시밀러로 가장 먼저 허가/판매되고 있는 당사 제품 Lapelga는 판매사인 캐나다의 넘버원 제네릭 제약사인 Apotex사가 담당하고 있으며, Apotex사는 기존의 탄탄한 마케팅력으로 판매하고 있습니다.</P>
<P>유럽 시장에서 Pelgraz는 Accord Healthcare (Intas 사의 유럽 판매전문 자회사)가 판매하고 있으며, Accord 는 이미 유럽시장에서 10여 개의 바이오의약품 등을 판매하며 마케팅 및 기업이미지가 좋은 회사로서 알려져 있어, 영국, 유럽연합, 중동 및 북아프리카 등에 판매하고 있습니다.</P>
<P></P>
<P>2) 구강건조증 치료제 MucoPEG™ </P>
<P>MucoPEG은 FDA 510(k) clearance 획득 후, 미국내 판매를 위해 구강건조 및 구강케어 제품을 판매하는 글로벌 기업에 기술이전 및 PEG 유도체 공급을 계획하고 있습니다. &cr;FDA 510(k) 허가 후 미국 파트너사에 라이센싱아웃을 추진하는 과정에서 파트너사들이 MucoPEG 대비 기존제품의 비교임상요구가 있었으며, 현재, 미국 내 구강 건조증 환자들을 대상으로 GSK사의 Biotene 가글 제품과 당사의 MucoPEG 비교 임상을 진행 중입니다. 이 비교임상 결과를 바탕으로 MucoPEG의 효과 우수성이 검증 된다면, 기술이전을 통한 기술료 수익 및 MucoPEG의 판매와 PEG 유도체 판매가 증가 할 것으로 기대합니다. &cr;또한, 중국 내 판매를 위해 Guangzhou Bairui 사의 자회사인 PharmaSolution에 MucoPEG을 기술이전 하였습니다. 현재 1차 기술료를 수령하고 중국 내 구강건조증 환자를 대상으로 한 임상시험을 진행 중이며, 제품 승인을 준비하고 있습니다. 마일스톤 기술료는 MucoPEG의 중국 판매승인을 획득한 후에 수령예정이며, 추후 판매량 기준 일정액의 로열티를 수령할 예정입니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK="F-16 B">7. 연구개발활동</SPAN>
<SPAN> &cr;&cr;가. 연구개발 담당조직&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(1) 연구개발 조직 개요</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="607" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="223"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구조직</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="53">선바이오(주)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="53">선바이오 연구소&cr;(연구개발본부)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">바이오신약사업부, 임상연구팀</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="255" ALIGN="CENTER" HSPACE="0">연구개발조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">[연구개발조직도]</IMG-CAPTION>
</IMAGE>

<P>(2) 연구개발 인력 현황&cr;&cr;공시서류 작성기준일 현재 당사는 박사급 2명, 석사급 5명 등 총 7명의 연구인력을 보유하고 있습니다.&cr;당사의 기업부설 연구소 연구소장인 노광 대표의 연구개발 총괄 책임을 바탕으로 PEGylation 기술관련 연구개발 및 기술이전의 다양한 성과를 이루었으며, 바이오신약사업부와 임상연구팀으로 구성되어 있습니다. 현재의 연구개발 핵심인력인 해당 기술 분야의 근무 년 수 10년 이상의 연구원들과 노광대표의 PEG 유도체 및 PEGylation 기술의 사업화 기획력을 바탕으로, 당사는 다양한 PEGylation 기술 응용 제품을 개발 및 계획하고 있습니다. 또한, 관련 분야의 기술 경향들을 모니터하고 업데이트, 공유하며 새로운 원천적인 기술 또는 제품 아이디어를 제안한 발명자에게 격려금 지급의 인센티브 구조를 운영하며 연구력을 향상시키고 있습니다.&cr;&cr;                                         
<SPAN>   </SPAN>
<SPAN><연구개발 인력 현황></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="623" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="266" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">박사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">석사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60">선바이오 연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">바이오신약사업부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30">4</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30">0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30">5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">임상연구팀</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30">0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30">2</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>< 연구소장 및 각 연구 개발본부 부서별 업무>
</P>

<TABLE WIDTH="621" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="449"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="458" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>업 무</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>연구소장</P>
</TD>

<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="99">
<P> 연구개발 계획수립 및 R&D 운영 총괄</P>
<P> 제품개발 계획 및 단계별 설계 검토</P>
<P> 사업화 기획업무 지원 </P>
<P> 공동 연구개발 관련 대외 업무 총괄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>바이오신약사업부</P>
<P>; 4 명 </P>
</TD>

<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="145">
<P> PEGylation 연구개발 계획 및 진행</P>
<P> 제품 개발 및 단계별 진행 </P>
<P> 인허가 전략 수립 및 일정관리</P>
<P> 신규 정부 R&D 프로젝트 검토 및 연구기획</P>
<P> 정부 R&D 과제 수행</P>
<P> PEGylation 기술관련 특허 관리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>임상연구팀</P>
<P>; 2 명</P>
</TD>

<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="76">
<P> 개발제품 비임상 독성 및 효력 시험</P>
<P> 개발제품 임상시험 계획 및 설계</P>
<P> 신규 PEG 유도체 안전성 시험 </P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>  
<SPAN>&cr;(3) 핵심 연구인력&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당사의 핵심 연구인력은 연구소장인 노광 박사와 연구경력 10년 이상의 책임연구원들이며, 바이오신약 사업부와 임상연구팀의 석사이상 연구인력이 연구개발에 참여하고 있습니다. &cr;</SPAN>
<SPAN>&cr;연구소장인 노광 박사는 미국 Rutgers 대학에서 생명공학 박사학위를 취득하였으며, 당시 지도교수인 Dr. Frank F. Davis 와 Dr. Abraham Abuchowski 교수는 1977년 최초로 PEGylation 기술을 연구개발하여 현재 "PEGylation의 아버지"로 평가되고 있습니다.  박사학위 취득 후 노광박사는 지도교수 </SPAN>
<SPAN>Davis 교수가 창업한 Enzon 사에서 R&D Project Leader로서 근무(1988-1996)하며 Schering-Plough 사와 함께 C형 간염 치료제인 PEG-interferon alpha (PegIntron?)를 공동 개발하였고, PEG-hemoglobin 등과 같은 다양한 프로젝트를 수행하여 다수의 특허, 논문 그리고 관련서적을 발표하는 등 많은 연구개발 성과를 이루었습</SPAN>
<SPAN>니</SPAN>
<SPAN>다. 그리고, 현재까지 약 </SPAN>
<SPAN>30여년간 PEGylation 원천기술을 바탕으로 다양한 의약품 개발 및 응용연구를 하고 있습니다. </SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN></SPAN>
</P>
<P>&cr;                                         <핵심 연구인력 현황></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="35"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="310"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">직위</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="51" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">성명</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="44" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">담당업무</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="152" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">주요경력</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="319" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">주요 연구실적</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="490" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">연구&cr;소장&cr;(대표이사)</TD>
<TD WIDTH="51" HEIGHT="490" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">노광</TD>
<TD WIDTH="44" HEIGHT="490" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">연구총괄</TD>

<TD WIDTH="152" HEIGHT="490" VALIGN="MIDDLE">
<P USERMARK="F-10">미국 Enzon Pharmaceuticals, Inc. &cr;프로젝트 리더('88~'95)&cr;&cr;미국 뉴저지주Rutgers University 생명공학 박사('88.2)&cr;&cr;서울대학교 화학생물공학부 학사('81.2)&cr;</P>
</TD>

<TD WIDTH="319" HEIGHT="490">
<P USERMARK="F-10">[논문]&cr;- Dual Functionality of Calmodulin in Cell Activation: A Kinetic Investigation of Cardiac Automaticity. K Nho - 1989 - Rutgers University</P>
<P USERMARK="F-10">- Peg-Bovine Hemoglobin: Safety en a Canine Dehydrated Hypovolemic-Hemorrhagic Shock Model 1992, Vol. 20, No. 2-4 , Pages 511-524</P>
<P USERMARK="F-10">- PEG-Modified Hemoglobin as an Oxygen Carrier Poly(Ethylene Glycol) Chemistry Topics in Applied Chemistry 1992, pp 171-182</P>
<P USERMARK="F-10">- Dual role of calmodulin in excitable cells Annals of biomedical engineering, 1993, Vol. 21, pp.669-677</P>
<P USERMARK="F-10">- Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel BMC Cancer 2010, 10:211 </P>
<P USERMARK="F-10">- Pharmacokinetics of 125I-radiolabelled PEG-hemoglobin SB1 2006, Vol. 34 No. 3, Pages 277-292</P>
<P USERMARK="F-10">- Prolngation of islet gaft survival by activated polyethylene glycol at the cell sulface: 0153. 2003, Volume 76, Issue 4, ppg S67&cr;[특허] 50여편</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="847" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">차장&cr;(책임연구원)</TD>
<TD WIDTH="51" HEIGHT="847" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">안민정</TD>
<TD WIDTH="44" HEIGHT="847" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">연구기술관리</TD>

<TD WIDTH="152" HEIGHT="847" USERMARK="F-10 0X0000FF" VALIGN="MIDDLE">
<P USERMARK="F-10">한국 생명공학연구원&cr; 프로테옴해석연구실 &cr;(2002.02～2004.03)&cr;&cr;명지대학교 생명과학과 대학원 졸업(2002.02)&cr;&cr;명지대학교 생명과학과 졸업(2000.02)&cr;</P>
</TD>

<TD WIDTH="319" HEIGHT="847" USERMARK="F-10 0X0000FF">
<P USERMARK="F-10">[특허]</P>
<P USERMARK="F-10">- PEG를 유효성분으로 하는 구강건조증 예방 치료 또는 개선을 위한 구강 청정 의약 조성물 (2015.6 등록)</P>
<P USERMARK="F-10">- 히알루론산을 함유하는 PEG 하이드로젤 시스템으로 구성된 연골 활액 충진제(2016.07 국내특허 등록, 국제PCT 출원)</P>
<P USERMARK="F-10">폴리에틸렌글리콜 수화젤 주사제 (등록번호 :10-1637883)</P>
<P USERMARK="F-10">Polyethylene glycol hydrogel injection: PCT/KR2016/006434</P>
<P USERMARK="F-10">Polyethylene glycol hydrogel injection: WO2017/057824 A1</P>
<P USERMARK="F-10">- Novel modified hemoglobin as blood substitute : 63/044,579 </P>
<P USERMARK="F-10">- Hemoglobin derivate co-conjugated with fatty acid-linked PEG and alkoxy PEG as a blood substitute : PCT/KR2021/003530 </P>
<P USERMARK="F-10">- Tertiary alkoxy polyethylene glycol and derivatives thereof :US 10,882,954 B2 (2021.01)</P>
<P USERMARK="F-10">-Siloxy Polyethylene Glycol and Derivatives thereof 17/208,057 </P>
<P USERMARK="F-10">- A uricase co-conjugated with fatty acid-linked polyethylene glycol and methoxy polyethylene glycol, and use thereof : 63/162,342 &cr;외 3편</P>
<P USERMARK="F-10">  </P>
<P USERMARK="F-10">[국가과제]</P>
<P USERMARK="F-10">- 중소기업청 혁신개발사업</P>
<P USERMARK="F-10">과제명: 생체고분자를 모발에 영구적으로 결합시키는 신개념 모발 트리트먼트 제제의 개발(기간: 2005.04.01.～2007.03.31)</P>
<P USERMARK="F-10">- 중소기업청 혁신개발사업</P>
<P USERMARK="F-10">과제명: 검증된 생체친화적 졸-겔 하이드로젤 조성물을 이용한 골관절염 질환 개선 치료제개발(기간:2015.10.01.~2018.01.)&cr;[논문]&cr;- Characterization of Diesel Oil-Degrading Bacteria/The Korean journal of microbiology vol. 39 no.2, 2003년, pp.108-113 &cr; 외 3편</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="497" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">실장&cr;(책임연구원)</TD>
<TD WIDTH="51" HEIGHT="497" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">손병희</TD>
<TD WIDTH="44" HEIGHT="497" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">임상연구</TD>

<TD WIDTH="152" HEIGHT="497" VALIGN="MIDDLE">
<P USERMARK="F-10">삼성생명과학연구소 &cr;임상의학연구센터 &cr;(2007.03~2009.)&cr;&cr;순천향대학교 생명공학과 대학원 졸업(2007.02)&cr;&cr;순천향대학교 유전공학과 졸업(2005.02)</P>
</TD>

<TD WIDTH="319" HEIGHT="497">
<P USERMARK="F-10">[특허]</P>
<P USERMARK="F-10">- PEG를 유효성분으로 하는 구강건조증 예방 치료 또는 개선을 위한 구강 청정 의약 조성물(2015.6)</P>
<P USERMARK="F-10">- 히알루론산을 함유하는 PEG 하이드로젤 시스템으로 구성된 연골 활액 충진제</P>
<P USERMARK="F-10">(2016.07 국내특허 등록, 국제PCT 출원)</P>
<P USERMARK="F-10">- A uricase co-conjugated with fatty acid-linked polyethylene glycol and methoxy polyethylene glycol, and use thereof : 63/162,342</P>
<P USERMARK="F-10">  </P>
<P USERMARK="F-10">[국가과제]</P>
<P USERMARK="F-10">- 중소기업청 혁신개발사업</P>
<P USERMARK="F-10">과제명: 검증된 생체친화적 졸-겔 하이드로젤 조성물을 이용한 골관절염 질환 개선 치료제개발 (기간:2015.10.01.~2018.01.)&cr;</P>
<P USERMARK="F-10">[논문]</P>
<P USERMARK="F-10">- Fibrinolytic Activity and Proteomic Analysis of Bacillus licheniformis HK-12 islated from Chungkuk-Jang. Journal of the Korean Academic Industrial Society, Vol, 9, No.3, pp. 800-806. 6, 2008. 외 6편</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="54" HEIGHT="498" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">실장&cr;(책임연구원)</P>
</TD>

<TD WIDTH="51" HEIGHT="498" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">윤동예</P>
</TD>

<TD WIDTH="44" HEIGHT="498" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">임상연구</P>
</TD>

<TD WIDTH="152" HEIGHT="498" VALIGN="MIDDLE">
<P USERMARK="F-10">㈜젠센 R&D개발본부(연구소)_팀장(2019.08~2020.09)&cr;&cr;㈜아이엠헬스케어 연구개발팀 근무_책임연구원&cr;(2017.03~2018.03)&cr;&cr;㈜엔케이맥스 연구개발팀 근무_팀장(2013.05~2014.07)&cr;&cr;가톨릭대학교(성의교정) 의학세포생물학 박사 졸업&cr;(2007.03~2011.08)&cr;</P>
<P USERMARK="F-10">충남대학교 생물학과 석사 졸업(2005.02~2007.02)&cr;&cr;한남대 미생물학과 졸업&cr;(2004.02)</P>
</TD>

<TD WIDTH="319" HEIGHT="498" USERMARK="F-10">
<P USERMARK="F-10">[특허]</P>
<P USERMARK="F-10">저산소성 허혈 예방 또는 치료용 조성물(국내등록 10-1436684)</P>
<P USERMARK="F-10">  </P>
<P USERMARK="F-10">[논문]</P>
<P USERMARK="F-10">- Non-episodic angioedema with eosinophilia successfully treated with reslizumab.</P>
<P USERMARK="F-10">Chu H, Youn DY, Park HS, Ye YM, Park YB, Ban GY Allergy Asthma Immunol Res. 2020 12(2):371-74.</P>
<P USERMARK="F-10">-Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirinexacerbated respiratory disease.</P>
<P USERMARK="F-10">Ban GY, Youn DY, Ye YM, Park HS PLoS One. 2020 15(10):e0240334.&cr;-BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.</P>
<P>Im CN, Yun HH, Song B, Youn DY, Cui MN, Kim HS, Park GS, Lee JH. Oncotarget. 2016 7(23):35056-70</P>
<P USERMARK="F-10">외 14편</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;나. 연구개발비용&cr;&cr;</SPAN>
<SPAN>(1) 연구개발비용</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="614" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="614" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="614" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">구 분</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2018년도</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2019년도</P>
</TH>

<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2020년도</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154">
<P USERMARK="F-12">비용</P>
<P USERMARK="F-12">처리</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">원재료비</P>
</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">85,257</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">86,114</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">71,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">인건비</P>
</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">163,895</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">199,236</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">256,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">감가상각비</P>
</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">88,854</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">82,695</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">기타경비</P>
</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">327,530</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">307,251</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">212,011</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발비용 합계</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">576,682</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">681,455</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">622,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" USERMARK="F-9">연구개발비/매출액비율&cr;[연구개발비용계÷당기매출액×100]</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="47">13.81%</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="47">10.41%</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="47">11.40%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">매출액</P>
</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">4,174,512</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">6,547,190</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">5,458,529</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(2) 연구개발 투자규모 및 비중</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="631">

<COLGROUP>
<COL WIDTH="622"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="631" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="625" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="156"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">년도</P>
</TH>

<TH WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2018년도</P>
</TH>

<TH WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2019년도</P>
</TH>

<TH WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">2020년도</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">매출액</P>
</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">4,174,512</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">6,547,190</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">5,458,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">경상연구비</P>
</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">576,682</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">681,455</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">622,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-12">연구비율(%)</P>
</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">13.81%</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">10.41%</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">11.40%</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<P>
<SPAN>당사의 </SPAN>
<SPAN>바이오 신약관련 파이프라인 개발을 위해 2018년 분석 및 제조시설(3층 MucoPEG 공정실) 투자를 단행하였으며, 외부 CRO 업체(비임상연구소 2개 업체) 및 고려대 뇌신경과학교실 연구팀 등 대학교 연구팀과 다양한 연구교류 및 개발을 진행하고  있습니다. </SPAN>
</P>
<P>향후 연구개발 관련 pipeline들의 전임상 및 각 파이프라인의 scale up 생산을 계획하고 있으며, 진행정도에 따라 PEG-Hb 산소운반체 파이프라인들의 임상 1상 시험도 계획하고 있습니다. PEG-Hb, PEG-EPO, PEG-uricase 등 PEG-단백질 제품 파이프라인들은 1년여에 걸친 전임상 및 효력시험으로 안전성을 확인하고, scale-up 생산의 수율 및 순도를 확인하는 생산 공정 set-up이 이루어질 예정입니다. 이에 따라 단백질의 분리정제 시스템 장비를 추가하여 여러 pipeline 제품의 생산효율을 증가시킬 계획입니다. </P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>또한 더욱 활발한 연구를 위해 </SPAN>
<SPAN>석박사급 연구원의 추가 채용을 진행하며 연구인력 및 시설 확충을 위해 적극적으로 투자를 진행하고 있습니다.</SPAN>
</P>

<P>
<SPAN>&cr;다. 연구개발실적</SPAN>
</P>
<P></P>

<P>(1) 연구개발 진행 현황 및 향후 계획&cr;공시 서류 작성 기준일 현재 당사가 연구개발 완료 또는 진행 중인 신약[개량 신약, 복제약(시밀러) 등]의 현황은 다음과 같습니다.&cr;&cr;                                       
<SPAN> </SPAN>
<SPAN>  <연구개발 진행 총괄표></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="50"></COL>
<COL WIDTH="37"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="83" USERMARK=" BC0XD7D7D7">구분</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="83" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="83" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="83" USERMARK=" BC0XD7D7D7">연구&cr;시작일</TD>
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" USERMARK=" BC0XD7D7D7">현재진행단계</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="83" USERMARK=" BC0XD7D7D7">연구&cr;중단일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="53" USERMARK=" BC0XD7D7D7">단계&cr;(국가)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53" USERMARK=" BC0XD7D7D7">승인일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="59" HEIGHT="400">바이오</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="46" HEIGHT="119">의료기기</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="70" USERMARK="F-10">MucoPEG™</TD>
<TD WIDTH="119" HEIGHT="70" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">구강건조증 치료제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="70" USERMARK="F-10">2011년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="70" USERMARK="F-10">510(k) 판매허가 획득&cr;(미국)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="70" USERMARK="F-10">2019.11.05</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="70" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="49" USERMARK="F-10">SynoGel</TD>
<TD WIDTH="119" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">연골활액충진제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="49" USERMARK="F-10">2014년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="49" USERMARK="F-10">전임상&cr;(미국)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="49" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="49" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="46" HEIGHT="281">신약</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="49" USERMARK="F-10">SB2&cr;인공혈액</TD>
<TD WIDTH="119" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">허혈성 질환치료제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="49" USERMARK="F-10">2015년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="49" USERMARK="F-10">전임상</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="49" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="49" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="28" USERMARK="F-10">SB2</TD>
<TD WIDTH="119" HEIGHT="28" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">뇌졸중 응급처치지</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="28" USERMARK="F-10">2015년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="28" USERMARK="F-10">전임상</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="49" USERMARK="F-10">SB3</TD>
<TD WIDTH="119" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">당뇨병성 망막증 치료제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="49" USERMARK="F-10">2019년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="49" USERMARK="F-10">전임상</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="49" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="49" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="49" USERMARK="F-10">SB4</TD>
<TD WIDTH="119" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">당뇨병성 족부궤양치료제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="49" USERMARK="F-10">2019년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="49" USERMARK="F-10">전임상</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="49" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="49" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="53" USERMARK="F-10">PEG-EPO</TD>
<TD WIDTH="119" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">신부전증 빈혈 치료제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">2019년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="53">연구, &cr;전임상</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="53" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="53" USERMARK="F-9">PEG-Uricase</TD>
<TD WIDTH="119" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">통풍치료제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">2019년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="53">연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="53" USERMARK="F-10">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="53" USERMARK="F-10">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="292" ALIGN="CENTER" HSPACE="0">pipeline 개발완료 및 제품화시기.jpg</IMG>
<IMG-CAPTION ATOC="N">pipeline 개발완료 및 제품화시기</IMG-CAPTION>
</IMAGE>

<P>
<SPAN>&cr;당사의 여러 제품들은 치료분야 및 의약품 품목 분류에 따라 연구단계와 허가 및 제품화 기간이 상이합니다. 이에 따라 개발 완료 및 제품화가 빠른 품목 및 적용방법, 적응증 분류를 통하여 장/단기 제품화를 계획하고 있습니다.&cr;</SPAN>
</P>
<P>당사의 다양한 PEG 유도체 및 PEGylation 기술을 이용하여 개발 완료한 제품은 바이오시밀러 제품 2건(Pegfilgrastim, PEG-IFN; B형간염 치료제)과 바이오 의료기기 MucoPEG™ 1건이 있습니다. 이후 시장 확대를 위한 추가적인 기술이전 및 비교 임상시험 등을 계획하며, 제품의 가치와 매출 향상을 위해 꾸준히 노력하고 있습니다.&cr;&cr;핵심 기술인 PEGylation 기술을 바탕으로 신약, 바이오시밀러, 의료기기 등 다양한 분야에서 신규 PEG 유도체 및 이를 이용한 제품관련 특허를 국내외에 출원/등록하고 있습니다. </P>

<P>
<SPAN>&cr;(가) 품목 : MucoPEG™</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="624" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="86"></COL>
<COL WIDTH="520"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="529" HEIGHT="30" USERMARK="F-10">바이오 의료기기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="49" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD WIDTH="529" HEIGHT="49" USERMARK="F-10">구강건조 증상(통증, 구취,염증,건조감)완화와 불쾌감을 덜어주고, 상쾌하게 보습하고, 구강 건조를 윤활시키는 구강 보습제.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="112" USERMARK=" BC0XD7D7D7">작용기전</TD>
<TD WIDTH="529" HEIGHT="112" USERMARK="F-10">MucoPEG™은 PEG(polyethylene gycol) 유도체와 구강점막 상피 세포의 결합을 적용한 구강조성물로서 친수성과 보습성이 높은 PEG가 구강세표 표면에 오랜 시간 잔류하면서 구강건조증을 완화 시키는 것을 목표로 합니다. 노화 또는 질병으로 인한 구강 건조증이 있는 사람들을 위한 구강 보습효과와 보습 지속력을 증가시켜 구강건조증을 완화하는 위생 증진 조성물로 개발됨.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="70" USERMARK=" BC0XD7D7D7">제품의 특성</TD>
<TD WIDTH="529" HEIGHT="70" USERMARK="F-10">당사의 MucoPEG은 기존 화학합성 의약품의 타액선 자극을 통한 무분별한 타액증가의 부작용이 없으며, 일반 보습제를 이용한 일시적인 구강건조 완화효과와 비교하여 구강점막에 공유결합하여 보습지속성이 크게 증가된 제품임.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="112" USERMARK=" BC0XD7D7D7">진행경과</TD>

<TD WIDTH="529" HEIGHT="112" USERMARK="F-10">

<P USERMARK="F-10">
<SPAN>- 미국 FDA 기준 의료기기/인공타액 제품으로 510(k) 판매허가 획득&cr;- PharmaSolution(Guangzhou Bairui사의 자회사, Hong Kong, China)와 중국내 예비임상을 바탕으로 기술이전 및 제품판매, 그리고 중국내 허가 준비중.&cr; -510(k)의 판매 허가 획득을 바탕으로 경재업체에 라이센스아웃을 위해 미국에서 구강건조증 환자를 대상으로 경쟁사 제품과 비교임상을 진행하고 있음.</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="133" USERMARK=" BC0XD7D7D7">향후계획</TD>

<TD WIDTH="529" HEIGHT="133" USERMARK="F-10">
<SPAN> 향후 미국의 비교 임상결과에 따라 기술이전 및 주원료 PEG 유도체, MucoPEG 제품 판매 및 로열티 수익을 계획하고 있음.&cr;기술 및 제품의 인지도 확대를 위해 미국 구강건조증 환자를 대상으로 한 비교임상 후, 임상시험을 진행한 의료기관의 의료진을 통하여 논문 및 포스터 등으로 연구결과를 발표할 예정임. 또한, 임상시험 기관의 치과의사들에게 MucoPEG 샘플을 제공하여 홍보할 예정이며 조금씩 한국의 선바이오 MucoPEG의 인지도를 올릴 것임. </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30" USERMARK=" BC0XD7D7D7">경쟁제품</TD>
<TD WIDTH="529" HEIGHT="30" USERMARK="F-10">GSK, Colgate-Palmolive 사 등 oral care Mouthwashes, 인공타액 제품 등.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="112" USERMARK=" BC0XD7D7D7">관련논문 등</TD>
<TD WIDTH="529" HEIGHT="112" USERMARK="F-10">국내 특허 등록 및 미국특허 출원 외 해당제품 관련 논문게재 및 학회발표 사례는 없음.&cr;- 2015년 06월 폴리에틸렌 글리콜 유도체를 유효성분으로 포함하는 구강 건조증 예방, 치료 또는 개선을 위한 구강 청정제 조성물 및 의약조성물 국내특허 등록 (제10-1526258호)&cr;- 2013년 10월 Method of Relieving, Improving, Preventing or Treating Xerostomia 미국특허 출원 (US2014/0155457 A1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="486" USERMARK=" BC0XD7D7D7">시장규모</TD>

<TD WIDTH="529" HEIGHT="486" USERMARK="F-10">
<P USERMARK="F-10">- 전 세계 구강 건조증 치료제 시장 규모는 2018 년에 6 억 5,530 만 달러로 추정되었으며 2019 년에서 2026 년 사이에 연평균 3.6 % 성장할 것으로 예상함.</P>

<IMAGE>
<IMG WIDTH="520" HEIGHT="225" ALIGN="CENTER" HSPACE="0">xerostomia-therapeutics-market.jpg</IMG>
<IMG-CAPTION ATOC="N">세계 구강 건조증 치료제 시장</IMG-CAPTION>
</IMAGE>
<P USERMARK="F-10">&cr;구강건조증치료제 시장은 전 세계적으로 관련 질병의 증가로 인해 성장이 예상. HIV 및 쇼그렌 증후군의 발생이 증가함에 따라 시장 성장이 가속화되고 있음. American college의 Rheumatology에 따르면 미국에서 약 310 만 명이 Sjogren의 장애를 가지고 있는 것으로 추정함. 또한 화학 요법 및 방사선 요법과 같은 암 치료 요법의 채택 및 사용이 증가함에 따라 구강 건조증 발생도 증가하여 시장이 더욱 확대되고 있음(Polaris Market Research).&cr;이에 따라, 기존 구강건조증 치료제의 일시적 효과의 단점을 보완한 당사의 구강건조증 치료제 MucoPEG 이 출시 될 경우 큰 파급력을 보일 것으로 예상함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타사항</TD>
<TD WIDTH="529" HEIGHT="30" USERMARK="F-10">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(나) 품목 : SynoGel
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="86"></COL>
<COL WIDTH="522"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD WIDTH="531" HEIGHT="30" USERMARK="F-10">바이오 의료기기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">적응증</TD>
<TD WIDTH="531" HEIGHT="30" USERMARK="F-10">골관절염의 통증완화를 위한 연골활액 충진제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE">작용기전</TD>
<TD WIDTH="531" HEIGHT="91" USERMARK="F-10">두 종류의 PEG 유도체를 이용한 하이드로젤(Hydrogel)기술로 4 개의 반응기를 가진 4 가지(4 arm)PEG 유도체 두 종류를 액체상태에서 혼합하여 연골강내 주사기를 이용 주입 후, 연골강내에서 각각의 반응기가 서서히 반응하여 Hydrogel을 형성하는 연골활액 충진제용 주사제로써 연골강내 국소적으로 주사하는 제품.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="238" ALIGN="CENTER" VALIGN="MIDDLE">제품의 특성</TD>
<TD WIDTH="531" HEIGHT="238" USERMARK="F-10">- 기존 제품의 높은 점도로 인하여 관절(연골강) 내 투입 시 높은 돌출압에 의해 통증이 유발되는 단점을 감소시키고, 가교화 시간을 조절하여 주사 시 낮은 점도로 주입을 용이하게 함. 또한, 주입 후 연골강내에서 두 종류의 PEG 유도체가 반응하여 서서히 펩티드 결합을 형성하면서 점탄성이 우수한 수화젤을 형성하게 함으로써, 관절 내 1회 투여로 관절염 질환에 의해 유발된 통증 억제, 연골 보호 효과 및 활막 염증 억제 효과가 우수한 주사제로 개발되고 있음. &cr;- 기존제품은 다회 (3～5회) 투여로 인하여 환자의 치료 순응도가 낮아 효과 지속시간을 연장하기 위한 다양한 연구개발 시도가 진행되고 있으나, 당사의 Synogel 1회 투여로 기존 3～5회 투여 시의 효과 및 그 이상의 지속효과를 나타낸다면 환자의 순응도가 높아질 것이며, 그에 따라 과거 관절 치료를 적용할 수 없었던 환자에게도 적용이 가능해지고, 전체적으로 관절강 내 주사제 치료를 받는 환자 수가 증가하는 등의 효과를 보일 것으로 예상됨.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="301" ALIGN="CENTER" VALIGN="MIDDLE">진행경과</TD>

<TD WIDTH="531" HEIGHT="301" USERMARK="F-10">
<SPAN>- 제품개발에 적합한 물질의 탐색을 위해 당사에서 생산하는 PEG 유도체   선별시험을 수행&cr;- 선별시험을 통해 선택한 PEG 유도체의 물리적 특성 (점탄성) 측정시험    실시 (Koptri; ㈜한국고분자시험연구원)&cr;- 기존 제품의 단점을 보완한 기술의 차별적 특성 확인&cr;- 통증완화 비교시험(비임상효력시험)을 관절염 동물모델을 이용하여 수행(Chemon; ㈜켐온)&cr;- Pilot SynoGel™의 제품화를 위한 중소기업 기술개발사업 협약체결 &cr;  ; 기술혁신개발사업&cr;- ADME Study를 위한 14C-AM 합성 제조 (Curachem; 큐라켐)&cr;- SynoGel™의 장기잔존확인 및 ADME 분석을 위한 시험 ; MPI Research&cr;</SPAN>
<SPAN>- ~2019년, Wuxi Apptec.(US)에서 미국 의료기기 등록을 위한 비임상 시험 (생체적합성 시험) 완료 후  특정 시험항목의 부적합 판정&cr;- 조성 관련 추가 연구 진행 중.</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">향후계획</TD>
<TD WIDTH="531" HEIGHT="49" USERMARK="F-10">제품의 조성관련 추가연구를 진행하여, 모든 전임상 시험(생체적합성 시험 외)을 완료 후 미국 임상 진행 예정. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">경쟁제품</TD>
<TD WIDTH="531" HEIGHT="49" USERMARK="F-10">Genzyme, Aimmer Biomet, Sanofi 사의 Synvisc-One?, Hyalgan?, Supartz?등 연골활액 충진제품.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="217" ALIGN="CENTER" VALIGN="MIDDLE">관련논문 등</TD>
<TD WIDTH="531" HEIGHT="217" USERMARK="F-10">국내 특허 등록 및 PCT 출원, 미국, 유럽 특허 출원 외 해당제품 관련 논문게재 및 학회발표 사례는 없음.&cr;- 2004년 SynoGel™의 전신이 되는 하이드로젤 제조방법에 대한&cr;   국내특허 등록 (제 10-0444944호)&cr;- 2016년 7월 SynoGel™ (폴리에틸렌글리콜 수화젤 주사제) &cr;   국내특허 등록 (제 10-1637883호)&cr;- 2016년 SynoGel™ (Polyethylene Glycol Hydrogel Injection) &cr;  국제 PCT 출원 (PCT/KR2016/006434)&cr;- 2017년 6월 미국특허 출원 (US 2017/0340774 A1)&cr;- 2017년 12월 유럽특허 출원 (16851972.6)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="77" ALIGN="CENTER" VALIGN="MIDDLE">시장규모</TD>

<TD WIDTH="531" HEIGHT="77" USERMARK="F-10">
<SPAN>- 미국의 전문 시장조사 기관인 Grand view research의 정보에 따르면, 2019년 기준 연골활액 충진제(Viscosupplementation)관련 시장 규모는 약 38억 달러이며, </SPAN>
<SPAN>2020년까지 78억 달러에 도달 할 것이라고 예측하였고, </SPAN>
<SPAN>매년 CAGR 9.2% 로 성장할 것을 전망하였음.</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타사항</TD>

<TD WIDTH="531" HEIGHT="30" USERMARK="F-10">
<SPAN>정부과제 중소기업청 과제 완료(2015.10~2018.01)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(다) 품목 : SB(SB1~ 4) project
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="86"></COL>
<COL WIDTH="521"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD WIDTH="530" HEIGHT="28" USERMARK="F-10">바이오 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE">적응증</TD>
<TD WIDTH="530" HEIGHT="70" USERMARK="F-10">- 허혈성 질환치료제, 뇌졸중 응급처치지, 당뇨병성 망막증 치료제, 당뇨병성족부궤양치료제 등 허혈부위의 용이한 산소공급&cr;- 응급 수혈을 위한 인공혈액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE">작용기전</TD>
<TD WIDTH="530" HEIGHT="70" USERMARK="F-10">산소운반 단백질인 헤모글로빈(Hb)에 PEGylation 기술을 도입, PEGylated Hb을 제조하여, 적혈구가 통과할 수 없는 미세혈관 및 질환상태의 혈관을 용이하게 통과하여 산소를 공급함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="217" ALIGN="CENTER" VALIGN="MIDDLE">제품의 특성</TD>
<TD WIDTH="530" HEIGHT="217" USERMARK="F-10">헤모글로빈의 표면에 PEG를 화학적으로 안정한 형태로 결합한 PEG-단백질 형태로서 이종단백질의 인체투여로 인한 면역거부 반응을 최소화하며, 건강한 세포보다는 신속한 산소공급이 필요로 하는 저산소상태의 세포(Hypoxia)에 선택적으로 산소를 전달하는 특징이 있음.&cr;산소운반체의 가능성은 크나, 인공혈액이라는 대규모의 임상시험 투자에 앞서서, 일단 비교적 소규모이지만 임상의 실시와 결과가 보다 명확히 규정되는 뇌졸중응급처치 개발에 초점을 두고 있음.  &cr;혈전이나 출혈 등 원인에 관계없이, 사고 직후 투여하여, 사고 후 처치까지의 서너시간 동안 피가 안 통하는 혈전부위 뇌세포에 산소를 전달하는 것이 시험 프로토콜이며, 혈전뇌졸중의 경우에 혈전부위 뇌세포를 정상적으로 유지하는 것이 시험을 통해 확인되었음. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="217" ALIGN="CENTER" VALIGN="MIDDLE">진행경과</TD>
<TD WIDTH="530" HEIGHT="217" USERMARK="F-10">PEGylated Hb의 비임상시험 완료&cr;; 설치류에서의 급성/아급성 독성, 비설치류에서의 급성/아급성 독성, 유전독성/면역독성, 설치류에서의 약물동태 및 약력학 시험, 비설치류에서의 약물동태 및 약력학 시험, 일반약리작용 시험 등 - 과거 수행하였던 비임상시험 결과는 현재 대부분 유효하다는 식약처의 유권해석을 받음.&cr;고려대 뇌신경과학 연구소와 공동연구를 진행하여 효능시험을 확인, 관련 특허만료를 고려한 새로운 제형 및 기술로의 신규 후보물질을 연구 개발 중.&cr;신규후보 물질을 위한 신규 PEG 유도체 및 PEG-Hb 기술 특허를 출원하였으며, Rat 동물에서의 생존율에 의한 기본 독성, 반감기, 기타 산소전달 관련 효력시험들을 진행(인천 루다큐어 주식회사)하고 있음. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE">향후계획</TD>
<TD WIDTH="530" HEIGHT="70" USERMARK="F-10">새로운 제형 및 기술의 신규 후보물질에 대한 허혈부위의 산소전달 및 출혈 시 인공혈액 대체제를 목적으로 다양한 연구개발 및 효능시험이 진행 중이며, 안정한 제형 및 생산 제조과정을 개선하여 비임상 독성시험을 계획하고 있음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">경쟁제품</TD>
<TD WIDTH="530" HEIGHT="49" USERMARK="F-10">Sangart, Biopure,Prolong Pharma사 등 여러 개발 업체들 가운데 사람을 대상으로한 임상이 완료되거나 상용화 업체는 아직 없음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">관련논문 등</TD>
<TD WIDTH="530" HEIGHT="49" USERMARK="F-10">Attenuated Cerebral Ischemic Injury by Polyethylene Glycol-Conjugated Hemoglobin. Biomolecules & Therapeutics, 17(3), 270-275 (2009)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="364" ALIGN="CENTER" VALIGN="MIDDLE">시장규모</TD>
<TD WIDTH="530" HEIGHT="364" USERMARK="F-10">-세계 보건기구 (World Health Organization)에 따르면, 뇌졸중으로 인한 사망자가 매년 620만 명에 달하며, 2016년 기준 약 1400만 건의 뇌졸중이 발생하였음. 뇌졸중은 전체 사망원인 중 약 10%를 차지하고 있으며, 암에 이어 가장 높은 비중을 차지하고 있고, 인구 고령화에 따른 추세를 고려하였을 때, 2030년에는 현재보다 뇌졸중 발생이 약 3배 증가할 것으로 예측되고 있음.&cr; [출처: Paper-Investigation of Stroke Evaluation Methodology and Related Factors Through the Literature Review J Ergon Soc Korea 2017;  36(6): 693-704, http://dx.doi.org/10.5143/JESK.2017.36.6.693, https://www.worldstrokecampaign.org/learn/facts-and-figures.html&cr;- 2017년 뇌졸중 치료제 관련 시장은 현재 1.5조 원 남짓한 수준이지만, 이는 현재 시장에서 사용되 는 혈전용해제 등의 시장 규모에 불과하며, 향후 산소운반체를 활용한 적극적 응급처치용 신약이 개발된다면 이는 관련 시장에 지각 변동을 가져올 것으로 예상됨.&cr;- 글로벌 잠재적인 인공 혈액 대체품 시장은 2022년까지 약 52억 달러($5,204 million)로 예상되며, 2027년까지 약177억 달러($17,775 million)의 가치를 가정하여 27.8 % 성장할 것으로 예상하기도 함. 특히, 외상성 부상 부문은 2022 년 인공 혈액 대체물 시장에 약19억 달러($1,993 million)로 가장 큰 기여를 할 것으로 예상함(출처: 4) Artificial Blood Substitutes Global Market and Patent Landscape Report till 2025, AheadIntel).</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="95" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">기타사항</TD>
<TD WIDTH="530" HEIGHT="49" USERMARK="F-10">고려대 뇌신경과학 연구소 김원기 교수와 연구협력&cr;인천 루다큐어 주식회사에서 동물 독성 및 효력시험 진행 중.</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(라) 기타 바이오베터 및 신약개발; PEG-uricase&cr;바이오신약 PEG-uricase 통풍치료제는 기존의 Savient Pharmaceuticals에서 개발된 Krystexxa™(Pegloticase의 상품명)의 주사 부위에 아나필락시스와 같은 이상반응, 약물에 대한 자가 항체 형성에 의한 약물의 무반응 및 약물효과 감소의 문제점을 해결하기 위해, 당사의 신규한 PEG 유도체를 이용하여 연구개발하고 있습니다. 기존 바이오의약품과 바이오시밀러에 사용되는 PEG 말단기의 methoxy기를 변화시켜, 다양한 구조의 3차 alkoxy기로 이루어진 신규 PEG 유도체를 발명하여 미국특허(#10,882,954)로 등록 되었으며, 이 PEG를 이용하여 uricase를 PEGylation하여 기존의 자가 항체 형성 문제점을 해결 하고자 연구개발 중이며, 이 PEGylation 기술은  미국특허 출원을 준비하고있습니다.&cr;&cr;(2) 연구개발 완료 실적&cr;&cr;공시서류 작성기준일 현재 개발이 완료된 신약[개량신약, 복제약(시밀러) 등 포함]의 현황은 다음과 같습니다.&cr;
<SPAN USERMARK=" 0X0000FF"></SPAN>&cr;                                         < 연구개발 완료 실적>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="48"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="85" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="73" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">적응증</TD>
<TD USERMARK="F-10 BC0XD7D7D7" WIDTH="76" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">개발완료일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="152" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">현재현황</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="160" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="57" HEIGHT="175" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">바이오&cr;시밀러</TD>
<TD WIDTH="85" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">Pelgraz&cr;Lapelga&cr;Neupeg</TD>
<TD WIDTH="73" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">호중구&cr; 감소증 &cr;치료제</TD>
<TD WIDTH="76" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">2004년</TD>

<TD WIDTH="152" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-10 BC0X28BFFF">2008(인도),&cr;2018(유럽,캐나다,호주)&cr;승인 판매중</SPAN>
</TD>
<TD WIDTH="160" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">Intas(인도)에 &cr;라이센스아웃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">PEG-IFN</TD>
<TD WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">C형 간염치료제</TD>
<TD WIDTH="76" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">2004년</TD>
<TD WIDTH="152" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">2014 인도승인</TD>

<TD WIDTH="160" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-10 BC0X28BFFF">Intas(인도)에 &cr;라이센스아웃</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="57" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE">의료&cr;기기</TD>
<TD WIDTH="85" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">MucoPEG™</TD>
<TD WIDTH="73" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">구강&cr;건조증 &cr;치료제</TD>
<TD WIDTH="76" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">2019년</TD>
<TD WIDTH="152" HEIGHT="91" VALIGN="MIDDLE" USERMARK="F-10">- 2019년 11월 5일&cr;   FDA 510(k) 판매허가&cr;- 중국내 제품허가 준비&cr;- 미국 비교임상 진행중 </TD>

<TD WIDTH="160" HEIGHT="91" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">
<SPAN>중국Guangzhou Bairui&cr;(PharmaSolution사) &cr;기술이전</SPAN> 및 임상용 &cr;제품 판매
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당사가 Intas 사에 기술이전하여 인도 시장 </SPAN>
<SPAN>및 최근 캐나다와 유럽에서</SPAN>
<SPAN> 판매중인 Neupeg</SPAN>
<SPAN>™</SPAN>
<SPAN>(</SPAN>
<SPAN>Lapelga</SPAN>
<SPAN>™</SPAN>
<SPAN>/Pelgraz™</SPAN>
<SPAN>)은 로열티 수입원이며 더불어 Neupeg™의 원료인 PEG유도체를 Intas사에 공급 중</SPAN>
<SPAN>이며, 바이오시밀러 의약품과 관련된 매출의 기여도는 다음 표와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="631">

<COLGROUP>
<COL WIDTH="622"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="631" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="163" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>년도</P>
</TH>

<TH WIDTH="154" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년도</P>
</TH>

<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년도</P>
</TH>

<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년도</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전체매출</P>
</TD>
<TD WIDTH="154" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,174,512</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,190</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,458,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Neupeg™ </P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>로열티</P>
</TD>
<TD WIDTH="154" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,505</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,056,037</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,049,857</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>원료공급</P>
</TD>
<TD WIDTH="154" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,628,016</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,607,075</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,451,237</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>%</P>
</TD>
<TD WIDTH="154" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39.10%</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84.70%</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84.70%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 기타 연구개발 실적&cr;</P>
<P>(가) 정부 및 기관 과제 수행 내역</P>

<TABLE WIDTH="823" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="277"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="78" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">프로그램명</P>
<P USERMARK="F-12">(시행부처/기관)</P>
</TH>

<TH WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="78" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">과 제 명</P>
</TH>

<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="78" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">출연금(만원)/</P>
<P USERMARK="F-12">총 개발기간</P>
<P>(시작-종료)</P>
</TH>

<TH WIDTH="286" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="78" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">연 구 결 과 </P>
</TH>

<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="78" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-12">상품화</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">공업기반기술</P>
<P USERMARK="F-10">개발사업</P>
<P USERMARK="F-10">(산업자원부)</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">뇌졸중 &cr; 응급치료제 </P>
<P USERMARK="F-10">개발</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">1억6천</P>
<P USERMARK="F-10">(98. 05. 01 &cr; ～ 99. 10. 30)</P>
</TD>

<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="70">
<P USERMARK="F-10">뇌졸중 응급치료제의 개발을 위해일부 비임상 동물 독성시험을 완료 (뇌졸중 응급치료제의 안전성 확인)</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70">
<P USERMARK="F-10">기관 과제 완료</P>
<P USERMARK="F-10">; 연구 진행 중.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">보건의료기술</P>
<P USERMARK="F-10">개발사업</P>
<P USERMARK="F-10">(보건복지부)</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">항암 &cr; 활성제의 </P>
<P USERMARK="F-10">개발</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2억3천</P>
<P USERMARK="F-10">(98. 05. 01 &cr; ～ 00. 04. 30)</P>
</TD>

<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">저산소상태의 악성 암세포에 산소를 공급하여, 치료가 가능한 고산소 상태의 양성 암세포로 변형시켜 항암제 활성의 증가를 확인하는 효력시험 완료</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">기관 과제 완료</P>
<P USERMARK="F-10">; 연구 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">중소기업기술</P>
<P USERMARK="F-10">혁신개발사업</P>
<P USERMARK="F-10">(중기청)</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" HEIGHT="133" ALIGN="CENTER">
<P USERMARK="F-10">생체고분자를 &cr; 모발에 영구적으로 &cr; 결합시키는 &cr; 신 개념 모발 &cr; 트리트먼트 &cr;제제의 개발</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">2억4천</P>
<P USERMARK="F-10">(05. 04. 01 &cr; ～ 07. 03. 31)</P>
</TD>

<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">- 지적재산권 : 2 건수 (등록 1건, 출원 1건)</P>
<P USERMARK="F-10">- 학술회의 발표 : 1건수</P>
<P USERMARK="F-10">- ICID 등록, 신청 : 등록 2건, 신청 2건</P>
<P USERMARK="F-10">- 박람회 출품 : 2007 서울 국제 화장품미용박람회 출품, 2011 라스베가스 미용박람회 등</P>
<P USERMARK="F-10">- 기술적으로 성공하여, 관련 컨벤션 참여</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기관 과제 완료</P>
<P USERMARK="F-10">;원료 (PEG 유도체) &cr; 가격대비 낮은 &cr; 제품 가격 문제로 &cr; 상품화 실패</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">전남  테크노파크</P>
<P USERMARK="F-10">입주기업  핵심역량</P>
<P USERMARK="F-10">기술개발사업&cr;(전남  테크노파크)</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">다중암</P>
<P USERMARK="F-10">폴리에틸렌글리콜 및 </P>
<P USERMARK="F-10">유도체 개발</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">5천</P>
<P USERMARK="F-10">(2010.05.01&cr; ~2010.12.31)</P>
</TD>

<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">새로운 합성방법을 통해 다중암 (8-armPEG-OH ) 및 유도체를 개발.</P>
<P USERMARK="F-10">이를 이용하여 기존의 다중암 폴리에틸렌글리콜 유도체와는 차별화된 제품생산이 가능.</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">기관 과제 완료</P>
<P USERMARK="F-10">; PEG 유도체 &cr; 상품 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">중소기업기술</P>
<P USERMARK="F-10">혁신개발사업</P>
<P USERMARK="F-10">(중기청)</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">검증된 생체친화적 &cr; 졸-겔 하이드로젤 &cr; 조성물을 이용한 &cr; 골관절염 질환 &cr; 개선 치료제 개발</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">4억1천6백</P>
<P USERMARK="F-10">(15. 10. 12 &cr; ～ 18. 01. 11)</P>
</TD>

<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="133">
<P USERMARK="F-10">생체 친화적인 고분자 PEG유도체를 이용한 하이드로젤에 관한 것으로, PEG-하이드로젤 기술을 관절염 주사액 조성물로 사용하여, 관절염 증상 개선 효과 및 체내 지속을 증가시킨 PEG- 연골활액 충진용 주사제를 개발하는 것을 목표로 함. </P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="133">
<P USERMARK="F-10">기관 과제 &cr; 종료.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>(나) 지적재산권 등&cr;당사가 보유한 지적재산권의 목록은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1015">

<COLGROUP>
<COL WIDTH="24"></COL>
<COL WIDTH="31"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="442"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="33" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>번</P>
<P>호</P>
</TH>

<TH WIDTH="40" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구</P>
<P>분</P>
</TH>

<TH WIDTH="138" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>등록번호(출원)</P>
</TH>

<TH WIDTH="451" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내 용</P>
</TH>

<TH WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>권리자</P>
</TH>

<TH WIDTH="118" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>등록(출원)</P>
</TH>

<TH WIDTH="145" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적용제품</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">1</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0195609</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">헤모글로빈 변성체 그의 제조방법 및 그를 함유하는 항암 활성제 (특허권 만료)</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">노광</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 1996.06.11</P>
<P USERMARK="F-10">등록: 1999.02.12</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">산소운반체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">2</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-2091828</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">폴리에틸렌글리콜-석시니미딜프로피오네이트</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 1998.08.21</P>
<P USERMARK="F-10">등록: 2001.03.16</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">산소운반체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">3</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-2099413</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">헤모글로빈의 누출위험이 없는 헤모글로빈-리포좀 시스템</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 1998.11.18</P>
<P USERMARK="F-10">등록: 2001.06.08</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">산소운반체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">4</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0316154</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">폴리에틸렌글리콜-헤모글로빈 결합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 1998.03.26</P>
<P USERMARK="F-10">등록: 2001.11.17</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">산소운반체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">5</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0330733</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">폴리에틸렌글리콜포스페이트, 그의 합성방법 및 그를 방사능보호제로 사용하는 방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">노광</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 1999.11.30</P>
<P USERMARK="F-10">등록: 2002.03.18</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">방사능보호제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">6</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0353392</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">높은 생체활성도를 갖는 생체활성 단백질과 PEG의 결합체 제조방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2000.03.13</P>
<P USERMARK="F-10">등록: 2002.09.06</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">PEGylation 기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">7</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0444944</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">생체접착용 폴리에틸렌글리콜 수화젤</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.05.24</P>
<P USERMARK="F-10">등록: 2004.08.09</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">지혈봉합용 젤</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">8</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0451308</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">단백질 의약품 정제방법에서의 바이러스 제거방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.12.28</P>
<P USERMARK="F-10">등록: 2004.09.22</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">산소운반체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">9</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0459105</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">변형된 인터페론 α 2a 및 2b, 그리고 이들과 PEG 유도체와의 배합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.11.06</P>
<P USERMARK="F-10">등록: 2005.08.25</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">신약 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0480432</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">G-CSF와 폴리에틸렌글리콜 유도체의 배합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.12.04</P>
<P USERMARK="F-10">등록: 2005.03.23</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">11</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0480423</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">에리트로포이에틴과 폴리에틸렌글리콜 유도체의 배합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.12.04</P>
<P USERMARK="F-10">등록: 2005.03.23</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">12</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0480429</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">인터페론-알파와 폴리에틸렌글리콜 유도체의 배합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.12.04</P>
<P USERMARK="F-10">등록: 2005.03.23</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">13</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0480430</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">인터페론-베타와 폴리에틸렌글리콜 유도체의 배합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.12.04</P>
<P USERMARK="F-10">등록: 2005.03.23</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">14</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0488351</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">신규한 폴리에틸렌글리콜-프로피온알데히드 유도체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.12.11</P>
<P USERMARK="F-10">등록: 2005.04.29</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">15</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0511749</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">변형된 인터페론-베타, 및 이의 화학적으로 변형된 배합체</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2001.11.06</P>
<P USERMARK="F-10">등록: 2005.08.25</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">신약 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">16</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 6858736 B2</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Hexa-arm polyethylene glycol and its derivatives and the methods of preparation thereof</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2002.12.23</P>
<P USERMARK="F-10">등록: 2005.02.22</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">나노테크놀로지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">17</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0512483</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.05.07</P>
<P USERMARK="F-10">등록: 2005.08.29</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">18</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 6828401 B2</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Preparation method of peg-maleimide derivatives</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.10.29</P>
<P USERMARK="F-10">등록: 2004.12.07</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">19</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 6916962 B2</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Monofunctional polyethylene glycol aldehydes</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.05.07</P>
<P USERMARK="F-10">등록: 2005.07.12</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">20</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 6956135 B2</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Monofunctional polyethylene glycol aldehydes</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.09.12</P>
<P USERMARK="F-10">등록: 2005.10.18</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">21</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 7041855 B2</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Monofunctional polyethylene glycol aldehydes</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.11.18</P>
<P USERMARK="F-10">등록: 2006.05.09</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">22</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0551096</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">신규한 와이-폴리에틸렌글리콜 유도체 및 그의 제조방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.08.08</P>
<P USERMARK="F-10">등록: 2006.02.03</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">23</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 7217845 B2</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Bifunctional polyethylene glycol derivatives</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2003.11.21</P>
<P USERMARK="F-10">등록: 2007.05.15</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">24</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0631855</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">신규한 와이-폴리에틸렌글리콜 유도체 및 그의 합성 방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2004.04.01</P>
<P USERMARK="F-10">등록: 2006.09.27</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">바이오시밀러</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">25</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0671935</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">폴리에틸렌글리콜 유도체를 유효성분으로 함유하는 모발 코팅용 조성물</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2004.10.22</P>
<P USERMARK="F-10">등록: 2007.01.15</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">모발 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">26</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-0862651</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">모발 처리용 조성물, 모발 처리제 및 이를 이용한 모발처리방법</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2007.05.09</P>
<P USERMARK="F-10">등록: 2008.10.02</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">모발 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">27</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-1526258</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">폴리에틸렌 글리콜 유도체를 유효성분으로 포함하는 구강 건조증 예방, 치료 또는 개선을 위한 구강 청정제 조성물 및 의약 조성물</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2013.05.15</P>
<P USERMARK="F-10">등록: 2015.06.01</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">구강건조증 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">28</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국내</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">10-1637883</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">폴리에틸렌글리콜 수화젤 주사제</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2015.09.30</P>
<P USERMARK="F-10">등록: 2016.07.04</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">연골활액 충진제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">29</P>
</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">국제</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">PCT/KR2016&cr; /006434</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Polyethylene glycol hydrogel injection</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원: 2016.06.17.</P>
<P USERMARK="F-10">공개</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">연골활액 충진제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="33" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">30</TD>

<TD WIDTH="40" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">미국</P>
</TD>

<TD WIDTH="138" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">US 2017/0340774 A1</P>
</TD>

<TD WIDTH="451" HEIGHT="49" VALIGN="MIDDLE">
<P USERMARK="F-10">Polyethylene glycol hydrogel injection</P>
</TD>

<TD WIDTH="90" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원:2017.06.12</P>
<P USERMARK="F-10">공개:2017.11.30</P>
</TD>

<TD WIDTH="145" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">연골활액 충진제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="33" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">31</TD>

<TD WIDTH="40" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">유럽</P>
</TD>

<TD WIDTH="138" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">WO2017/057824 A1</P>
</TD>

<TD WIDTH="451" HEIGHT="28" VALIGN="MIDDLE">
<P USERMARK="F-10">Polyethylene glycol hydrogel injection</P>
</TD>

<TD WIDTH="90" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">선바이오㈜</P>
</TD>

<TD WIDTH="118" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">출원:2017.12.22</P>
</TD>

<TD WIDTH="145" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-10">연골활액 충진제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="33" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">32</TD>
<TD USERMARK="F-10" WIDTH="40" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD USERMARK="F-10" WIDTH="138" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">US 16/381,499</TD>
<TD USERMARK="F-10" WIDTH="451" HEIGHT="28" VALIGN="MIDDLE">Tertiary Alkoxy Polyethylene Glycol and Derivatives thereof</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">선바이오㈜</TD>
<TD USERMARK="F-10" WIDTH="118" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">출원:2019.04.11</TD>
<TD USERMARK="F-10" WIDTH="145" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">신규 PEG 유도체</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="33" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">33</TD>
<TD WIDTH="40" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">미국</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">63/044,579</TD>
<TD WIDTH="451" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-10">Novel modified hemoglobin as blood substitute</TD>

<TD WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-10">선바이오㈜</SPAN>
</TD>

<TD WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-10">출원:2020.06.26</SPAN>
</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">산소운반체</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(다) 기술이전 수혜 또는 기술이전</SPAN>
</P>

<P>
<SPAN>당</SPAN>
<SPAN>사의 바이오시밀러 및 신약 개발기술 또는 PEGylation 기술과 PEG 유도체 제조기술 등을 개발 협력업체에 기술이전 한 사항을 아래와 같이 표로 정리하였습니다.  &cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="994">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="575"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>계약일</P>
</TH>

<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>계약성격</P>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>계약 제품 </P>
<P>또는 기술</P>
</TH>

<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>계약상대(국가)</P>
</TH>

<TH WIDTH="584" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>계약의 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">2003. 11. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">PEG-GCSF</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">Intas Pharmaceuticals Ltd.</P>
<P USERMARK="F-10">(India)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="112">

<P>
<SPAN USERMARK="F-10">PEG-GCSF의 개발을 위한 기술이전 및 PEG유도체 공급 계약. PEG-GCSF는 항암치료시 사용되는 백혈구 생성 촉진제이며, 본 계약은 INTAS에서 생산한 GCSF의약품에 </SPAN>
<SPAN USERMARK="F-10">당사의</SPAN>
<SPAN USERMARK="F-10"> PEG유도체를 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">의 페길레이션 기술로 부착하는 제조공정 기술이전에 관한 것임. 이 제조기술을 Intas의 연구진들이 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">를 3개월 방문체류하여 기술 습득함 </SPAN>
</P>
<P USERMARK="F-10">계약금 :USD150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">2003. 11.</P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약 </P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">PEG-인터페론</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">Intas Pharmaceuticals Ltd.</P>
<P USERMARK="F-10">(India)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="112">

<P>
<SPAN USERMARK="F-10">PEG-인터페론의 개발을 위한 기술이전 및 PEG유도체 공급 계약. PEG-인터페론은C형 간염치료제이며, 본 계약은 INTAS에서 생산한 인터페론 의약품에 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">의 PEG유도체를 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">의 페길레이션 기술로 부착하는 제조공정 기술이전에 관한 것임. 이 제조기술을 Intas의 연구진들이 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">를 3개월 방문체류하며, 기술 습득함 </SPAN>
</P>
<P USERMARK="F-10">계약금 USD150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2004. 6.</P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">PEG-GCSF,</P>
<P USERMARK="F-10">PEG-인터페론,</P>
<P USERMARK="F-10">PEG-EPO</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">Serum Institute of India, Ltd.</P>
<P USERMARK="F-10">(India)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91">

<P>
<SPAN USERMARK="F-10">PEG-GCSF, PEG-인터페론, PEG-EPO의 개발을 위한 기술이전 및 PEG유도체 공급 계약. 본 계약은 Serum에서 생산한 GCSF, 인터페론, EPO 의약품에 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">의 PEG유도체를 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">의 페길레이션 기술로 부착하는 제조공정 기술이전에 관한 것임. &cr;계약금 USD420,000</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2005.8. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">공동개발 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">Adamantane-PEG-Lactose</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">Calando Pharmaceuticals Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91">

<P>
<SPAN USERMARK="F-10">Adamantane-PEG-Lactose의 개발을 위한 공동개발 및 PEG유도체 공급 계약. </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 제공하는 PEG유도체에 한쪽은 Adamantane을 부착하고, 다른 한쪽은 Lactose를 부착하여 만드는 항암제 캐리어이며, 이의 개발을 위하여 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 기술 개발을 하고 시료를 생산하여 Calando에 기술 이전함. </SPAN>
</P>
<P USERMARK="F-10">계약금 USD150,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2005.11. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">P1SH-2</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">BioSite, Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91">

<P>
<SPAN USERMARK="F-10">P1SH-2의 제조기술이전 및 공급계약. 이 PEG제품은 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 제조하여 Biosite에 공급하는 것이며, 이 제품의 제조공정 및 분석방법에 관한 기술을 이전하고, 공급계약을 체결. 이 제품은 Biosite에서 마약검출 등 의료진단기기의 제조에 사용됨. </SPAN>
</P>
<P USERMARK="F-10">Signing Fee USD140,000, Extra Fee (DMF Filing) USD100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2005.11 </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">P1MAL-5</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">BioSite, Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91">

<P>
<SPAN USERMARK="F-10">P1MAL-5 의 제조기술이전 및 공급계약. 이 PEG제품은 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">의 특허품목이며, </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 제조하여 Biosite에 공급하는 것이며, 이 제품의 제조공정 및 분석방법에 관한 기술을 이전하고, 공급계약을 체결. 이 제품은 Biosite에서 혈액 진단 등 의료진단기기의 제조에 사용 </SPAN>
</P>
<P USERMARK="F-10">Signing Fee USD140,000, Extra Fee (DMF Filing) USD100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2005.11. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">공급 계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">Methoxy PEG Sulfhydryl 20K</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">CytImmune Sciences, Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91">

<P>
<SPAN USERMARK="F-10">Methoxy PEG Sulfhydryl 20K의 공급계약. 이 PEG제품은 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 제조하여 Cytimmune에 공급하는 것이며, 이 제품의 제조공정 및 분석방법에 관한 기술을 이전하고, 공급계약을 체결. 이 제품은 Cytimmune에서 현재 항암제 캐리어로 사용되며 임상3상 중. </SPAN>
</P>
<P USERMARK="F-10">Signing Fee USD100,000, Extra Fee (DMF Filing) USD100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">2005.12. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">공동개발 및</P>
<P USERMARK="F-10">공급계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">Transferrin-PEG-Adamantane</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10"></P>
<P USERMARK="F-10">Calando Pharmaceuticals Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="112">

<P>
<SPAN USERMARK="F-10">Transferrin-PEG-Adamantane의 개발을 위한 공동개발 및 PEG유도체 공급 계약. </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 제공하는 PEG유도체에 한쪽은 Adamantane을 부착하고, 다른 한쪽은 Transferrin을 부착하여 만드는 항암제 캐리어이며, 이의 개발을 위하여 </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 기술 개발을 하고 시료를 생산하여 Calando에 기술 이전 </SPAN>
</P>
<P USERMARK="F-10">계약금 USD 175,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">2006. 4. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">공급 및</P>
<P USERMARK="F-10">기술계약</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91">
<P USERMARK="F-10">P2AC-3</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">Cartilix, Inc.</P>
<P USERMARK="F-10">(USA)</P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91">

<P>
<SPAN USERMARK="F-10">P2AC-3의 제조기술이전 및 공급계약. </SPAN>
<SPAN USERMARK="F-10">당사</SPAN>
<SPAN USERMARK="F-10">가 제조하여 공급하는 이 PEG 제품은 Cartilix에서 성형용dermal filler의 개발에 사용되는 주성분이며, 본 제품의 제조기술 및 분석기술을 기술 이전 &cr;Signing Fee USD200,000, &cr;Extra Fee (DMF Filing) USD100,000</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">2013. 8. </P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">기술이전 및</P>
<P USERMARK="F-10">공급계약(수정)</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="112">
<P USERMARK="F-10">PEG-GCSF </P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10"></P>
<P USERMARK="F-10">Intas Pharmaceuticals Ltd.</P>
<P USERMARK="F-10">(India) </P>
</TD>

<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="112">
<P USERMARK="F-10">PEG-GCSF의 개발을 위한 기술이전 및 PEG유도체 공급계약(2003년 원 계약)의 수정계약. 2003년 원 계약의 수정계약으로서, 시장의 범위를 제3시장에서 전세계 시장으로 확대. </P>
<P USERMARK="F-10">-On signing of this Amending Agreement USD300,000 </P>
<P USERMARK="F-10">-After Granting of marketing authorization in EU USD200,000 </P>
<P USERMARK="F-10">-After getting product approval in USA USD250,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2020.12</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">기술이전 및 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">MucoPEG&cr;구강건조증 &cr;치료제</TD>

<TD WIDTH="116" VALIGN="MIDDLE" HEIGHT="91">
<P USERMARK="F-10">PharmaSolution</P>
<P USERMARK="F-10">(Guangzhou Bairui사의 자회사, Hong Kong, China)</P>
</TD>
<TD WIDTH="584" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10">MucoPEG™ 구강건조증치료제의 제조기술의 이전 및 동 제품의 중국시장 판권의 부여</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B">8. 경영상의 주요 계약&cr;</SPAN>
<SPAN USERMARK="F-16"></SPAN>
<SPAN>- 해당사항 없음&cr;</SPAN>
<SPAN USERMARK="F-16 B">&cr;9. 영업실적 등에 대한 예측/전망</SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>&cr;본 항목에는 '자본시장과금융투자업에관한법률’ 제119조제3항에서 규정하는 바에 따라 미래의 매출규모 및 이익규모 등 영업실적을 비롯한 경영성과, 자본금 규모 및 자금흐름 등 재무상태에 대한 예측 또는 전망에 관한 사항이 포함되어 있습니다. 또한 특정한 사실의 발생 또는 특정한 계획의 수립으로 인한 경영성과 또는 재무상태의 변동 및 일정시점에서의 목표수준에 관한 사항도 포함되어 있습니다. 이러한 기재 또는 표시에 대해서 예측치와 실제 결과치가 다를 수 있으니 투자자 여러분들께서는 주의하여 주시기 바랍니다. 또한, 이와 같은 예측 및 전망자료 등은 '자본시장과금융투자업에관한법률' 제125조제2항에 따라 손해배상 책임 대상에 해당되지 않습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN>&cr;당사의 사업은 다음과 같은 투자위험사항을 가지고 있으니 투자자께서는 주의하여 주시기 바랍니다.&cr;&cr;(1) 산업의 성장성과 관련된 위험&cr;당사는 바이오시밀러 제품의 기술이전을 통하여 기술이전 수익 및 제품매출에 따른 로열티를 수령하는 업체로 향후 전개될 바이오시밀러 시장규모 및 성장률에 영향을 받습니다. &cr;&cr;(2) 시장경쟁의 심화에</SPAN>
<SPAN> 따른 위험&cr;</SPAN>
<SPAN>바이오시밀러 시장은 과거 바이오신약을 개발했던Amgen, Genentech, Gilead Sciences와 같은 바이오제약사들이 독점적 판매로 바이오의약품 시장의 수혜를 누려왔지만, 현재 합성의약품을 기반으로 성장한 Novatis, Teva, Pfizer 등 주요 대형 제약회사들이 바이오시밀러 시장에 진출하여 바이오시밀러 시장의 경쟁이 활발해지고고 있습니다. 또한 국내에서는 셀트리온, 삼성바이오에피스, 한화케미칼 등이 바이오시밀러 사업에 적극적으로 투자하여, 활발한 시장 활동을 하고 있습니다.&cr;</SPAN>
<SPAN>&cr;(3) 산업의 규제와 관련한 위험&cr;</SPAN>
<SPAN>바이오 의약품 산업은 국민의 건강 및 생명과 관련된 산업으로 타 산업에 비해 엄격한 정부의 제도적 규제를 받고 있습니다. 그 중, 의약품의 판매승인을 위한 품목허가를 획득하려면 해당 국가(예, 미국 FDA, EU의 EMA 등)에서 제시하는 규정에 따라 개발에 필요한 심의 절차를 진행해야 합니다. 연구 개발 단계 후, 비임상 시험을 통해 독성에 대한 안정성을 확보하고, 임상시험계획승인신청(IND)을 요청하여 임상시험 진행에 대한 허가를 받습니다. 임상시험이 완료되면 임상시험 결과 자료를 제출하여 품목허가승인신청(NDA)을 요청하고, FDA는 후보물질의 품목허가 여부를 판단하게 됩니다. 품목허가를 받은 후에 의약품의 판매가 가능합니다.&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P>                                                                                                         (단위 : 원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="201" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(단위:원)</P>
</TH>

<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제24기</P>
</TH>

<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제23기</P>
</TH>

<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제22기</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년12월말</P>
</TH>

<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년12월말</P>
</TH>

<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년12월말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회계처리 기준</P>
</TH>

<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS</P>
</TH>

<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS</P>
</TH>

<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[유동자산]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,399,359,177</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,829,128,765</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,899,813,859</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>·당좌자산</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,583,242,700</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,978,440,641</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,454,759,784</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>·재고자산</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">816,116,477</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">850,688,124</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">445,054,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[비유동자산]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,372,395,063</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,052,323,787</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,873,609,314</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>·투자자산</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,765,076,768</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,780,864,792</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,166,374</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>·유형자산</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,361,800,741</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,053,580,196</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,588,442,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>·기타비유동자산</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">245,517,554</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">217,878,799</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">267,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>자산총계</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,771,754,240</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,881,452,552</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,773,423,173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[유동부채]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,496,866,015</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,831,823,403</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">301,764,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[비유동부채]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,438,834,834</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,631,945,491</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">105,731,567</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>부채총계</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,935,700,849</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,463,768,894</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">407,495,593</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[자본금]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,835,270,000</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,835,270,000</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,825,470,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[자본잉여금]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,810,945</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,810,945</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,574,114,945</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[기타자본항목]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,660,349,775</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,443,764,775</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,290,248,900</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P>[이익잉여금]</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">339,622,671</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(862,162,062)</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,323,906,265)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>자본총계</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,836,053,391</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,417,683,658</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,365,927,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채 및 자본총계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,771,754,240</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,881,452,552</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,773,423,173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P> 매출액</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,458,528,590</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,189,952</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,174,511,643</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P> 영업이익</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,638,949,037</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,679,025,895</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">63,801,802</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P> 법인세차감전계속사업이익</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,201,900,074</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,461,744,203</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,556,391</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE"> 법인세등</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(115,341)</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(77,793,435)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">
<P> 당기순이익(손실)</P>
</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,201,784,733</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,461,744,203</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(25,237,044)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE"> 기본주당순이익(손실)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">105</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">127</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3)</TD>
</TR>
</TBODY>
</TABLE>
<P>주석1) 당사의 자산총액은 일천억원에 미달하므로 소규모기업에 해당합니다.&cr;주석2) 당사는 관계회사 투자주식을 보유하지 않으며 따라서 요약재무정보에 관계회사 투자주식 평가방법을 기재하지 않았습니다.&cr;</P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">재무제표_직접작성</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P>해당사항없음</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P>해당사항없음</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="742" BORDER="0">

<COLGROUP>
<COL WIDTH="362"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="742" HEIGHT="30" USERMARK=" B">재 무 상 태 표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="742" HEIGHT="30">제 24(당)기 2020년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="742" HEIGHT="30">제 23(전)기 2019년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="371" HEIGHT="30">선바이오 주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="371" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="742" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="240"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="186"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="249" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과           목</TH>
<TH ALIGN="CENTER" WIDTH="102" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">주석</TH>
<TH ALIGN="CENTER" WIDTH="196" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">제 24(당)기</TH>
<TH ALIGN="CENTER" WIDTH="195" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">제 23(전)기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="742" HEIGHT="30" COLSPAN="4">자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  I. 유동자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">5,399,359,177</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">3,829,128,765</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     현금및현금성자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4,5,6,7,8,32</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">2,516,028,739</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">806,432,810</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     단기금융상품</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6,7,9</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">10,000,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     매출채권및기타채권</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5,6,7,10</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">2,051,553,085</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,165,116,304</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     재고자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">816,116,477</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">850,688,124</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     당기법인세자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">23</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">3,069,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     기타유동자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">14</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">5,660,876</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">3,822,387</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  II. 비유동자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">12,372,395,063</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">13,052,323,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     유형자산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">4,361,800,741</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">5,053,580,196</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     투자부동산</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">13</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">7,765,076,768</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">7,780,864,792</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="249" HEIGHT="30">
<SPAN USERMARK=" 0X0000FF">     </SPAN>
<SPAN>기타비유동채권</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5,6,7</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">245,517,554</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">217,878,799</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 자  산  총  계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">17,771,754,240</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">16,881,452,552</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="742" HEIGHT="30" COLSPAN="4"> 부채 　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  I. 유동부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">2,496,866,015</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,831,823,403</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     매입채무및기타채무</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5,6,7,15</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">173,455,849</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">279,126,808</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     단기차입금</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5,6,7,16</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">160,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     유동리스부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4,5,6,7,18</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">269,389,020</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">306,923,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     유동성전환사채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4,5,6,7,17</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">1,922,776,670</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">1,710,847,874</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     유동파생상품금융부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6,7,17</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">96,755,035</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">351,622,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     기타유동부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">20</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">34,457,640</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">23,303,510</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     당기법인세부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">30</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">31,801</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  II. 비유동부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">6,438,834,834</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">6,631,945,491</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     장기차입금</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4,5,6,7,16</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">5,000,000,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">5,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     복구충당부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">19</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">113,386,702</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">107,127,224</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">     리스부채</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4,5,6,7,18</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">1,325,448,132</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">1,524,818,267</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 부  채  총  계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">8,935,700,849</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">9,463,768,894</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="742" HEIGHT="30" COLSPAN="4"> 자본　 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  I. 자본금</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">21</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">3,835,270,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">3,835,270,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  II. 자본잉여금</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">21</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">3,000,810,945</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">3,000,810,945</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  III. 자본조정</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">21,23</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">1,660,349,775</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">1,443,764,775</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">  IV. 이익잉여금(결손금)</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">22</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">339,622,671</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">(862,162,062)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 자  본  총  계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">8,836,053,391</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">7,417,683,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 부채 및 자본총계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">17,771,754,240</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">16,881,452,552</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="743" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="734"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="743" HEIGHT="30">첨부된 주석은 본 재무제표의 일부입니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="745" BORDER="0">

<COLGROUP>
<COL WIDTH="366"></COL>
<COL WIDTH="361"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="745" HEIGHT="30" USERMARK=" B">포 괄 손 익 계 산 서</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="745" HEIGHT="30">제 24(당)기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="745" HEIGHT="30">제 23(전)기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="375" HEIGHT="30">선바이오 주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="370" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="721">

<COLGROUP>
<COL WIDTH="242"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과          목</TH>
<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주석</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 24(당)기</TH>
<TH WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 23(전)기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 매출</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">5,458,528,590</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">6,547,189,952</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">   제품매출</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">24</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">3,408,671,500</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">5,491,152,780</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">   기술료수입</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">24,33</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">2,049,857,090</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">1,056,037,172</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 매출원가</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">2,019,739,785</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">2,841,257,170</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">   제품매출원가</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">27</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">2,019,739,785</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">2,841,257,170</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 매출총이익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">3,438,788,805</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">3,705,932,782</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 판매비와관리비</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">25,26,27,34</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">1,799,839,768</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">2,026,906,887</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 영업이익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">1,638,949,037</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">1,679,025,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 금융수익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">28</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">304,897,085</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">158,751,662</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 금융비용</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">28</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">742,655,028</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">393,441,924</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 기타수익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">29</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">708,998</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">17,408,586</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 기타비용</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">29</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">18</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 법인세비용차감전순이익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">1,201,900,074</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 법인세비용</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">30</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">115,341</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 당기순이익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">1,201,784,733</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 기타포괄손익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 당기총포괄손익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">1,201,784,733</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 주당손익</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 기본주당순이익(손실)</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">31</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">105</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">127 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 희석주당순이익(손실)</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">31</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">100</TD>

<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">127 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="745" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="736"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="745" HEIGHT="30">첨부된 주석은 본 재무제표의 일부입니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="826" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="517"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="826" HEIGHT="30" USERMARK=" B">자 본 변 동 표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="826" HEIGHT="30">제 24(당)기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="826" HEIGHT="30">제 23(전)기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">선바이오 주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="526" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="826" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과          목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본잉여금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본조정</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결손금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 2019.01.01(전기초)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,825,470,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">2,574,114,945</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">1,290,248,900</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">(2,323,906,265)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">5,365,927,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="826" HEIGHT="30" COLSPAN="6"> 당기총포괄손익:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 당기순이익</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">1,461,744,203</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="826" HEIGHT="30" COLSPAN="6"> 자본에 직접 반영된 소유주와의 거래: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 주식선택권의 행사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">9,800,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">426,696,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">(79,924,000)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">356,572,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 주식보상비용</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">233,439,875</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">233,439,875</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 2019.12.31(전기말)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,835,270,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,000,810,945</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">1,443,764,775</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">(862,162,062)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">7,417,683,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 2020.01.01(당기초)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,835,270,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,000,810,945</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">1,443,764,775</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">(862,162,062)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">7,417,683,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="826" HEIGHT="30" COLSPAN="6"> 당기총포괄손익:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 당기순이익</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">1,201,784,733</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">1,201,784,733</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="826" HEIGHT="30" COLSPAN="6"> 자본에 직접 반영된 소유주와의 거래: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 주식보상비용</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">216,585,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">216,585,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="207" HEIGHT="30"> 2020.12.31(당기말)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,835,270,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">3,000,810,945</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">1,660,349,775</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30">339,622,671</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">8,836,053,391</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="826" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="817"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="826" HEIGHT="30">첨부된 주석은 본 재무제표의 일부입니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="783" BORDER="0">

<COLGROUP>
<COL WIDTH="349"></COL>
<COL WIDTH="416"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="783" HEIGHT="30" USERMARK=" B">현 금 흐 름 표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="783" HEIGHT="30">제 24(당)기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="783" HEIGHT="30">제 23(전)기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="358" HEIGHT="30">선바이오 주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="425" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="901">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="305" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과          목</TH>
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주석</TH>
<TH WIDTH="256" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 24(당)기</TH>
<TH WIDTH="256" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 23(전)기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">I. 영업활동으로 인한 현금흐름</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">32</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,310,133,054</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">758,127,503</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P16">1. 영업에서 창출된 현금</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,443,973,428</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">885,798,295</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P32"> 당기순이익</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,201,784,733</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P32"> 조정사항</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">32</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,242,188,695</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(575,945,908)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">   2. 이자의 수취</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">547,888</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">11,327,909</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">   3. 이자의 지급</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(137,373,862)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(135,966,431)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="305" HEIGHT="30" USERMARK=" B">
<SPAN USERMARK=" !B">   4. 법인세의 환급(납부)</SPAN>
</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,985,600</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(3,032,270)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">II. 투자활동으로 인한 현금흐름</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(121,837,000)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(7,799,338,794)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P16">1. 투자활동으로 인한 현금유입액</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">168,166,374</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     단기대여금의 감소</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">150,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     장단기금융상품의 감소</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">18,166,374</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     기타보증금의 감소</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P16">2. 투자활동으로 인한 현금유출액</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(124,837,000)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(7,967,505,168)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     단기금융상품의 취득</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">10,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     투자부동산의 취득</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">7,788,758,804</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     유형자산의 취득</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">114,837,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">159,006,364</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     유형자산 취득 미지급금의 지급</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">19,740,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">III. 재무활동으로 인한 현금흐름</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">32</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(477,223,000)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">7,224,690,503</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P16">1. 재무활동으로 인한 현금유입액</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">7,474,506,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     단기차입금의 증가</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">160,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     장기차입금의 증가</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">5,000,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     전환사채의 발행</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,999,040,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     주식선택권의 행사</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">315,466,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30" USERMARK=" P16">2. 재무활동으로 인한 현금유출액</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(477,223,000)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(249,815,497)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     단기차입금의 상환</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">160,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     리스료의 지급</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">316,800,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">249,815,497</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">     미지급배당금의 지급</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">423,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">Ⅳ. 현금및현금성자산의 증가</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,711,073,054</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">183,479,212</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">Ⅴ. 현금및현금성자산의 환율변동효과</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(1,477,125)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(31,247,782)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">Ⅵ. 기초의 현금및현금성자산</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">8</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">806,432,810</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">654,201,380</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">Ⅶ. 기말의 현금및현금성자산</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">8</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,516,028,739</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">806,432,810</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="781" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="772"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="781" HEIGHT="30">첨부된 주석은 본 재무제표의 일부입니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="753">

<COLGROUP>
<COL WIDTH="349"></COL>
<COL WIDTH="386"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="753" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">이익잉여금처분계산서</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="753" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 24(당)기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="753" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 23(전)기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="358" HEIGHT="30" VALIGN="BOTTOM">선바이오 주식회사</TD>
<TD WIDTH="395" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="751">

<COLGROUP>
<COL WIDTH="249"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="751" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="258" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="247" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제24(당)기</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제23(전)기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="247" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>처분예정일:</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2021년 </SPAN>
<SPAN>5월 </SPAN>
<SPAN>14일</SPAN>
<SPAN></SPAN>
</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처리확정일: 2020년 3월 23일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30"> I. 미처분이익잉여금(미처리결손금)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">283,743,621</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(918,041,112)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    전기이월미처리결손금</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(918,041,112)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(2,379,785,315)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    당기순이익</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">1,201,784,733</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30"> II. 이익잉여금처분액(결손금처리액)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="53"> III. 차기이월미처분이이익잉여금&cr;     (미처리결손금)</TD>
<TD WIDTH="124" HEIGHT="53" ALIGN="RIGHT"></TD>
<TD WIDTH="123" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">283,743,621</TD>
<TD WIDTH="123" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(918,041,112)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>
<P USERMARK="F-16 0XFF0000 B">주석</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 24(당)기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 23(전)기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">선바이오 주식회사</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>1. 회사의 개요&cr;</SPAN>
<SPAN>&cr;선바이오 주식회사(이하, "당사")는 1997년 7월 10일에 의약품의 연구개발과 생산 및판매를 사업목적으로 설립되었으며, 2016년 1월 22일자로 당사의 주식을 한국거래소 코넥스시장에 상장하였습니다.&cr;&cr;당사의 설립시 납입자본금은 750,000천원이었으나, 이후 수차의 증자를 거쳐 보고기간종료일 현재 납입자본금은</SPAN>
<SPAN> </SPAN>
<SPAN>3,835,270</SPAN>
<SPAN>천원</SPAN>
<SPAN>으로서 주주 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="599" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="263"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="599" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="272" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주주명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30">  노광 외 특수관계자</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30">             2,785,493</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30">36.31%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30">  이수화학</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30">                403,360</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30">5.26%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30">  자기주식</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30">                   7,997</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30">0.10%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30">  기타주주</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30">             4,473,690</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30">58.32%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30">             7,670,540</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;2. 재무제표 작성기준</P>
<P>&cr;2.1 재무제표 작성기준&cr;당사의 재무제표는 한국채택국제회계기준(이하 기업회계기준)에 따라 작성되었습니다. 한국채택국제회계기준은 국제회계기준위원회("IASB")가 발표한 기준서와 해석서 중 대한민국이 채택한 내용을 의미합니다.&cr;&cr;재무제표는 다음을 제외하고는 역사적 원가에 기초하여 작성하였습니다.&cr;&cr;- 공정가치로 측정되는 특정 금융상품&cr;- 공정가치로 측정되는 파생상품&cr;&cr;한국채택국제회계기준은 재무제표 작성 시 중요한 회계추정의 사용을 허용하고 있으며, 회계정책을 적용함에 있어 경영진의 판단을 요구하고 있습니다. 보다 복잡하고 높은 수준의 판단이 필요한 부분이나 중요한 가정 및 추정이 필요한 부분은 주석3에서 설명하고 있습니다. &cr;&cr;2.2 회계정책과 공시의 변경&cr;2.2.1 당사가 채택한 제ㆍ개정 기준서 및 해석서&cr;당사는 2020년 1월 1일로 개시하는 회계기간부터 다음의 제ㆍ개정 기준서 및 해석서를 신규로 적용하였습니다.&cr;&cr;(1) 기업회계기준서 제1001호 '재무제표 표시', 제1008호 '회계정책, 회계추정의 변경 및 오류' 개정 - 중요성의 정의&cr;중요성의 정의를 명확히 하였습니다. 정보를 누락하거나 잘못 기재하거나 불분명하게 하여 주요 이용자의 의사결정에 영향을 줄 것으로 합리적으로 예상할 수 있다면 그 정보는 중요합니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;&cr;(2) 기업회계기준서 제1103호 '사업결합' 개정 - 사업의 정의&cr;사업의 정의를 충족하기 위해서는 산출물의 창출에 유의적으로 기여하는 투입물과 실질적인 과정이 반드시 포함되어야 하며, 산출물에서 원가 감소에 따른 경제적 효익은 제외하였습니다. 또한, 취득한 총자산의 대부분의 공정가치가 식별가능한 단일 자산 또는 비슷한 자산의 집합에 집중되어 있는 경우에는 사업의 취득이 아니라고 간주할 수 있는 선택적 집중테스트가 추가되었습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;&cr;(3) 기업회계기준서 제1109호 '금융상품', 제1039호 '금융상품: 인식과 측정', 제1107호 '금융상품: 공시' 개정 - 이자율지표 개혁&cr;이자율지표 개혁으로 인한 불확실성이 존재하는 동안 위험회피회계 적용과 관련하여예외규정을 추가하였습니다. 예외규정에서는 예상현금흐름의 발생가능성이 매우 높은지, 위험회피대상항목과 위험회피수단 사이의 경제적 관계가 있는지, 양자간에 높은 위험회피효과가 있는지를 평가할 때, 위험회피대상항목과 위험회피수단이 준거로하고 있는 이자율지표는 이자율지표 개혁의 영향으로 바뀌지 않는다고 가정합니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;&cr;2.2.2 당사가 적용하지 않은 제ㆍ개정 기준서 및 해석서&cr;제정 또는 공표되었으나 시행일이 도래하지 않아 적용하지 아니한 제ㆍ개정 기준서 및 해석서는 다음과 같습니다.&cr;&cr;(1) 기업회계기준서 제 1116호 '리스' 개정 - 코로나19 (COVID-19) 관련 임차료 면제ㆍ할인ㆍ유예에 대한 실무적 간편법&cr;실무적 간편법으로, 리스이용자는 코로나19의 직접적인 결과로 발생한 임차료 할인 등(rent concession)이 리스변경에 해당하는지 평가하지 않을 수 있으며, 이로 인해 당기손익으로 인식된 금액을 공시해야 합니다. 동 개정사항은 2020년 6월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.&cr;&cr;(2) 기업회계기준서 제1109호 '금융상품', 제1039호 '금융상품: 인식과 측정', 제1107호 '금융상품: 공시', 제 1104호 ‘보험계약’ 및 제 1116호 ‘리스’ 개정 - 이자율지표 개혁&cr;이자율지표 개혁과 관련하여 상각후원가로 측정되는 금융상품의 이자율지표 대체시 장부금액이 아닌 유효이자율을 조정하고, 위험회피관계에서 이자율지표 대체가 발생한 경우에도 중단 없이 위험회피회계를 계속할 수 있도록 하는 등의 예외규정을 포함하고 있습니다. 동 개정사항은 2021년 1월 1일 이후에 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.&cr;&cr;(3) 기업회계기준서 제1103호 ‘사업결합’ 개정 - 개념체계의 인용&cr;인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 ‘충당부채, 우발부채 및 우발자산’ 및 해석서제2121호 ‘부담금’의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은없을 것으로 예상하고 있습니다.&cr;&cr;(4) 기업회계기준서 제1016호 ‘유형자산’ 개정 - 의도한 사용 전의 매각금액&cr;기업이 자산을 의도한 방식으로 사용하기 전에 생산된 품목의 판매에서 발생하는 수익을 생산원가와 함께 당기손익으로 인식하도록 요구하며, 유형자산의 취득원가에서차감하는 것을 금지하고 있습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은없을 것으로 예상하고 있습니다.&cr;&cr;(5) 기업회계기준서 제1037호 ‘충당부채, 우발부채 및 우발자산’ 개정 - 손실부담계약: 계약이행원가&cr;손실부담계약을 식별할 때 계약이행원가의 범위를 계약 이행을 위한 증분원가와 계약 이행에 직접 관련되는 다른 원가의 배분이라는 점을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다. &cr;&cr;(6) 한국채택국제회계기준 연차개선 2018-2020&cr;한국채택국제회계기준 연차개선 2018-2020은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.&cr;- 기업회계기준서 제1101호 ‘한국채택국제회계기준의 최초 채택’: 최초채택기업인 종속기업&cr;- 기업회계기준서 제1109호 ‘금융상품’: 금융부채 제거 목적의 10% 테스트 관련 수수료&cr;- 기업회계기준서 제1116호 ‘리스’: 리스 인센티브&cr;- 기업회계기준서 제1041호 ‘농립어업’: 공정가치 측정&cr;</P>
<PGBRK></PGBRK>
<P>(7) 기업회계기준서 제1001호 ‘재무제표 표시’ 개정 - 부채의 유동/비유동 분류&cr;보고기간말 현재 존재하는 실질적인 권리에 따라 유동 또는 비유동으로 분류되며, 부채의 결제를 연기할 수 있는 권리의 행사가능성이나 경영진의 기대는 고려하지 않습니다. 또한, 부채의 결제에 자기지분상품의 이전도 포함되나, 복합금융상품에서 자기지분상품으로 결제하는 옵션이 지분상품의 정의를 충족하여 부채와 분리하여 인식된경우는 제외됩니다. 동 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 당사는 동 개정으로 인한 재무제표의 영향을 검토 중에 있습니다.&cr;&cr;2.4 외화환산&cr;(1) 기능통화와 표시통화&cr;당사의 재무제표는 당사의 영업활동이 이루어지는 주된 경제활동의 통화(이하 "기능통화") 및 표시통화인 원화로 작성하여 보고하고 있습니다.&cr;&cr;(2) 외화거래와 보고기간말의 환산&cr;외화거래는 거래일의 환율 또는 재측정되는 항목인 경우 평가일의 환율을 적용한 기능통화로 인식됩니다. 외화거래의 결제나 화폐성항목의 환산에서 발생하는 외환차이는 당기손익으로 인식됩니다. 다만, 조건을 충족하는 현금흐름위험회피나 순투자의 위험회피의 효과적인 부분과 관련되거나 보고기업의 해외사업장에 대한 순투자의 일부인 화폐성항목에서 생기는 손익은 기타포괄손익으로 인식합니다.&cr;&cr;비화폐성 금융자산ㆍ부채로부터 발생하는 외환차이는 공정가치 변동손익의 일부로 보아 당기손익-공정가치 측정 지분상품으로부터 발생하는 외환차이는 당기손익으로인식하고, 기타포괄손익-공정가치측정 지분상품의 외환차이는 기타포괄손익에 포함하여 인식됩니다.&cr;</P>
<P>2.5 현금및현금성자산</P>
<P>당사는 취득일로부터 만기일이 3개월 이내인 투자자산을 현금및현금성자산으로 분류하고 있습니다. 지분상품은 현금성자산에서 제외되나, 상환일이 정해져 있고 취득일로부터 상환일까지의 기간이 단기인 우선주와 같이 실질적인 현금성자산인 경우에는 현금및현금성자산에 포함됩니다.&cr;</P>
<P>2.6 재고자산</P>
<P>재고자산의 단위원가는 총평균법으로 결정하고 있으며, 취득원가는 매입원가, 전환원가 및 재고자산을 이용가능한 상태로 준비하는데 필요한 기타원가를 포함하고 있습니다. 제품이나 재공품의 원가에 포함되는 고정제조간접원가는 생산설비의 실제조업도에 기초하여 배부하고 있습니다.&cr;재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 재고자산을 순실현가능가치로 감액한 평가손실과 모든 감모손실은 감액이나 감모가 발생한 기간에 비용으로 인식하고 있으며, 재고자산의 순실현가능가치의 상승으로 인한 재고자산평가손실의 환입은 환입이 발생한 기간의 비용으로 인식된 재고자산의 매출원가에서 차감하고 있습니다. </P>
<P></P>
<P>2.7 금융상품&cr;(1) 금융자산의 인식 및 측정</P>
<P>당사는 금융자산의 관리를 위한 사업모형과 금융자산의 계약상 현금흐름 특성에 따라 금융자산을 상각후원가측정금융자산, 기타포괄손익공정가치측정금융자산 및 당기손익공정가치측정금융자산의 세가지 범주로 분류하고 분류 명칭에 따라 후속적으로 측정하고 있습니다. 내재파생상품은 주계약이 기준서 제1109호의 적용범위에 해당되는 경우에는 분리하지 않고 복합금융상품 전체에 대해 위 세가지 범주중의 하나로 분류합니다.</P>
<P>유의적인 금융요소를 포함하지 않는 매출채권은 최초인식시점에 거래가격으로 측정하고 이외에는 공정가치로 측정하며, 당기손익공정가치측정금융자산이 아닌 경우 금융자산의 취득과 직접 관련되는 거래원가는 최초 인식시점에 공정가치에 가산하고 있습니다. </P>
<P> </P>
<P>① 상각후원가측정금융자산</P>
<P>계약상 현금흐름의 수취를 목적인 사업모형하에서 계약조건에 따라 특정일에 원금과원금잔액에 대한 이자지급만으로 구성되는 현금흐름이 발생하는 금융자산을 상각후원가측정금융자산으로 인식하고 있습니다. 원금은 최초 인식시점의 공정가치이며 이자는 화폐의 시간가치에 대한 대가 및 신용위험에 대가 등을 포함합니다. 상각후원가측정금융자산은 유효이자율법에 따라 측정하고 이자수익은 당기손익에 반영하고 있습니다.</P>
<P> </P>
<P>② 기타포괄손익공정가치측정금융자산</P>
<P>계약상 현금흐름의 수취와 매도를 목적으로 하는 사업모형하에서 계약조건에 따라 특정일에 원금과 원금잔액에 대한 이자지급만으로 구성되는 현금흐름이 발생하는 금융자산을 기타포괄손익공정가치측정금융자산으로 인식하고 있습니다. 공정가치의 변동으로 인한 차이는 기타포괄손익에 반영하고 처분시 당기손익으로 재순환시키며 이자수익은 당기손익의 금융수익에, 손상차손(환입) 및 외환손익은 기타손익에 반영하고 있습니다. </P>
<P>한편, 당사는 단기매매목적으로 보유하지 않는 지분상품은 최초 인식시점에 기타포괄손익공정가치측정금융자산으로 취소불가능한 선택을 할 수 있습니다. 이러한 선택을 하는 경우에는 배당금을 제외하고 해당 지분상품으로부터 발생하는 모든 손익은 기타포괄손익으로 인식하고 후속적으로 당기손익으로 재순환시키지 않습니다.</P>
<P> </P>
<P>③ 당기손익공정가치측정금융자산</P>
<P>금융자산이 상각후원가 또는 기타포괄손익공정가치로 측정하지 않는 경우에는 당기손익공정가치측정금융자산으로 분류하며 단기매매목적의 지분증권, 파생상품 등을 포함하고 있습니다. 기준서 1109호의 분류기준에 따라 상각후원가 또는 기타포괄손익공정가치로 측정하는 금융자산으로 분류되더라도 회계불일치를 해소하기 위해 당기손익공정가치측정금융자산으로 취소 불가능한 지정을 할 수 있습니다. 당기손익공정가치측정금융자산과 관련된 손익은 당기손익으로 인식하고 있습니다.</P>
<P> </P>
<P>(2) 금융부채의 분류 및 측정</P>
<P>당사는 계약의 실질에 따라 금융부채를 상각후원가측정금융부채, 당기손익공정가치측정금융부채로 분류하고 있습니다. 한편, 당사가 복합금융상품을 발행한 경우에는 자본요소와 부채요소를 분리하고 부채요소의 공정가치를 측정하여 최초 장부금액을 부채요소에 먼저 배부하고 있습니다.</P>
<P>금융부채는 최초인식시점에 공정가치로 측정하며, 당기손익공정가치측정금융부채가 아닌 경우 금융부채의 발행과 직접 관련되는 거래원가는 최초 인식시점에 공정가치에 가산하고 있습니다. 후속적으로는 상각후원가측정금융부채는 유효이자율을 적용하여 측정하고 관련 이자비용은 당기손익으로 인식하며, 당기손익공정가치측정금융부채는 공정가치로 측정하고 공정가치의 변동액을 당기손익으로 인식합니다. </P>
<P> </P>
<PGBRK></PGBRK>
<P>(3) 금융자산의 손상</P>
<P>당사는 상각후원가측정금융자산과 기타포괄손익공정가치로 측정하는 채무상품에 대해 기대신용손실모형을 적용하고 있습니다. </P>
<P>당사는 신용손상측정대상 금융자산에 대해 최초 인식 후 신용위험의 유의적 증가가 있는지에 대한 개별평가 및 대상금융자산의 경제적 성격을 고려한 집합평가를 매 보고기간 말에 수행하고 있습니다. 신용위험의 유의적인 증가가 있는지를 평가할 때 신용등급, 재무구조, 연체정보 및 현재 및 미래의 예측가능한 경제적 상황의 변동 등을 종합적으로 고려하여 판단하고 있습니다. </P>
<P>&cr;(4) 복합금융상품&cr;당사가 발행한 복합금융상품은 보유자의 선택에 의해 지분상품으로 전환될 수 있는 전환사채입니다. 동 복합금융상품의 조기상환권과 전환권은 경제적 특성 및 위험이 주계약의 경제적 특성 위험과 밀접하게 관련되어 있지 않아 복합내재파생상품으로 분리하여 별도의 파생상품부채로 인식하고 후속적으로 공정가치를 재측정하여 차액은 당기손익으로 인식하고 있습니다. 내재파생상품으로 인식된 조기상환권 및 전환권을 제외한 부채요소는 후속적으로 상각후원가로 인식됩니다.&cr;&cr;2.8 투자부동산 &cr;투자부동산은 임대수익이나 시세차익 또는 두 가지 모두를 얻기 위하여 당사가 보유하고 있는 부동산으로서 최초 인식시점에 원가로 측정하고 거래원가는 최초 측정에 포함하고 있습니다. 최초 인식 이후 투자부동산은 취득원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 표시하고 있습니다.&cr;후속원가는 자산으로부터 발생하는 미래경제적효익이 유입될 가능성이 높으며, 자산의 원가를 신뢰성 있게 측정할 수 있는 경우 자산의 장부금액에 포함하거나 적절한 경우 별도의 자산으로 인식하고 있으며, 일상적인 수선ㆍ유지와 관련하여 발생하는 원가는 발생시점에 당기손익으로 인식하고 있습니다.&cr;투자부동산 중 토지에 대해서는 감가상각을 하지 않으며, 토지를 제외한 투자부동산은 경제적 내용연수에 따라 20년을 적용하여 정액법으로 상각하고 있습니다. 투자부동산의 감가상각방법, 잔존가치 및 내용연수는 매 보고기간말에 재검토하고 있으며, 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 회계처리하고 있습니다.&cr;부동산의 용도가 변경되는 경우에만 투자부동산의 대체가 발생하고 있으며 투자부동산, 자가사용부동산, 재고자산 사이에 대체가 발생할 때에 대체 전 자산의 장부금액을 승계하고 있습니다.&cr;투자부동산을 처분하거나, 투자부동산의 사용을 영구히 중지하고 처분으로도 더 이상의 경제적효익을 기대할 수 없는 경우에는 재무상태표에서 제거하고 있으며, 투자부동산의 폐기나 처분으로 발생하는 손익은 순처분금액과 장부금액의 차액이며 폐기나 처분이 발생한 기간에 당기손익으로 인식하고 있습니다. </P>
<P></P>
<PGBRK></PGBRK>
<P>2.9 유형자산&cr;유형자산은 최초에 원가로 측정하여 인식하고 있습니다. 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다.</P>
<P>유형자산은 최초 인식후에 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 하고 있습니다.</P>

<P>
<SPAN></SPAN>
<SPAN>유형자산은 자산의 취득원가에서 잔존가치를 차감한 금액에 대하여 아래에 제시된 내용연수에 걸쳐 해당 자산에 내재되어 있는 미래경제적효익의 예상 소비 형태를</SPAN>
<SPAN> 가장 잘 반영한 정액법으로 상각하고 있습니다. 또한, 유형자산을 구성하는 일부의 원가가 당해 유형자산의 전체 원가와 비교하여 유의적이라면 해당 유형자산을 감가상각할 때, 그 부분은 별도로 구분하여 감가상각하고 있습니다.&cr;</SPAN>
<SPAN>한편, 유형자산의 제거로 인하여 발생하는 손익은 순매각금액과 장부금액의 차이로 결정되고 그 차액은 당기손익으로 인식하고 있습니다.&cr;</SPAN>
</P>
<P>당사가 보유하고 있는 유형자산의 추정 내용연수는 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="288"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="297" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="297" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추정내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기계장치</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER">10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">임차자산개량권</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER">10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기타유형자산</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>
<P>당사는 매 보고기간말에 자산의 잔존가치와 내용연수 및 감가상각방법을 재검토하고재검토 결과 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.</P>
<P></P>
<P>2.10 차입원가&cr;적격자산의 취득, 건설 또는 제조와 직접 관련된 차입원가는 당해 자산 원가의 일부로 자본화하고 있으며, 기타차입원가는 발생기간에 비용으로 인식하고 있습니다. 적격자산이란 의도된 용도로 사용하거나 판매가능한 상태가 될 때까지 상당한 기간을 필요로 하는 자산을 말하며, 금융자산과 단기간 내에 제조되거나 다른 방법으로 생산되는 재고자산은 적격자산에 해당되지 아니하며, 취득시점에 의도된 용도로 사용할 수 있거나 판매가능한 상태에 있는 자산인 경우에도 적격자산에 해당되지 아니합니다.</P>
<P>적격자산을 취득하기 위한 목적으로 특정하여 차입한 자금에 한하여, 보고기간 동안 그 차입금으로부터 실제 발생한 차입원가에서 당해 차입금의 일시적 운용에서 생긴 투자수익을 차감한 금액을 자본화가능차입원가로 결정하며, 일반적인 목적으로 자금을 차입하고 이를 적격자산의 취득을 위해 사용하는 경우에 한하여 당해 자산 관련 지출액에 자본화이자율을 적용하는 방식으로 자본화가능차입원가를 결정하고 있습니다. 자본화이자율은 보고기간 동안 차입한 자금(적격자산을 취득하기 위해 특정 목적으로 차입한 자금 제외)으로부터 발생된 차입원가를 가중평균하여 산정하고 있습니다. 보고기간 동안 자본화한 차입원가는 당해 기간 동안 실제 발생한 차입원가를 초과할 수 없습니다.&cr;</P>
<P>2.11 정부보조금&cr;정부보조금은 당사가 정부보조금에 부수되는 조건을 준수하고 그 보조금을 수취하는것에 대해 합리적인 확신이 있을 경우에만 인식하고 있습니다.&cr;당사는 정부보조금을 정부보조금으로 보전하려 하는 관련원가가 비용으로 인식되는 기간에 걸쳐 관련비용에서 차감하는 방법으로 인식하고 있습니다&cr;&cr;2.12 비금융자산의 손상&cr;종업원급여에서 발생한 자산, 재고자산, 이연법인세자산을 제외한 모든 비금융자산에 대해서는 매 보고기간말마다 자산손상을 시사하는 징후가 있는지를 검토하며, 만약 그러한 징후가 있다면 당해 자산의 회수가능액을 추정하고 있습니다. 단, 아직 사용할 수 없는 무형자산에 대해서는 자산손상을 시사하는 징후와 관계없이 매년 회수가능액과 장부금액을 비교하여 손상검사를 하고 있습니다.</P>
<P>회수가능액은 개별 자산별로, 또는 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속하는 현금창출단위별로 회수가능액을 추정하고 있습니다. 회수가능액은 사용가치와 순공정가치 중 큰 금액으로 결정하고 있습니다. 사용가치는 자산이나 현금창출단위에서 창출될 것으로 기대되는 미래현금흐름을 화폐의 시간가치 및 미래현금흐름을 추정할 때 조정되지 아니한 자산의 특유위험에 대한 현행 시장의 평가를 반영한 적절한 할인율로 할인하여 추정합니다.</P>
<P>자산이나 현금창출단위의 회수가능액이 장부금액에 미달하는 경우 자산의 장부금액을 감소시키며 즉시 당기손익으로 인식하고 있습니다. </P>
<P>매 보고기간말에 자산에 대해 과거기간에 인식한 손상차손이 더 이상 존재하지 않거나 감소된 것을 시사하는 징후가 있는지를 검토하고 직전 손상차손의 인식시점 이후 회수가능액을 결정하는데 사용된 추정치에 변화가 있는 경우에만 환입합니다. 손상차손환입으로 증가된 장부금액은 과거에 손상차손을 인식하기 전 장부금액의 감가상각 또는 상각 후 잔액을 초과할 수 없습니다.</P>
<P>&cr;2.13 종업원급여&cr;(1) 단기종업원급여&cr;종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 결제될 단기종업원급여는 근무용역과 교환하여 지급이 예상되는 금액을 근무용역이 제공된 때에 당기손익으로 인식하고 있습니다. 단기종업원급여는 할인하지 않은 금액으로 측정하고있습니다.</P>
<P>&cr;(2) 기타장기종업원급여&cr;종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 지급되지 않을 기타장기종업원급여는 당기와 과거기간에 제공한 근무용역의 대가로 획득한 미래의 급여액을 현재가치로 할인하고 있습니다. 재측정에 따른 변동은 발생한 기간에 당기손익으로 인식하고 있습니다.</P>
<P>&cr;(3) 퇴직급여: 확정기여제도&cr;확정기여제도와 관련하여 일정기간 종업원이 근무용역을 제공하였을 때에는 그 근무용역과 교환하여 확정기여제도에 납부해야 할 기여금에 대하여 자산의 원가에 포함되는 경우를 제외하고는 당기손익으로 인식하고 있습니다. 납부해야 할 기여금은 이미 납부한 기여금을 차감한 후 부채(미지급비용)로 인식하고 있습니다. 또한, 이미 납부한 기여금이 보고기간말 이전에 제공된 근무용역에 대해 납부하여야 하는 기여금을 초과하는 경우에는 초과 기여금 때문에 미래 지급액이 감소하거나 현금이 환급되는 만큼을 자산(선급비용)으로 인식하고 있습니다.&cr;</P>
<P>2.14 충당부채&cr;과거사건의 결과로 존재하는 현재의 법적의무 또는 의제의무 이행을 위하여 경제적효익을 갖는 자원이 유출될 가능성이 높으며 그 의무의 이행에 소요되는 금액의 신뢰성 있는 추정이 가능한 경우 충당부채를 인식하고 있습니다. &cr;충당부채로 인식하는 금액은 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하여 현재의무를 보고기간말에 이행하기 위하여 소요되는 지출에 대한 최선의 추정치입니다. 화폐의 시간가치 효과가 중요한 경우 충당부채는 의무를 이행하기위하여 예상되는 지출액의 현재가치로 평가하고 있습니다. &cr;또한 과거사건은 발생하였으나 불확실한 미래사건의 발생여부에 의해서 존재여부가 확인되는 잠재적인 의무가 있는 경우 또는 과거사건이나 거래의 결과 현재 의무가 존재하나 자원이 유출될 가능성이 매우 높지 않거나 당해 의무를 이행하여야 할 금액을신뢰성 있게 추정할 수 없는 경우에는 우발부채로 하여 주석으로 기재하고 있습니다.&cr;</P>
<P>2.15 리스&cr;리스는 리스제공자가 대가와 교환하여 식별되는 자산의 사용 통제권을 일정기간 동안 리스이용자에게 이전하는 계약입니다. &cr;당사는 계약의 약정시점에, 계약 자체가 리스인지, 계약이 리스를 포함하는지를 판단합니다. 리스이용자 및 리스제공자는 리스계약이나 리스를 포함하는 계약에서 계약의 각 리스요소를 리스가 아닌 요소(이하 '비리스요소'라고 함)와 분리하여 리스로 회계처리합니다. 다만, 당사는 리스이용자로서의 회계처리에서 실무적 간편법을 적용하여 비리스요소를 리스요소와 분리하지 않고 각 리스요소와 관련 비리스요소를 하나의 리스요소로 회계처리합니다.&cr;&cr;(1) 리스이용자로서의 회계처리&cr;당사는 리스개시일에 기초자산을 사용할 권리를 나타내는 사용권자산(리스자산)과 리스료를 지급할 의무를 나타내는 리스부채를 인식합니다. &cr;사용권자산은 최초 인식 시 원가로 측정하고, 후속적으로 원가에서 감가상각누계액과 손상차손누계액을 차감하고, 리스부채의 재측정에 따른 조정을 반영하여 측정합니다. 또한 사용권자산은 리스개시일부터 사용권자산의 내용연수 종료일과 리스기간&cr;종료일 중 이른 날까지의 기간동안 감가상각합니다. 사용권자산은 재무상태표에 '유형자산'으로 분류합니다.&cr;리스부채는 리스개시일 현재 지급되지 않은 리스료의 현재가치로 측정합니다. 현재가치 측정시 리스의 내재이자율을 쉽게 산정할 수 있는 경우 그 이자율로 리스료를 할인합니다. 내재이자율을 쉽게 산정할 수 없는 경우에는 리스이용자가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산을 획득하는 데 필요한 자금을 차입한다면 지급해야 할 이자율인 리스이용자의 증분차입이자율을 사용합니다.&cr;&cr;당사는 증분차입이자율을 다음과 같이 산정합니다.&cr;- 가능하다면 회사가 받은 최근 제3자 금융 이자율에 제3자 금융을 받은 이후 재무상태의 변경을 반영&cr;- 최근 제3자 금융을 받지 않은 경우 무위험이자율에 신용위험을 조정하는 상향 접근법을 사용&cr;- 국가, 통화, 담보, 보증과 같은 리스에 특정한 조정을 반영&cr;개별 리스이용자가 리스와 비슷한 지급일정을 가진 분할상환 차입금 이자율을 쉽게 관측(최근의 금융 또는 시장 자료를 통해)할 수 있는 경우, 당사는 증분차입이자율을 산정할 때 그 이자율을 시작점으로 사용합니다.&cr;&cr;리스부채는 후속적으로 리스부채에 대하여 인식한 이자비용만큼 증가하고, 리스료의지급을 반영하여 감소합니다. 지수나 요율(이율)의 변동, 잔존가치보증에 따라 지급할 것으로 예상되는 금액의 변동, 매수선택권이나 연장선택권을 행사할 것이 상당히 확실한지 또는 종료선택권을 행사하지 않을 것이 상당히 확실한지에 대한 평가의 변동에 따라 미래 리스료가 변경되는 경우에 리스부채를 재측정합니다. &cr;한편, 단기리스(리스개시일에 리스기간이 12개월 이하인 리스)와 소액자산(예 : 기초자산 US$5,000 이하) 리스의 경우 예외규정을 선택하여 리스료를 리스기간에 걸쳐 정액기준으로 비용을 인식합니다. &cr;&cr;(2) 리스제공자로서의 회계처리&cr;당사는 리스약정일에 리스자산의 소유에 따른 위험과 보상의 대부분을 이전하는 리스는 금융리스로 분류하고, 금융리스 이외의 모든 리스는 운용리스로 분류합니다. 운용리스로부터 발생하는 리스료수익은 리스기간에 걸쳐 정액기준으로 인식하고, 운용리스의 협상 및 계약단계에서 발생한 리스개설 직접원가는 리스자산의 장부금액에 가산한 후 리스료 수익에 대응하여 리스기간 동안 비용으로 인식합니다.&cr;</P>
<P>2.16 납입자본</P>
<P>보통주는 자본으로 분류하며 자본거래와 직접 관련되어 발생하는 증분원가는 세금효과를 반영한 순액으로 자본에서 차감하고 있습니다.</P>
<P>우선주는 상환하지 않아도 되거나 당사의 선택에 의해서만 상환되는 경우와 배당의 지급이 당사의 재량에 의해 결정된다면 자본으로 분류하고, 주주총회에서 배당을 승인하면 배당금을 인식하고 있습니다. 주주가 특정일이나 그 이후에 확정되거나 확정가능한 금액의 상환을 청구할 수 있거나 의무적으로 상환해야 하는 우선주는 부채로 분류하고 있습니다. 관련 배당은 발생시점에 이자비용으로 보아 당기손익으로 인식하고 있습니다.&cr;당사가 자기지분상품을 재취득하는 경우에 이러한 지분상품은 자기주식의 과목으로 자본에서 직접 차감하고 있습니다. 자기지분상품을 매입 또는 매도하거나 발행 또는 소각하는 경우의 손익은 당기손익으로 인식하지 아니합니다. 당사가 자기주식을 취득하여 보유하는 경우 지급하거나 수취한 대가는 자본에서 직접 인식하고 있습니다.&cr;</P>
<P>2.17 주식기준보상&cr;당사는 제공받는 재화나 용역의 대가로 종업원에게 주식이나 주식선택권을 부여하는주식결제형 주식보상거래에 대하여 제공받는 재화나 용역의 공정가치 또는 제공받는재화나 용역의 공정가치를 신뢰성있게 측정할 수 없다면 부여한 지분상품의 공정가치에 기초하여 재화나 용역의 공정가치를 간접측정하고 그 금액을 가득기간 동안에 종업원급여(당기비용)과 자본으로 인식하고 있습니다. 주식선택권의 가득조건이 용역제공조건 또는 시장조건이 아닌 가득조건인 경우에는 궁극적으로 가득되는 주식선택권의 실제 수량에 기초하여 결정되도록 인식된 종업원비용을 조정하고 있습니다.</P>
<P>&cr;2.18 고객과의 계약에서 생기는 수익&cr;(1) 수익인식모형&cr;당사의 고객과의 계약에서 생기는 수익은 제품매출, 기술료수익으로 구성되어 있습니다. 당사는 고객과의 계약이 개시되는 단계에서부터 통제가 고객에게 이전되는 시점 또는 통제가 고객에게 이전되는 기간에 걸쳐 다음의 5단계 수익인식모형에 따라 수익을 인식하고 있습니다.</P>
<P> </P>
<P>① 계약의 식별</P>
<P>당사는 고객과의 사이에서 집행가능한 권리와 의무가 생기게 하는 합의를 계약으로 식별하고 계약으로 식별된 경우에는 수행의무의 식별 등 이후 단계를 추가 검토하여 수익인식여부를 판별하며, 계약으로 식별되지 못하였으나 고객에게서 대가를 받은 경우에는 부채로 인식하고 있습니다.</P>
<P> </P>
<P>② 수행의무의 식별</P>
<P>수행의무는 고객과의 계약에서 ‘구별되는 재화나 용역’이나 ‘실질적으로 서로 같고 고객에게 이전하는 방식도 같은 일련의 구별되는 재화나 용역’을 고객에게 이전하기로 한 약속을 의미합니다. 당사는 계약 개시시점에 고객과의 계약에서 약속한 재화나 용역을 검토하여 수행의무를 식별하고 있습니다.</P>
<P> </P>
<P>③ 거래가격의 산정</P>
<P>거래가격은 고객에게 약속한 재화나 용역을 이전하고 그 대가로 기업이 받을 권리를 갖게 될 것으로 예상하는 금액으로서 추정치의 제약을 고려한 변동대가, 유의적인 금융요소, 비현금대가 및 고객에게 지급할 대가 등을 고려하여 산정하고 있습니다. 당사는 반품가능성을 과거의 경험률에 근거하여 합리적으로 추정하여 변동대가에 반영하고, 수행의무를 이전하는 시점과 고객이 그에 대한 대가를 지급하는 시점 간의 기간이 12개월 이내이므로 유의적인 금융요소는 없다고 판단하고 있습니다.</P>
<P> </P>
<P>④ 거래가격의 배분</P>
<P>당사는 하나의 계약에서 식별된 여러 수행의무에 상대적 개별판매가격을 기초로 거래가격을 배분하고 있습니다. 각 수행의무의 개별판매가격이 없는 경우에는 시장평가조정접근법 등을 고려하여 개별판매가격을 적절하게 추정하고 있습니다. </P>
<P> </P>
<P>⑤ 수익인식</P>
<P>당사는 계약개시 시점에 해당 계약과 관련하여 수행의무를 이행할 때 수익을 인식할지 또는 수행의무를 이행하는 기간에 걸쳐 수익을 인식할지 여부를 판단하고 있습니다. 당사가 의무를 수행하는 대로 고객이 동시에 효익을 얻고 소비하는 경우, 당사가 의무를 수행하여 자산이 만들어지거나 가치가 높아지는 것과 비례하여 고객이 그 자산을 통제하는 경우, 또는 의무를 수행하여 만든 자산이 당사 자체에는 대체용도가 없으나 현재까지 수행을 완료한 부분에 대해 집행가능한 지급청구권은 있는 경우에는 수행의무를 이행하는 기간에 걸쳐 수익을 인식합니다. </P>
<P>수행의무를 이행하는 기간에 걸쳐 수익을 인식하는 경우에는 투입법에 따라 산정된 진행률을 적용하여 수익과 원가를 측정하고 당사의 수행정도를 나타내지 못하는 투입물의 영향은 투입법에서 적절히 제외하고 있습니다.</P>
<P> </P>
<PGBRK></PGBRK>
<P>(2) 본인과 대리인의 구분</P>
<P>당사는 상품과 관련된 거래에서는 상품의 제공을 주선하는 대리인의 역할을 수행한다고 판단하여 관련 수수료만 수익으로 인식하고 있으며 이외 다른 거래에서는 본인의 역할을 수행하므로 수행의무의 이행결과로 이전되는 대가의 총액을 수익으로 인식하고 있습니다.</P>
<P> </P>
<P>(3) 계약체결 증분원가와 계약이행원가</P>
<P>당사는 회수가 가능한 계약체결 증분원가 및 조건을 충족하는 계약이행원가에 대해 자산으로 인식하고 있습니다. 이러한 자산은 관련된 재화나 용역을 고객에게 이전하는 방식과 일치하는 체계적 기준으로 상각하며, 자산과 관련된 재화나 용역의 대가로당사가 받을 것으로 예상하는 잔액과 향후 비용으로 인식될 직접원가와의 차액이 당해 자산의 장부가액보다 작은 경우 그 장부금액과의 차이를 손상차손으로 인식하고 있습니다.</P>
<P></P>

<P>
<SPAN>2.19 금융수익과 비용 </SPAN>
</P>

<P>
<SPAN>금융수익은 매도가능금융자산을 포함한 투자로부터의 이자수익</SPAN>
<SPAN>, 배당수익, 매도가능금융자산처분손익 및 당기손익인식금융상품의 공정가치의 변동</SPAN>
<SPAN>을 포함하고 있습니다. 이자수익은 기간의 경과에 따라 유효이자율법을 적용하여 당기손익으로 인식하며, 배당수익은 주주로서 배당을 받을 권리가 확정되는 시점에 수익을 인식하고 있습니다.</SPAN>
</P>

<P>
<SPAN>금융비용은 차입금에 대한 이자비용, 충당부채의 상각액 및 당기손익인식금융상품의공정가치의 변동을 포함하고 있습니다. 차입금에 대한 이자비용은 유효이자율법을 적용하여 기간의 경과에 따라 당기손익으로 인식하고 있습니다.&cr;</SPAN>
</P>
<P>2.20 법인세</P>

<P>
<SPAN>법인세비용은 당기법인세와 이연법인세로 구성되어 있으며 </SPAN>
<SPAN>기타포괄손익이나 자본에 직접 인식되는 거래나 사건에서 발생하는 세액을 제외하고는</SPAN>
<SPAN> 당기손익으로 인식하고 있습니다.&cr;</SPAN>
</P>
<P>(1) 당기법인세</P>
<P>당기법인세비용은 보고기간말 현재 제정되었거나 실질적으로 제정된 세법에 근거하여 측정합니다. 경영진은 적용 가능한 세법 규정이 해석에 따라 달라질 수 있는 상황에 대하여 당사가 세무신고 시 적용한 세무정책에 대하여 주기적으로 평가하고 있으며, 세무당국이 불확실한 법인세 처리를 수용할 가능성이 높은지 고려합니다. 당사는법인세 측정 시 가장 가능성이 높은 금액 또는 기댓값 중 불확실성의 해소를 더 잘 예측할 것으로 예상되는 방법을 사용하여 불확실성의 영향을 반영합니다.</P>
<P></P>
<P>(2) 이연법인세&cr;이연법인세부채와 이연법인세자산을 측정할 때에는 보고기간말에 당사가 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따른 세효과를 반영하고 있습니다. 차감할 일시적차이로 인하여 발생하는 이연법인세자산은 일시적차이가 예측가능한 미래에 소멸할 가능성이 높고, 일시적차이가 사용될 수 있는 기간에과세소득이 발생할 가능성이 높은 경우에 인식하고 있습니다.&cr;&cr;이연법인세자산의 장부금액은 매 보고기간말에 검토하고, 이연법인세자산으로 인한 혜택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않은 경우 이연법인세자산의 장부금액을 감소시키고 있습니다.&cr;&cr;이연법인세자산과 부채는 보고기간말 제정되었거나 실질적으로 제정된 세법에 근거하여 당해 자산이 실현되거나 부채가 지급될 보고기간에 적용될 것으로 기대되는 세율을 사용하여 측정하고 있습니다. </P>
<P>한편, 이연법인세자산과 부채는 동일 과세당국이 부과하는 법인세이고, 당사가 인식된 금액을 상계할 수 있는 법적 권한을 가지고 있으며 당기 법인세부채와 자산을 순액으로 결제할 의도가 있는 경우에만 상계하고 있습니다. </P>
<P>&cr;2.21 주당손익&cr;당사는 보통주 기본주당이익과 희석주당이익을 계속영업손익과 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 보고기간 동안에 유통된 보통주식수를 가중평균한 주식수로 나누어계산하고 있습니다. 희석주당이익은 종업원에게 부여한 주식기준보상 등 모든 희석화 효과가 있는 잠재적 보통주의 영향을 고려하여 보통주에 귀속되는 당기순손익 및 가중평균유통보통주식수를 조정하여 계산하고 있습니다.&cr;</P>
<PGBRK></PGBRK>

<P>3. 중요한 회계추정 및 가정&cr;재무제표 작성에는 미래에 대한 가정 및 추정이 요구되며 경영진은 회사의 회계정책을 적용하기 위해 판단이 요구됩니다. 추정 및 가정은 지속적으로 평가되며, 과거 경험과 현재의 상황에 비추어 합리적으로 예측가능한 미래의 사건을 고려하여 이루어집니다. 회계추정의 결과가 실제 결과와 동일한 경우는 드물 것이므로 중요한 조정을유발할 수 있는 유의적인 위험을 내포하고 있습니다.&cr;&cr;2020년도 중 COVID-19의 확산은 국내ㆍ외 경제에 중대한 영향을 미치고 있습니다.이는 생산성 저하와 매출의 감소나 지연, 기존 채권의 회수 등에 부정적인 영향을 미칠 수 있습니다. 
<SPAN>이로 인해 회사의 재무상태와 경영성과에도 부정적인 영향이 발생할수 있습니다.&cr;&cr;재무제표 작성시 사용된 중요한 회계추정 및 가정은 COVID-19에 따른 불확실성의 변동에 따라 조정될 수 있으며, COVID-19로 인하여 회사의 사업, 재무상태 및 경영성과 등에 미칠 궁극적인 영향은 현재 예측할 수 없습니다.&cr;&cr;다음 회계연도에 자산 및 부채 장부금액의 조정에 영향을 미칠 수 있는 경영진 판단과 유의적 위험에 대한 추정 및 가정은 다음과 같습니다. 일부 항목에 대한 유의적인 판단 및 추정에 대한 추가적인 정보는 개별 주석에 포함되어 있습니다.&cr;&cr;(1) 법인세&cr;회사의 과세소득에 대한 법인세는 세법 및 과세당국의 결정을 적용하여 산정되므로 최종 세효과를 산정하는 데에는 불확실성이 존재합니다.&cr;&cr;(2) 금융상품의 공정가치</SPAN>
</P>
<P>당사의 회계정책과 공시사항은 다수의 금융 및 비금융자산과 부채에 대해 공정가치 측정을 요구하고 있는 바, 당사는 공정가치평가 정책과 절차를 수립하고 있습니다. 동 정책과 절차에는 공정가치 서열체계에서 수준 3으로 분류되는 공정가치를 포함한모든 유의적인 공정가치 측정의 검토를 책임지는 평가부서의 운영을 포함하고 있으며, 그 결과는 재무담당임원에게 직접 보고되고 있습니다.&cr;&cr;평가부서는 정기적으로 관측가능하지 않은 유의적인 투입변수와 평가 조정을 검토하고 있습니다. 공정가치 측정에서 중개인 가격이나 평가기관과 같은 제3자 정보를 사용하는 경우, 평가부서에서 제3자로부터 입수한 정보에 근거한 평가가 공정가치 서열체계 내 수준별 분류를 포함하고 있으며 해당 기준서의 요구사항을 충족한다고 결론을 내릴 수 있는지 여부를 판단하고 있습니다.&cr;&cr;당사는 유의적인 평가 문제를 감사에 보고하고 있습니다.&cr;&cr;자산이나 부채의 공정가치를 측정하는 경우, 당사는 최대한 시장에서 관측가능한 투입변수를 사용하고 있습니다. 공정가치는 다음과 같이 가치평가기법에 사용된 투입변수에 기초하여 공정가치 서열체계 내에서 분류됩니다.&cr;- 수준 1: 측정일에 동일한 자산이나 부채에 대한 접근 가능한 활성시장의 조정되지 않은 공시가격&cr;- 수준 2: 수준 1의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수&cr;- 수준 3: 자산이나 부채에 대한 관측가능하지 않은 투입변수&cr;&cr;자산이나 부채의 공정가치를 측정하기 위해 사용되는 여러 투입변수가 공정가치 서열체계 내에서 다른 수준으로 분류되는 경우, 당사는 측정치 전체에 유의적인 공정가치 서열체계에서 가장 낮은 수준의 투입변수와 동일한 수준으로 공정가치 측정치 전체를 분류하고 있으며, 변동이 발생한 보고기간말에 공정가치 서열체계의 수준간 이동을 인식하고 있습니다.&cr;&cr;(3) 금융자산의 손상&cr;금융자산의 손실충당금은 부도위험 및 기대손실률 등에 대한 가정에 기초하여 측정됩니다. 회사는 이러한 가정의 설정 및 손상모델에 사용되는 투입변수의 선정에 있어서 회사의 과거 경험, 현재 시장 상황, 재무보고일 기준의 미래전망정보 등을 고려하여 판단합니다.</P>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>4. </SPAN>
<SPAN>자본위험관리</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당사의 자본관리 정책은 투자자와 채권자, 시장의 신뢰 및 향후 발전을 위해 자본을 유지하는 것입니다. 이사회는 부채비율 및 차입금비율 관리를 통해 자본과 관련된 위험을 분기별로 평가하고 있으며, 해당 비율 분석의 결과를 바탕으로 하여 적정자본을유지하기 위한 정책을 수립, 시행하고 있습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>보고기간종료일 현재 자본조달비율은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="595" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">총차입금</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">8,517,614</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">8,702,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">차감 : 현금및현금성자산</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">806,433</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">순부채</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">6,001,585</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">7,896,156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">자본총계</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">8,836,053</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">7,417,684</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">자본조달비율</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">67.9%</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">106.5%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN>5. </SPAN>
<SPAN>금융위험관리</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>당사는 금융상품과 관련하여 신용위험, 유동성위험 및 시장위험에 노출되어 있습니다. 본 주석은 당사가 노</SPAN>
<SPAN>출되어 있는 위의 위험에 대한 정보와 당사의 위험관리 목표,정책, 위험 평가 및 관리 절차, 그리고 자본관리에 대해 공시하고 있습니다. 추가적인계량적 정보에 대해서는 본 재무제표 전반에 걸쳐서 공시되어 있습니다.</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;(</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>1) </SPAN>
<SPAN>위험관리 정책&cr;</SPAN>당사의 위험관리 체계를 구축하고 감독할 책임은 이사회에 있으며 당사의 위험관리 정책은 당사가 직면한 위험을 식별 및 분석하고, 적절한 위험 한계치 및 통제를 설정하고, 위험이 한계치를 넘지 않도록 하기 위해 수립되었습니다. 위험관리정책과 시스템은 시장 상황과 당사의 활동변경을 반영하기 위해 정기적으로 검토되고 있습니다. 당사는 훈련 및 관리기준, 절차를 통해 모든 종업원들이 자신의 역할과 의무를 이해할 수 있는 엄격하고 구조적인 통제환경을 구축하는 것을 목표로 하고 있습니다.
</P>

<P>
<SPAN>당사의 내부감사는</SPAN>
<SPAN> 경영진이 당사의 위험관리 정책 및 절차의 준수여부를 어떻게 관리하는지 감독하고, 당사의 위험관리체계가 적절한지 검토하여 위험관리 통제 및 절차에 대한 정기 및 특별 검토를 수행하고 결과는 이사회에 보고하고 있습니다.</SPAN>
</P>
<P></P>
<P>(2) 시장위험</P>
<P>시장위험이란 시장가격의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험을 의미합니다. 시장가격 관리의 목적은 수익은 최적화하는 반면 수용가능한 한계 이내로 시장위험 노출을 관리 및 통제하는 것입니다.&cr;</P>
<P>① 환위험</P>
<P>당사의 기능통화인 원화 외의 통화로 표시되는 판매, 구매 및 차입에 대해 환위험에 노출되어 있습니다. 이러한 거래들이 표시되는 주된 통화는 USD입니다. 당사는 외화부채 규모의 최소화 및 조기결제 등 환위험 노출을 최소화하기 위한 정책을 수립, 운용하고 있습니다.&cr;</P>
<PGBRK></PGBRK>

<P>당기말 및 전기말 현재 당사의 외화자산부채는 다음과 같습니다. 
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="658">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="658" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6" VALIGN="MIDDLE">(단위: 천원, USD)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구  분</TH>
<TH WIDTH="94" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">통화</TH>
<TH WIDTH="204" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="203" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2" VALIGN="MIDDLE">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">외화금액</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">원화환산액</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">외화금액</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">원화환산액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">USD</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">32,774</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">35,658</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">627,361</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">726,359</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">매출채권</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">USD</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">1,853,423</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">2,016,524</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">1,797,100</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,080,682</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">합계</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">1,886,197</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">2,052,182</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">2,424,461</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,807,041</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;② 민감도 분석&cr;보고기간종료일 현재 당사의 금융자산을 구성하는 외화(USD)에 대하여 원화가 변동을 보인다면 당사의 자본과 손익은 증가 또는 감소하였을 것입니다. 이와 같은 분석은 당사가 각 보고기간말에 합리적으로 가능하다고 판단하는 정도의 변동을 가정한 것으로서 분석 시에는 이자율과 같은 다른 변수는 변동하지 않는다고 가정하였습니다. &cr;&cr;당기말 및 전기말 현재 이러한 가정을 기초로 기능통화의 환율 10% 변동시 환율변동이 손익에 미치는 영향은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="590">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="590" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="240" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">당기말</TH>
<TH WIDTH="238" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10% 상승</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10% 하락</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10% 상승</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10% 하락</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융자산</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">205,218</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(205,218)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">280,704</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">(280,704)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>③ 이자율위험</P>
<P>당사는 변동금리부 금융부채 규모의 증가에 따라 부수되는 이자율 부담을 최소화하기 위한 일환으로 연간 자금수지 계획을 수립하고 시행하고 있으며 장기금융부채를 최소화하고 자금유입의 스케줄에 따라 금융부채의 조달금액 및 차입기간을 최소화하고 있습니다.&cr;</P>
<PGBRK></PGBRK>
<P>당기말 및 전기말 현재 당사가 보유하고 있는 변동이자부 금융상품의 장부금액은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="591">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="182"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="591" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융부채</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">5,160,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 신용위험&cr;신용위험이란 당사의 고객이나 거래상대방이 금융상품에 대한 계약상의 의무를 이행하지 않아 당사가 재무손실을 입을 위험을 의미합니다. 주로 거래처에 대한 매출채권과 기타채권에서 발생합니다.&cr;&cr;① 매출채권 및 기타채권&cr;당사는 계약상대방의 재무상태, 과거 경험 및 기타 요소들을 평가하여 신용도가 일정수준 이상인 계약상대방과 거래하는 정책을 운영하고 있습니다. 당사의 신용위험에 대한 노출은 주로 거래처별 특성의 영향을 받으며 고객이 영업하고 있는 산업 및 고객이 위치한 국가의 파산위험 등은 당사의 신용위험에 큰 영향을 주지 않습니다. 당사는 모든 신규 고객에 대해 개별적으로 신용도를 검토합니다.&cr;</P>
<P>또한, 당사는 매출채권 및 기타채권에서 발생할 것으로 예상되는 손실에 대해 충당금을 설정하고 있습니다. 이 충당금은 개별적으로 유의적인 항목에 대한 구체적인 손상차손과 유사한 특성을 가진 금융자산 집합이 발생하였으나 아직 식별되지 않은 손상으로 구성됩니다. 금융자산 집합의 충당금은 유사한 금융자산의 회수에 대한 과거 자료에 근거하여 결정되고 있습니다. 채무증권의 경우 개별분석을 통하여 발생할 것으로 예상되는 손실은 채무증권에서 직접 차감하고 있습니다.&cr;&cr;당사는 금융보증계약 체결 시에는 이사회의 승인 등과 같은 내부 의사결정 프로세스에 따라 계약의 필요성을 평가하고 승인하여 신용위험 등 관련 리스크를 최소화하고 있습니다.</P>
<P></P>
<PGBRK></PGBRK>
<P>당기말 및 전기말 현재 당사의 대손위험에 대한 최대노출정도는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="579" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="579" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">내  역</TH>
<TH WIDTH="193" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="193" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30">매출채권</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">2,016,524</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">2,080,682</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30">미수금</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">47,362</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">118,918</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30">보증금</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">264,000</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">267,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">2,327,886</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">2,466,600</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>당기말 및 전기말
<SPAN> 현재 </SPAN>
<SPAN>매출채권및기타채권</SPAN>의 각 지역별 신용위험에 대한 최대 노출정도는 다음과 같습니다.
</P>

<TABLE BORDER="1" WIDTH="596" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="596" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" COLSPAN="4" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="317" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" COLSPAN="2">구  분</TH>
<TH WIDTH="140" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="139" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">해 외</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">미국</TD>
<TD WIDTH="140" ALIGN="RIGHT" HEIGHT="30">169,075</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">79,194</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">인도</TD>
<TD WIDTH="140" ALIGN="RIGHT" HEIGHT="30">1,847,449</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">2,001,488</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="317" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">국  내</TD>
<TD WIDTH="140" ALIGN="RIGHT" HEIGHT="30">311,362</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">385,918</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="317" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">합  계</TD>
<TD WIDTH="140" ALIGN="RIGHT" HEIGHT="30">2,327,886</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">2,466,600</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;회사는 집합평가 매출채권에 대해 기대신용손실률(실무적 간편법)을 적용하여 전체기간 기대신용손실금액을 산정하였습니다. 당기말과 전기말 현재 연체일을 기준으로구분한 매출채권 및 대손충당금의 내역은 다음과 같습니다.&cr;1) 당기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="754">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="754" HEIGHT="30" COLSPAN="7" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">  (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미연체</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 이하</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">9개월 이하</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 이하</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 초과</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">총장부금액</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,004,665</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,859</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">2,016,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">기대손실률</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.02%</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.66%</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11.06%</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">41.67%</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100.00%</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">0.61%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">전체 기간 기대신용손실</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">474</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,859</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">12,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">순장부금액</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,004,191</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">2,004,191</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<P>2) 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="754">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="754" HEIGHT="30" COLSPAN="7" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">  (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미연체</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 이하</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">9개월 이하</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 이하</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 초과</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">총장부금액</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,022,214</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,924</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,924</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,620</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">2,080,682</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">기대손실률</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.65%</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10.59%</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27.32%</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">62.50%</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100.00%</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">1.66%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">전체 기간 기대신용손실</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,174</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,428</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,262</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,620</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">34,484</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="30" VALIGN="MIDDLE">순장부금액</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,009,040</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,496</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,662</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">2,046,198</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>당기말과 전기말 현재 매출채권을 제외한 기타 금융자산에 대하여 연체된 내역은 없습니다.&cr;
</P>
<PGBRK></PGBRK>
<P>② 금융자산 등 신용위험 관리&cr;신용위험은 금융기관과의 거래에서도 발생할 수 있으며, 해당 거래는 현금및현금성자산, 각종 예금 그리고 파생금융상품 등의 금융상품 거래를 포함합니다. 이러한 위험을 줄이기 위해, 당사는 신용등급이 높은 은행들에 대해서만 거래를 하는 것을 원칙으로 하고 있으며, 기존의 거래가 없는 금융기관과의 신규거래는 자금팀의 승인, 관리, 감독하에 이루어지고 있습니다. &cr;</P>
<P>(4) 유동성위험</P>

<P>
<SPAN>유동성위험이란 당사가 금융부채에 관련된 의무를 충족하는 데 어려움을 겪게 될 위험을 의미합니다. 당사의 유동성 관리방법은 재무적으로 어려운 상황에서도 받아들일 수 없는 손실이 발생하거나, 당사의 평판에 손상을 입힐 위험 없이 만기일에 부채를 상환할 수 있는 충분한 유동성을 유지하도록 하는 것입니다. &cr;</SPAN>
<SPAN>당사는 금융부채 상환을 포함하여 </SPAN>
<SPAN>상당한 기간에 </SPAN>
<SPAN>대한 예상 운영비용을 충당할 수 있는 충분한 자금여력을 보유하고 있다고 판단하고 있습니다. 여기에는 합리적으로 예상할 수 없는 극단적인 상황으로 인한 잠재적인 효과는 포함되지 않았습니다.&cr; </SPAN>
<SPAN>&cr;금융부채의 잔존계약만기에 따른 만기분석은 다음과 같습니다.</SPAN>
</P>
<P>① 당기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="780">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="780" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구  분</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3개월 이내</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3~6개월 이내</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6~12개월 이내</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 이상</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">매입채무및기타채무</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">전환사채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,249,728</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">2,249,728</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">27,666</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">27,973</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">56,561</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">5,056,254</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">5,168,454</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">리스부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">79,200</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">79,200</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">158,400</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,425,600</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,742,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">280,322</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,356,901</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">214,961</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">6,481,854</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">9,334,038</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-10"></SPAN>
<SPAN></SPAN>
</P>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="780">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="780" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3개월 이내</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3~6개월 이내</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6~12개월 이내</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 이상</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">매입채무및기타채무</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">161,536</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">161,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">전환사채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">2,249,728</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">2,249,728</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">39,674</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">40,115</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">81,111</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">5,242,011</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">5,402,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">리스부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">79,200</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">79,200</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">158,400</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,742,400</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">2,059,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">559,537</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">119,315</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">239,511</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">9,234,139</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">10,152,502</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>6. </SPAN>
<SPAN>금융상</SPAN>
<SPAN>품 공정가치&cr;</SPAN>
<SPAN>(1) 당기말 및 전기말 현재 공정가치로 후속 측정되지 않는 금융상품의 장부금액과 공정가치는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="222" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="220" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">금융자산:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">806,433</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">806,433</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  매출채권및기타채권</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,051,553</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,051,553</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,165,116</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,165,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  비유동기타채권</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">217,879</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">217,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금융자산 합계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">4,823,100</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">4,823,100</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,189,428</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,189,428</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">금융부채:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  매입채무및기타채무</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  차입부채</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,517,614</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,517,614</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,702,589</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,702,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금융부채 합계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,691,070</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,691,070</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,981,716</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,981,716</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>당사는 상기와 같이 금융자산 및 금융부채는 장부금액이 공정가치와 합리적인 근사치라고 판단하고 있습니다.&cr;&cr;</SPAN>(2) 공정가치 서열체계&cr;당사는 공정가치로 측정되는 금융상품에 대하여 공정가치 측정에 사용된 투입변수에따라 다음과 같은 공정가치 서열체계로 분류하고 있습니다.
</P>
<P>&cr;- '수준 1'은 동일한 자산이나 부채에 대한 활성시장의 (조정되지 않은) 공시가격을       사용하여 도출되는 공정가치입니다.&cr;-  '수준 2'는 직접적 또는 간접적으로 관측가능한, 자산이나 부채에 대한 투입변수를    사용하여 도출되는 공정가치입니다.&cr;- '수준 3'은 자산이나 부채에 대하여 관측가능한 시장정보에 근거하지 않은 투입변       수(관측불가능한 변수)를 사용하는 평가기법으로부터 도출되는 공정가치입니다.</P>
<P></P>
<PGBRK></PGBRK>
<P>당기말 및 전기말 현재 공정가치로 측정되거나 공정가치가 공시되는 금융상품의 공정가치 서열체계 구분은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="706" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="706" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준1</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준2</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준3</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="706" HEIGHT="30" COLSPAN="6"> 당기말: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">   파생금융부채</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">96,755</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">96,755</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">96,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="706" HEIGHT="30" COLSPAN="6">전기말 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">   파생금융부채</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">351,622</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">351,622</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">351,622</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;수준 3으로 인식되는 공정가치의 변동내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="660" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본으로 재분류</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5"> 당기말: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">351,622</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">254,867</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">96,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">전기말 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(351,622)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">351,622</TD>
</TR>
</TBODY>
</TABLE>
<P>당기 및 전기 중 수준 1과 수준 2 간의 유의적인 이동은 없습니다.&cr;&cr;(3) 가치평가기법 및 투입변수  &cr;당사는 공정가치 서열체계에서 수준3으로 분류되는 금융상품의 공정가치에 대하여 다음의 가치평가기법 및 투입변수를 사용하고 있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="233"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="660" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="242" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가치평가기법</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">투입변수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" COLSPAN="4" VALIGN="MIDDLE"> 당기말: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="53" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">96,755</TD>
<TD WIDTH="242" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">현금흐름할인법&cr;이항옵션모형</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">할인율&cr;기대주가변동성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" COLSPAN="4" VALIGN="MIDDLE">전기말 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="53" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">351,622</TD>
<TD WIDTH="242" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">현금흐름할인법&cr;이항옵션모형</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">할인율&cr;기대주가변동성</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>7. 범주별 금융상품&cr;
<SPAN>당기말 및 전기말 현재 범주별 금융상품의 내역은 다음과 같습니다.&cr;(1) 당기말</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="935" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="935" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="171" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-&cr;공정가치측정&cr;금융자산</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-&cr;공정가치측정&cr;금융자산</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정&cr;금융자산</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-&cr;공정가치측정&cr;금융부채</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정&cr;금융부채</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="127" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="935" HEIGHT="30" COLSPAN="7"> 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   현금및현금성자산</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">2,516,029</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   단기금융상품</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">10,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   매출채권및기타채권</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,051,553</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">2,051,553</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   비유동기타채권</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">245,518</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,577,582</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">4,577,582</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="935" HEIGHT="30" COLSPAN="7" VALIGN="MIDDLE">금융부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  매입채무및기타채무</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">173,456</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">173,456</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  장기차입금</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">5,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">5,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  전환사채</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">1,922,777</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">1,922,777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  파생상품금융부채</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">96,755</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">96,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  리스부채</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">1,594,837</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">1,594,837</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">96,755</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">8,691,070</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">8,787,825</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) 전기말</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="935">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="935" HEIGHT="30" COLSPAN="7" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="171" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="128" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-&cr;공정가치측정&cr;금융자산</TH>
<TH WIDTH="128" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-&cr;공정가치측정&cr;금융자산</TH>
<TH WIDTH="127" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정&cr;금융자산</TH>
<TH WIDTH="127" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-&cr;공정가치측정&cr;금융부채</TH>
<TH WIDTH="127" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정&cr;금융부채</TH>
<TH WIDTH="127" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="935" HEIGHT="30" COLSPAN="7"> 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   현금및현금성자산</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">806,433</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">806,433</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   매출채권및기타채권</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,165,116</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,165,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">   비유동기타채권</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">217,879</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">217,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,189,428</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,189,428</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="935" HEIGHT="30" COLSPAN="7" VALIGN="MIDDLE">금융부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  매입채무및기타채무</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">279,127</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">279,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  단기차입금</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  장기차입금</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  전환사채</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,710,848</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,710,848</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  파생상품금융부채</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">351,622</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">351,622</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">  리스부채</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,831,741</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,831,741</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">351,622</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,981,716</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,333,338</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>8. 현금및현금성자산&cr;당기말 및 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="595" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위:천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">요구불예금</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">806,433</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>&cr;당기말 및 전기말 현재 사용이 제한된 현금및현금성자산과 부채나 우발부채에 대한 담보로 제공된 금융자산은 없습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>9</SPAN>
<SPAN>. 단기금융상품&cr;</SPAN>
<SPAN>당기말 및 전기말 현재 단기금융상품의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="595" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위:천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">정기적금</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>10. 매출채권및기타채권&cr;(1) 당기말 및 전기말 현재 매출채권및기타채권의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="222" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="220" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,004,191</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,046,198</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">미수금</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">47,362</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">118,918</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">보증금</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">217,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,051,553</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,165,116</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">217,879</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) 매출채권및기타채권은 대손충당금 및 현재가치할인차금이 차감된 순액으로 재무상태표에 표시되었으며, 당기말 및 전기말 현재 차감 전 총액기준에 의한 매출채권및기타채권과 대손충당금 및 현재가치할인차금의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="622" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="161" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="161" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE">매출채권및기타채권 총장부금액</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">2,327,886</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">2,466,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="622" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">대손충당금:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE">  매출채권</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">(12,333)</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">(34,484)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="622" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">현재가치할인차금:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE">  보증금</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">(18,482)</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">(49,121)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE">매출채권및기타채권 총장부금액</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">2,297,071</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">2,382,995</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당사의 매출채권및기타채권은 아래 거래처에 집중되어 있어, 아래 거래처 관련 중요한 신용위험이 존재합니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="604" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="307" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30" VALIGN="MIDDLE">매출채권및기타채권 순장부금액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">2,297,071</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">2,382,995</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30" VALIGN="MIDDLE">A사</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">1,845,074</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">1,986,355</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30" VALIGN="MIDDLE">주요거래처 채권비율</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">80.3%</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">83.4%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(4) 당기와 전기 중 매출채권및기타채권의 대손충당금 변동내역은 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="186"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="604" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">34,484</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">155,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">전입(환입)</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">(22,151)</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">(120,650)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">12,333</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">34,484</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(5) 상기 매출채권및기타채권에 대해 전기에 인식되어야 할 기술료수입에 대한 매출채권 761,890천원을 전기말 매출채권및기타채권에 반영하였습니다. 이에 따라 비교표시된 전년도 재무제표는 이러한 수정사항을 반영하여 재작성 되었습니다. 이로 인한 수정내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="596" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구  분</TH>
<TH WIDTH="381" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정전</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정금액</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">매출채권및기타채권</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,403,226</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">761,890</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,165,116</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>11. 재고자산&cr;(1) 당기말 및 전기말 현재 재고자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="809" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="809" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="RIGHT" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="116" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ROWSPAN="2">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" WIDTH="348" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH COLSPAN="3" ALIGN="CENTER" WIDTH="345" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="116" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">취득원가</TH>
<TH WIDTH="116" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">평가손실충당금</TH>
<TH WIDTH="116" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">장부금액</TH>
<TH WIDTH="115" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">취득원가</TH>
<TH WIDTH="115" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">평가손실충당금</TH>
<TH WIDTH="115" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">장부금액</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">65,553</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">(23,091)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">42,462</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">290,326</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(31,351)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">258,976</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">재공품</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">6,327</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">(958)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">5,369</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">165,592</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(52,157)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">113,435</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제품</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">875,165</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">(106,880)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">768,286</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">591,934</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(113,657)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">478,277</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">947,045</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">(130,929)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">816,117</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">1,047,852</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(197,165)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">850,688</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기 및 전기 중 재고자산 평가손실충당금 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="499">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="499" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">(197,165)</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">(185,911)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">폐기</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">191,922</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">101,695</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">환입(설정)</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">(125,686)</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">(112,949)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">(130,929)</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">(197,165)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>12. 유형자산&cr;</SPAN>
<SPAN>(1) 당기말 및 전기말 현재 당사의 유형자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="603" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">취득원가</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">8,599,224</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">8,481,159</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">(4,237,423)</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">(3,427,579)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">장부금액</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">4,361,801</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">5,053,580</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) </SPAN>
<SPAN></SPAN>
<SPAN>당기 및 전기 중 유형자산 변동내역은 다음과 같습니다.&cr;</SPAN>
<SPAN>① 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="827">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="827" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체 등</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">기계장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">419,545</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(66,995)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">352,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">차량운반구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">공구와기구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,890</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(4,346)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">12,544</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">비품</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">230,190</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">77,837</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(90,841)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">217,186</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">시설장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">373,007</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(128,579)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">244,428</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">구축설비자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,108,980</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">37,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(272,887)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,873,093</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,800</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">임차자산개량권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">35,774</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(35,774)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">사용권자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,852,393</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(266,761)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">59,567</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,645,199</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">5,053,580</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">114,837</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(830,409)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">23,793</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">4,361,801</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>&cr;② 전기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="945">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="945" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체 등</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회계정책변경</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">기계장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">488,598</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(69,053)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">419,545</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">차량운반구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">4,134</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(4,133)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">공구와기구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">3,689</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">19,150</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(5,949)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,890</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">비품</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">161,662</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">67,856</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(71,138)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">71,810</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">230,190</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">시설장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">246,130</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(101,105)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">227,982</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">373,007</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">구축설비자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,380,017</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(271,037)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,108,980</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">244,592</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">72,000</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(299,792)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">임차자산개량권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">59,621</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(23,847)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">35,774</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">사용권자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(284,984)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,137,377</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,852,393</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">3,588,443</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">159,006</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(831,246)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,137,377</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">5,053,580</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당기와 전기 중 유형자산 감가상각비의 배부내역은 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="183"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="602" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="217" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="193" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="192" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE">매출원가</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">548,546</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">516,653</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE">경상연구개발비</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">82,695</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">88,854</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE">판매비와관리비</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">199,168</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">225,739</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">830,409</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">831,246</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>13. 투자부동산&cr;(1) 당기말 및 전기말 현재 투자부동산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="183"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="602" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" VALIGN="MIDDLE" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="217" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">구  분</TH>
<TH WIDTH="193" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="192" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE">취득원가</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">7,788,759</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">7,788,759</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">(23,682)</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">(7,894)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE">장부금액</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">7,765,077</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT">7,780,865</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 투자부동산 장부금액의 변동내역은 다음과 같으며, 투자부동산에 대한 감가상각비는 판매비와관리비에 반영되어 있습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="603" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" ALIGN="RIGHT" WIDTH="603" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="194" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당  기</TH>
<TH WIDTH="193" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전  기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">7,780,865</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">취득</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">7,788,759</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">감가상각비</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">(15,788)</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">(7,894)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">7,765,077</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">7,780,865</TD>
</TR>
</TBODY>
</TABLE>
<P>당사의 투자부동산 장부금액은 공정가치와 유의적인 차이가 없습니다.&cr;&cr;(3) 보고기간 후 사건과 관련하여, 당사는 자산운용의 효율성 강화 및 현금유동성 확보에 따른 재무구조개선을 목적으로, 당기말 현재 보유하고 있는 투자부동산 전체(경기도 군포시 산본로 94소재의 토지 및 건물)에 대해 2021년 2월 10일 (주)삼경엠에스와 매매계약을 체결하였습니다. 매각예정금액은 7,800백만원으로 계약 시 계약금 780백만원을 수령하였습니다.&cr;</P>
<PGBRK></PGBRK>
<P>14. 기타유동자산&cr;당기말 및 전기말 현재 기타유동자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="499">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="499" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">선급금</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">3,097</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">선급비용</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,564</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,501</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">5,661</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">3,822</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;15. 매입채무 및 기타채무&cr;당기말 및 전기말 현재 매입채무 및 기타채무의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="222" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="220" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">매입채무</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">57,562</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">미지급금</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">85,218</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">152,378</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">미지급비용</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">88,238</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">69,187</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>16. 차입금
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN>(1) 당기말 및 전기말 현재 단기차입금의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE BORDER="1" WIDTH="611" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="611" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2">차입처</TH>
<TH WIDTH="122" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2">종류</TH>
<TH WIDTH="122" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2">이자율(%)</TH>
<TH COLSPAN="2" WIDTH="244" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30">금      액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="122" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30">당기말</TH>
<TH WIDTH="122" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">하나은행</TD>
<TD WIDTH="122" ALIGN="CENTER" HEIGHT="30">무역어음대출</TD>
<TD WIDTH="122" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" ALIGN="RIGHT" HEIGHT="30">160,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(2) 당기말 및 전기말 현재 장기차입금의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="695" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="112" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종류</TH>
<TH WIDTH="112" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">이자율(%)</TH>
<TH WIDTH="111" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">만기일</TH>
<TH WIDTH="248" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금 액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">하나은행</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">시설자금대출</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">2.244</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">2022-07-02</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="447" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">차감 : 유동성대체</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="447" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">차감 후 잔액</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(3) </SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>당기말 및 전기말 현재 당사의 차입금 등과 관련하여 금융기관 등에 담보로 제공한 자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="594">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="594" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="4">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">금융기관</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">담보제공자산</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권최고액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">하나은행</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="CENTER">투자부동산</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">7,765,077</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,360,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-10"></SPAN>
<SPAN>&cr;(4) 당기말 현재 당사의 차입금 등과 관련하여 대표이사로부터 320백만원의 지급보증을 제공받고 있습니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>17. 전환사채</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>(1)  당기와 전기 중 발행한 전환사채 장부가액의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="222" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="220" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">1,710,848</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">발행</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,586,304</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">상각</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">211,929</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">124,544</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">유동성대체</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,710,848</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(1,710,848)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">1,922,777</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,710,848</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-10"></P>
<P>(2) 당사가 발행한 전환사채의 상세 발행내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="609" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="442"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 사채의 종류</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">선바이오(주) 제3회 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 사채의 권면총액(원)</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 발행일</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019년 05월 13일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 만기일</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 05월 13일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 전환가격(원)</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">22,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 표면이자율</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 만기이자율</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="53"> 조기상환청구권</TD>
<TD WIDTH="451" VALIGN="MIDDLE" HEIGHT="53">발행일 이후 1년이 경과한 날로부터 일부 또는 전부에 대하여 만기전 조기상환청구 가능. 만기시 이자율 4% 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="53"> 매도청구권</TD>
<TD WIDTH="451" VALIGN="MIDDLE" HEIGHT="53">발행일 이후 1년이 경과한 날로부터 원금 상환 기일의 5 영업일 전까지 행사 가능. 만기시 이자율 4% 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30"> 전환권 청구기간</TD>
<TD WIDTH="451" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020년 05월 14일 ~ 2022년 05월 04일</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당기와 전기 중 주계약과 분리되어 당기손익공정가치로 측정되는 파생금융부채의 공정가치 변동과 관련손익은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="224"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="174"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="599" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">기초(발행일)</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(351,622)</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(412,736)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">평가이익</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">254,867</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,114</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">기말</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(96,755)</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(351,622)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>18. 리스
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>(1) 당사의 사용권자산에 대한 기초자산은 건물이며, 당기 및 전기 중 사용권자산 장부금액의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="597" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="189"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="597" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="199" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="198" HEIGHT="30">기초</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">1,852,393</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="199" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="198" HEIGHT="30">조정(*1)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">59,567</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="199" HEIGHT="30">2,137,377</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="198" HEIGHT="30">상각</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">(266,761)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="199" HEIGHT="30">(284,984)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="198" HEIGHT="30">기말</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">1,645,199</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="199" HEIGHT="30">1,852,393</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 회계기준서 변경효과 및 임차개량권자산의 리스자산 재분류가 포함되었습니다</SPAN>
<SPAN USERMARK="F-10">.&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>(2) 당기 및 전기 중 리스부채의 변동내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="597" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="597" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="299" HEIGHT="30">기초장부가액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,831,741</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="299" HEIGHT="30">조정(*1)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">23,662</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">2,081,557</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="299" HEIGHT="30">이자비용</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">56,234</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">66,984</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="299" HEIGHT="30">리스료 지급</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(316,800)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(316,800)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="299" HEIGHT="30">기말장부가액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,594,837</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,831,741</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 회계기준서 변경효과 등이 포함되었습니다.</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>&cr;(3) 당사가 리스부채를 측정하기 위하여 적용한 증분차입이자율은 3.218%이며, 당기중 리스부채 인식 면제 규정을 적용함에 따라 리스부채로 인식하지 아니한 단기리스료 및 소액 기초자산의 리스료는 3,480천원(전기: 3,480천원)입니다.&cr;&cr;(4) 당기 중 리스의 총 현금유출은 320,280천원(전기: 320,280천원)입니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>19. 복구충당부채&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>당사는 임차계약 종료 시 건물부지에 대한 원상복구의무를 부담하고 있으므로 동 복구의무 이행시 지출이 예상되는 비용의 현재가치를 당사의 재무상태표에 복구충당부채로 인식하고 있습니다.&cr;&cr;당기와 전기 중 복구충당부채의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">107,127</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">105,732</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">전입액</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">6,260</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">1,395</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">113,387</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">107,127</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>20. 기타유동부채</SPAN>
</P>
<P>당기말 및 전기말 현재 기타유동부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="499">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="499" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">예수금</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">19,548</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">22,881</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">선수금</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">14,910</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE">미지급배당금</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">423</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">34,458</TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">23,304</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>21. 자본금 및 기타불입자본</SPAN>
</P>

<P>
<SPAN>(1) 당기말 및 전기말 현재 당사의 자본금 내역은 다</SPAN>
<SPAN>음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="600" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" COLSPAN="3">(단위: 주, 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">수권주식수</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,000,000주</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,000,000주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">주당금액</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500원</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">발행주식수</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,670,540주</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,670,540주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">보통주자본금</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,835,270,000원</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,835,270,000원</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">&cr;(2) 자본잉여금&cr;</SPAN>
<SPAN USERMARK=" 0X000000">자본잉여금은</SPAN>
<SPAN USERMARK=" 0X000000"> 전액 주식발행초과금으로 구성되어 있으며, 당기말 및 전기말 현재 장부금액은 </SPAN>
<SPAN USERMARK=" 0X000000">각각 3,000,811천원</SPAN>
<SPAN USERMARK=" 0X000000">입니다.&cr;</SPAN>
</P>

<P>
<SPAN>(3) 자본조정&cr;당기말 및 전기말 현재 자본조정의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">자기주식</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">(224,955)</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">(224,955)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">1,885,305</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">1,668,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">1,660,350</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">1,443,765</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">&cr;(4) 보고기간 후 사건으로, 당사는 2020년 12월 23일 주식발행초과금을 재원으로 1주당 0.5주를 배정하는 무상증자를 결의하였으며, 2021년 1월 8일자로 </SPAN>
<SPAN USERMARK=" 0X000000">신주가 발행되었습니다. &cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">(5) 상기 자본잉여금 및 자본조정에 대해 전기 이전에 인식되어야 할 주식기준보상비용 41,106천원에 대한 주식발행초과금 12,995천원, 주식매수선택권 28,111천원을 반영하였습니다. 이에 따라 비교표시된 전년도 재무제표는 이러한 수정사항을 반영하여 재작성 되었습니다. 이로 인한 수정내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="596" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구  분</TH>
<TH WIDTH="381" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정전</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정금액</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">주식발행초과금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,987,816</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,995</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,811</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,640,609</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,111</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,668,720</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN>22. </SPAN>
<SPAN>이익잉여금(결손금)</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>(1) 당기말 및 전기말 현재 이익잉여금(결손금)의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="237"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="600" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="246" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" VALIGN="MIDDLE">미처분이익잉여금(미처리결손금)</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" VALIGN="MIDDLE">  기초금액</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">(918,041)</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">(2,379,785)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" VALIGN="MIDDLE">  당기순이익</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">1,201,785</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">1,461,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" VALIGN="MIDDLE">  기말금액</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">283,744</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">(918,041)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" VALIGN="MIDDLE">이익준비금</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">55,879</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">55,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">339,623</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">(862,162)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-10">
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">&cr;</SPAN>
<SPAN USERMARK="F-12">(2) 당기 및 전기의 이익잉여금처분계산서(결손금처리계산서)의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="751" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="249"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="751" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH COLSPAN="2" WIDTH="247" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제24(당)기</TH>
<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제23(전)기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="247" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>처분예정일:</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2021년 </SPAN>
<SPAN>5월 </SPAN>
<SPAN>07일</SPAN>
<SPAN></SPAN>
</TH>
<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처리확정일: 2020년 3월 23일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30"> I. 미처분이익잉여금(미처리결손금)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">283,743,621</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(918,041,112)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    전기이월미처리결손금</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">(918,041,112)</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">(2,379,785,315)</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    당기순이익</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">1,201,784,733</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">1,461,744,203</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30"> II. 이익잉여금처분액(결손금처리액)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="53"> III. 차기이월미처분이이익잉여금&cr;     (미처리결손금)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="53"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">283,743,621</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">(918,041,112)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN>(3) 상기 미처리결손금에 대해 전기 이전에 인식되어야 할 기술료수입 775,440천원,외화환산손실 13,549천원 및 주식기준보상비용 41,106천원을 전기 미처리결손금에 반영하였습니다. 이에 따라 비교표시된 전년도 재무제표는 이러한 수정사항을 반영하여 재작성 되었습니다. 이로 인한 수정내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="596" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="381" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정전</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정금액</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">미처리결손금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,638,825)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">720,784</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(918,041)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P></P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>23. 주식기준보상</SPAN>
<SPAN> &cr;(</SPAN>
<SPAN>1) 당기말 현재 당사는 임직원에게 주식결제형 주식기준보상을 부여하고 있으며 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="868">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정유형</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최고경영진</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타임직원</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타임직원</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최고경영진</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타임직원</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타임직원</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타임직원</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부여일</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2016-03-29</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2016-03-29</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2016-08-08</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017-03-17</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017-03-17</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018-03-21</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019-03-25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">최초부여수량(주)</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">40,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">58,500</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">변경후 부여수량(주)(*1)</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">40,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,000</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">행사개시일</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2018-03-29</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2018-03-29</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2018-08-08</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019-03-17</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019-03-17</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020-03-21</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-03-25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">행사만기일</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2021-03-31</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2021-03-31</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER">2021-08-07</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022-03-16</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022-03-16</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-20</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2026-03-24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">행사가격(원)</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,700</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,700</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,100</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,130</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,130</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,818</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">가득조건</TD>
<TD WIDTH="686" HEIGHT="30" COLSPAN="7" ALIGN="CENTER">용역제공조건 : 2년</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>(*1) 최초 부여 이후 가득기간 내에 퇴사 등의 사유로 인하여 변동된 수량이 반영되었습니다.&cr;&cr;(2) 당기말 현재 행사되지 않은 선택권의 수량은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="686">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="686" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부여일</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부여</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상실</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">행사</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016-03-29</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">95,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">95,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016-08-08</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017-03-17</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">42,400</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">42,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018-03-21</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019-03-25</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">35,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">35,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">192,400</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">192,400</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN>(3) 당사는 블랙숄즈모형을 통한 공정가치접근법을 적용해 보상원가를 산정하였으며당기말 현재 부여하고 있는 주식선택권의 공정가치 산정에 적용된 가정은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="640" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부여일</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2016-03-29</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2016-08-08</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2017-03-17</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018-03-21</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019-03-25</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">부여일 공정가치(원)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">11,388</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">10,821</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">6,175</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">6,962</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">11,880</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">부여일 주식가격(원)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">29,350</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">28,850</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">16,900</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">18,950</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">30,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">행사가격(원)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">28,700</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">28,100</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">16,130</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">18,818</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">29,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">예상주가변동성(*)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">0.513716</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">0.496443</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">0.453816</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">0.466805</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">0.449173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">기대행사기간</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3.5 년</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3.5 년</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3.5 년</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3.5 년</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">4.5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">기대배당금(원)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">146</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">147</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">무위험이자율</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1.51%</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1.24%</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1.74%</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2.34%</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1.82%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*) 대용기업의 과거 3.5년간의 실제 주가를 이용하여 산출되었습니다.&cr;</SPAN>
<SPAN USERMARK="F-10">&cr;</SPAN>
<SPAN>(4) 상기 주식선택권과 관련하여 당기 이후 인식할 보상원가는 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="287"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="305" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분 </TH>
<TH WIDTH="296" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금     액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2021년</TD>
<TD WIDTH="296" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,971</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>24. 매출</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>(1) 당사는 단일의 영업부문으로 구성되어 있으며, 당기 및 전기의 매출의 구성내역은 다음과 같습니다.&cr;① 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="999">

<COLGROUP>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="999" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" COLSPAN="9" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="555" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" COLSPAN="5">지역별 제품매출</TH>
<TH WIDTH="333" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">지역별 기술료수입</TH>
<TH WIDTH="111" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">합  계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">인도</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미국</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타 해외</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">국내</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소  계</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">인도</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타 해외</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,579,904</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">351,700</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">446,570</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,498</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,408,672</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,049,857</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,049,857</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">5,458,529</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;② 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="999">

<COLGROUP>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="999" HEIGHT="30" COLSPAN="9" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="555" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지역별 제품매출</TH>
<TH WIDTH="333" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지역별 기술료수입</TH>
<TH WIDTH="111" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">인도</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미국</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타 해외</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">국내</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소  계</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">인도</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타 해외</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,617,596</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">235,327</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">596,962</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">41,268</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,491,153</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">1,056,037</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">1,056,037</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">6,547,190</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기 및 전기 중 당사 매출액의 10% 이상을 차지하는 고객은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="186"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="600" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">A사</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">4,501,094</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">5,663,112</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN>(3) 상기 매출액에 대해 전기에 인식되어야 할 기술료수입 775,440천원을 전기 매출액에 반영하였습니다. 이에 따라 비교표시된 전년도 재무제표는 이러한 수정사항을 반영하여 재작성 되었습니다. 이로 인한 수정내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="596" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="381" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정전</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정금액</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수정후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,771,750</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">775,440</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,190</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>25. 종업원급여</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(1) 당기와 전기 중 비용으로 인식된 종업원급여의 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="258"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="602" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" VALIGN="MIDDLE" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="267" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">구  분</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당  기</TH>
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" HEIGHT="30" VALIGN="MIDDLE">급여</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">1,162,486</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">1,277,593</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" HEIGHT="30" VALIGN="MIDDLE">확정기여제도에 대한 비용(*)</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">97,720</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">94,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" HEIGHT="30" VALIGN="MIDDLE">종업원연차에 대한 부채의 증가</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">22,526</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">6,834</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" HEIGHT="30" VALIGN="MIDDLE">주식결제형 주식기준보상</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">216,585</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">274,546</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">1,499,317</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">1,653,386</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*) 당사는 확정기여형퇴직연금제도를 도입하여 당사 부담금을 납부함에 따라 당사가 납부하여야 할 부담금을 퇴직급여로 계상하고 있습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P>(2) 당기말 및 전기말 현재 종업원급여 관련 부채금액은 미사용연차에 대한 것으로서기타채무의 미지급비용으로 계상하고 있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="603" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="180" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">미지급비용</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT">73,359</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">50,833</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>26. 판매비와관리비&cr;당기 및 전기의 판매비와관리비의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="186"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">급여</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">317,642</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">463,544</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">27,325</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">38,183</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">복리후생비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">26,218</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">36,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">여비교통비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">96</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">459</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">접대비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">248</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">12,711</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">통신비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,135</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">수도광열비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">55,555</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">60,670</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">세금과공과금</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">138,477</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">31,726</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">감가상각비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">214,956</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">233,634</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">보험료</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">13,285</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">14,023</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">차량유지비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">658</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">622,062</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">681,455</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">운반비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">36,912</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">73,195</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">교육훈련비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">45</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">411</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">도서인쇄비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">100</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">사무용품비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">551</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">1,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">소모품비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">5,065</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">3,464</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">지급수수료</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">168,598</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">280,199</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">광고선전비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">13,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">대손상각비(환입)</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">(22,152)</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">(120,650)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">협회비</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">190,064</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">197,434</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">1,799,840</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="RIGHT">2,026,907</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>27. 비용의 성격별 분류&cr;</SPAN>당기 및 전기 중 발생한 비용의 성격별 분류에 대한 정보는 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="598">

<COLGROUP>
<COL WIDTH="244"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="253" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기</TH>
<TH WIDTH="172" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">재고자산의 변동</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(34,572)</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="RIGHT">(405,634)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">원재료의 사용액</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">394,286</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="RIGHT">1,434,330</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">종업원급여</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">1,499,317</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="RIGHT">1,653,386</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">감가상각비</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">846,197</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="RIGHT">839,141</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30">기타비용</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">1,114,352</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="RIGHT">1,346,941</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30" VALIGN="MIDDLE">매출원가 및 판매비와 관리비 합계</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">3,819,580</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="RIGHT">4,868,164</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>28. 금융수익과 금융비용&cr;당기 및 전기의 금융수익과 금융비용의 내역은 다음과 같습니다.&cr;① 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="867">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="867" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자수익(비용)</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외환차손익</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산손익</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">파생상품평가이익</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">상각후원가측정 금융자산</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,463</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(191,864)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(124,208)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(308,609)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">상각후원가측정 금융부채</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(377,756)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(377,756)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">당기손익인식 금융부채</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">254,867</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">254,867</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,260)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,260)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(376,553)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(191,864)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(124,208)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">254,867</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(437,758)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;② 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="867">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="867" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자수익(비용)</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외환차손익</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산손익</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">파생상품평가이익</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">상각후원가측정 금융자산</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,126</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,783</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(60,856)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(40,947)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">상각후원가측정 금융부채</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(273,328)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,866</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(253,462)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">당기손익인식 금융부채</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,114</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,114</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,395)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,395)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(265,597)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,649</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(60,856)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,114</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(234,690)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>29. 기타수익</SPAN>
<SPAN> 및 기타비용&cr;</SPAN>
<SPAN>당기 및 전기의 기타수익 및 기타비용의 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="867">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="280"></COL>
<COL WIDTH="280"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="867" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="289" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기</TH>
<TH WIDTH="289" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30">잡손익</TD>
<TD WIDTH="289" HEIGHT="30" ALIGN="RIGHT">709</TD>
<TD WIDTH="289" HEIGHT="30" ALIGN="RIGHT">17,409</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN>30. 이연법인세 및 법인세비용</SPAN>
<SPAN>&cr;</SPAN>(1) 당기와 전기 중 법인세비용의 구성요소는 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="599">

<COLGROUP>
<COL WIDTH="315"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="599" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="324" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">법인세부담액</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT">115</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE"> 일시적차이의 발생 및 소멸로 인한 금액</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">자본에 직접 반영된 법인세비용</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">법인세비용</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT">115</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기 및 전기의 법인세비용차감전순손익과 법인세비용간의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="317"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="600" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="326" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당  기</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30"> 법인세비용차감전순이익(A)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">1,201,900</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">1,461,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30"> 적용세율에 따른 세부담액</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">264,418</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">321,584</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" COLSPAN="3"> 조정사항:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">     비과세조정사항</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">(9,043)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">     세액감면 및 공제</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">224,763</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">51,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">     미인식 이연법인세자산의 변동</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">(552,133)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">(373,242)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">     기타조정사항</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">72,110</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30"> 법인세비용(B)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">115</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30"> 평균유효세율(B÷A)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">0.1%</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN USERMARK="F-10"></SPAN>
</P>
<PGBRK></PGBRK>

<P>(3) 당기와 전기 중 일시적차이의 증감내역 및 이연법인세자산(부채)의 내역은 다음과 같습니다.&cr;
<SPAN></SPAN>
<SPAN>① 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="966">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="966" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구분</TH>
<TH WIDTH="508" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4">차감할(가산할)일시적차이</TH>
<TH WIDTH="252" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">로열티매출(*1)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,638,619)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,638,619)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(360,496)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">대손충당금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,297</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(21,297)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,685</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">미지급비용</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,833</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,359</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(50,833)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,359</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,183</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,139</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">복구충당부채 </TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">107,127</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">113,387</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(107,127)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">113,387</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,568</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,945</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">사채할인발행차금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(780)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">307</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(473)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(172)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(104)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">상환할증금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,728</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,728</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">54,940</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">54,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">전환권조정</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(538,100)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">211,622</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(326,478)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(118,382)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(71,825)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">파생금융부채</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">351,622</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(254,867)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96,755</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">77,357</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,286</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">외화환산손실(*2)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,838</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,261</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(47,838)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,261</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,524</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,337</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">외화환산이익</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(532)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(53)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">532</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(53)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(117)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(12)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">임차자산개량권</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(35,773)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,773</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,870)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">재고자산평가손실</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">197,165</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">130,929</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(197,165)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">130,929</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43,376</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,804</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">리스부채</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,831,741</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,594,837</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,831,741)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,594,837</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,983</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">350,864</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">사용권자산</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,852,393)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,680,972)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,888,166</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,645,199)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(407,526)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(361,944)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소  계</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">429,773</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,282,871)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(374,468)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,227,566)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,549</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(270,066)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="966" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="7">미사용세무상결손금 및 세액공제에 대한 이연법인세</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE"> 이월결손금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">513,552</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(513,552)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,981</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE"> 이월공제세액</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">360,380</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">285,843</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="714" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5" ALIGN="CENTER">소  계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">473,361</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">285,843</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="714" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="5">합  계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">567,910</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="714" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">인식하지 아니한 이연법인세자산(*3)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(567,910)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(15,777)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 로열티수익을 미확정수익으로 보아 일시적차이로 반영하였습니다. &cr;(*2) 로열티수익과 관련하여 발생한 외화환산손실을 일시적차이에 추가하였습니다. &cr;(*3) 당사는 향후 회계연도에 소멸되는 일시적차이의 규모, 미래 과세소득의 규모 등을 종합적으로 고려할 때, 당기말 현재 이연법인세자산은 </SPAN>
<SPAN>미래 실현가능성이 불확실한 것으로 판단하여</SPAN>
<SPAN> 인식하지 아니하였습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
<PGBRK></PGBRK>
<P>② 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="805">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="805" HEIGHT="30" COLSPAN="7" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="401" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차감할(가산할)일시적차이</TH>
<TH WIDTH="200" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 미수수익</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(8,901)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,901</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,958)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 대손충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">147,732</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,297</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(147,732)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,297</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,501</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,685</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 미지급비용</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">70,398</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,833</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(70,398)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,833</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,488</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,183</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 복구충당부채 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">105,732</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">107,127</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(105,732)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">107,127</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,261</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,568</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 사채할인발행차금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(960)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">180</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(780)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(172)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 상환할증금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,728</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,728</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">54,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 전환권조정</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,464)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,364</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(538,100)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(118,382)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 파생금융부채</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">412,736</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(61,114)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">351,622</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">77,357</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 외화환산손실</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,780</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,838</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,780)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,838</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">612</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(14,803)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(532)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,803</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(532)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,257)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(117)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 임차자산개량권</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(59,621)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,848</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(35,773)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(13,117)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,870)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 재고자산평가손실</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">185,911</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">197,165</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(185,911)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">197,165</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">40,900</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43,376</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 리스부채</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,137,377</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(305,636)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,831,741</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,983</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 사용권자산</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,137,377)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">284,984</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,852,393)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(407,526)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소  계</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">429,228</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">422,768</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(422,223)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">429,773</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,430</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,549</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="805" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="7">미사용세무상결손금 및 세액공제에 대한 이연법인세</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE"> 이월결손금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,489,885</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(976,334)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">513,552</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">327,775</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE"> 이월공제세액</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">360,380</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">360,380</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="605" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5" ALIGN="CENTER">소  계</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">688,155</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">473,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="605" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="5">합  계</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">782,585</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">567,910</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="605" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">인식하지 아니한 이연법인세자산</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(782,585)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(567,910)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(4) 상계전 총액기준에 의한 이연법인세자산과 부채 등</P>

<TABLE AFIXTABLE="N" BORDER="1" WIDTH="611" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="611" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30" VALIGN="MIDDLE">이연법인세자산</TD>
<TD ALIGN="RIGHT" WIDTH="153" HEIGHT="30">72,281</TD>
<TD ALIGN="RIGHT" WIDTH="153" HEIGHT="30">737,879</TD>
<TD ALIGN="RIGHT" WIDTH="152" HEIGHT="30">810,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30" VALIGN="MIDDLE">이연법인세부채</TD>
<TD ALIGN="RIGHT" WIDTH="153" HEIGHT="30">(12)</TD>
<TD ALIGN="RIGHT" WIDTH="153" HEIGHT="30">(794,369)</TD>
<TD ALIGN="RIGHT" WIDTH="152" HEIGHT="30">(794,381)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30" VALIGN="MIDDLE">순액</TD>
<TD ALIGN="RIGHT" WIDTH="153" HEIGHT="30">72,269</TD>
<TD ALIGN="RIGHT" WIDTH="153" HEIGHT="30">(56,490)</TD>
<TD ALIGN="RIGHT" WIDTH="152" HEIGHT="30">15,779</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN></SPAN>
<SPAN>31. 주당손익</SPAN>
<SPAN>&cr;</SPAN>(1) 기본주당손익&cr;① 당기 및 전기의 기본주당손익 산정내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="864">

<COLGROUP>
<COL WIDTH="279"></COL>
<COL WIDTH="279"></COL>
<COL WIDTH="279"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="864" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="3">(단위: 주, 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="288" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">내  역</TH>
<TH WIDTH="288" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기</TH>
<TH WIDTH="288" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30">당기순이익</TD>
<TD WIDTH="288" HEIGHT="30" ALIGN="RIGHT">1,201,784,733</TD>
<TD WIDTH="288" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30">가중평균유통보통주식수</TD>
<TD WIDTH="288" HEIGHT="30" ALIGN="RIGHT">11,493,815</TD>
<TD WIDTH="288" HEIGHT="30" ALIGN="RIGHT">11,484,794</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30">기본주당손익</TD>
<TD WIDTH="288" HEIGHT="30" ALIGN="RIGHT">105</TD>
<TD WIDTH="288" HEIGHT="30" ALIGN="RIGHT">127</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;② 당기 및 전기의 가중평균유통보통주식수 산정내역은 다음과 같습니다&cr;<당기></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="865">

<COLGROUP>
<COL WIDTH="183"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="282"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="865" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4" VALIGN="MIDDLE">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="192" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 구분 </TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중치</TH>
<TH WIDTH="291" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" HEIGHT="30">기초</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">7,662,543</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="CENTER">366</TD>
<TD WIDTH="291" HEIGHT="30" ALIGN="RIGHT">2,804,490,738</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="574" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합      계</TD>
<TD WIDTH="291" HEIGHT="30" ALIGN="RIGHT">2,804,490,738</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="574" HEIGHT="30" COLSPAN="3" ALIGN="CENTER"></TD>
<TD WIDTH="291" HEIGHT="30" ALIGN="RIGHT">÷ 366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="574" HEIGHT="30" COLSPAN="3" ALIGN="CENTER"> 가중평균유통보통주식수 </TD>
<TD WIDTH="291" HEIGHT="30" ALIGN="RIGHT">7,662,543</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="574" HEIGHT="30" COLSPAN="3" ALIGN="CENTER"> 조정 후 가중평균유통보통주식수(*1)</TD>
<TD WIDTH="291" HEIGHT="30" ALIGN="RIGHT">11,493,815</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN><전기></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="861">

<COLGROUP>
<COL WIDTH="182"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="281"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="861" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4" VALIGN="MIDDLE">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 구분 </TH>
<TH WIDTH="190" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="190" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중치</TH>
<TH WIDTH="290" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="191" HEIGHT="30"> 기초</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="RIGHT">7,642,943 </TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER">365</TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT">2,789,674,195</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="191" HEIGHT="30"> 주식매입선택권의 행사</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="RIGHT">19,600 </TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER">253</TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT">4,958,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="571" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합      계</TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT">2,794,632,995</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="571" HEIGHT="30" COLSPAN="3" ALIGN="CENTER"></TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT">÷ 365</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="571" HEIGHT="30" COLSPAN="3" ALIGN="CENTER"> 가중평균유통보통주식수 </TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT">7,656,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="571" HEIGHT="30" COLSPAN="3" ALIGN="CENTER"> 조정 후 가중평균유통보통주식수(*1)</TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT">11,484,794</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 당사는 당기 중 1주당 0.5주를 배정하는 무상증자를 결의하였으며, 2021년 1월 중 </SPAN>
<SPAN>신주가 발행</SPAN>
<SPAN>되어 이를 반영하여 당기 및 전기의 가중평균유통보통주식수를 조정하였습니다</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(2) </SPAN>
<SPAN>희석주당손익&cr;희석주당손익은 모든 희석성 잠재적보통주가 보통주로 전환된다고 가정하여 조정한 가중평균 유통보통주식수를 적용하여 산정하고 있습니다. 당기말 현재 당사가 보유하고 있는 희석성 잠재적보통주로는 전환사채 및 주식매수선택권이 있습니다. </SPAN>
</P>

<TABLE BORDER="1" WIDTH="654" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="372"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="654" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 주, 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="381" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">희석주당이익에 계산에 사용된 이익</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,168,292,961</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">   기본주당이익 계산에 사용된 이익</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,201,784,733</TD>
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">   주식매수선택권에 대한 세후 주식보상비용</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">   전환사채에 대한 세후 이자비용</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,304,461</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">   전환사채에 대한 세후 공정가치변동</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(198,796,233)</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">희석주당이익 산출에 사용된 가중평균유통보통주식수</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">11,628,950</TD>
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">11,484,794</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">  기본주당이익 산출에 사용된 가중평균유통보통주식수</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,493,815</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,484,794</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">  주식매입선택권의 전환 가정(*1)</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">  전환사채의 전환 가정(*1)(*2)</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135,135</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">희석주당손익</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 당기 및 전기에 반희석 효과로 인해 희석주당이익을 계산할 때 고려하지 않았지만, 잠재적으로 미래에 기본주당이익을 희석할 수 있는 잠재적보통주의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="581">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구 분 </TH>
<TH WIDTH="280" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">발행될 보통 주식수(*2)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">전환사채</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">주식매입선택권</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">288,600</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">282,676</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*2) 무상증자를 반영하여 조정된 주식수입니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN>32. </SPAN>
<SPAN>영</SPAN>
<SPAN>업</SPAN>
<SPAN>으</SPAN>
<SPAN>로부터 창출된 현금&cr;(1) 당기 및 전기 중 영업으로부터 창출된 현금의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="581">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="581" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">1. 당기순손익</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,201,785</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,461,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">2. 조정 항목 :</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,412,326</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,371,325</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    재고자산평가손실</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">125,686</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,949</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    법인세비용</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">115</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    감가상각비</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">846,197</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">839,141</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    대손상각비(환입)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,152)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(120,650)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    이자비용</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">384,015</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">274,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    주식보상비용</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">216,585</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">274,546</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    외화환산손실 </TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,261</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,388</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    이자수익</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,461)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,127)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    외화환산이익</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(53)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(532)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    파생상품평가이익</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(254,867)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(61,114)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">3. 자산부채 증감:</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(170,138)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,947,271)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    매출채권의 감소(증가)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(58,573)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,370,211)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    미수금의 감소(증가)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">71,557</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(69,479)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    선급금의 감소(증가)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,777)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,816</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    선급비용의 증가</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(62)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(403)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    재고자산의 감소(증가)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(91,115)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(518,583)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    외상매입금의 증가(감소)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(57,562)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,582)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    미지급금의 증가(감소)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(67,160)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">54,378</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    예수금의 증가(감소)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,332)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">    선수금의 감소</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,909</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>   미지급비용의 </SPAN>
<SPAN>감소(증가)</SPAN>
</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,977</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(48,867)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">현금흐름표상 영업으로부터 창출된 현금</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,443,973</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">885,798</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(2) 당기 및 전기의 현금유출입이 없는 주요한 거래는 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="581">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="581" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">주식선택권의 행사</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">108,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">건설중인자산의 유형자산대체</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">299,792</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">임차개량자산의 사용권자산대체(순액)</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,774</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">사용권자산과 리스부채의 인식</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,081,557</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE">리스부채의 유동성대체</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,961</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,815</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 재무활동에서 생기는 부채의 조정내용</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="938">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채(유동)</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채(비유동)</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환사채</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단기차입금</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장기차입금</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">전기초</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">현금흐름</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(249,816)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,999,040</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,909,224</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">기타 비금융변동(*)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">288,192</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">288,192</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">회계정책의 변경</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">306,923</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,774,634</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,081,557</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">전기말 순부채</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">306,923</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,524,818</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,710,848</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,702,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">당기초</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">306,923</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,524,818</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,710,848</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,702,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">현금흐름</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,469)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(312,331)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(160,000)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(476,800)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">기타 비금융변동(*)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(33,065)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,961</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">211,929</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">291,825</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">당기말 순부채</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">269,389</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,325,448</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,922,777</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,517,614</TD>
</TR>
</TBODY>
</TABLE>

<P>(*) 기타 비금융변동에는 비현금변동과 지급 시점에 현금흐름표에서 영업활동으로 표시된 이자지급액이 포함되어 있습니다.&cr;
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>33. </SPAN>
<SPAN>약정사</SPAN>
<SPAN>항</SPAN>
<SPAN> 및 우발부채&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(1) 로열티계약</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당사는 </SPAN>
<SPAN>주요 제품매출처인 Intas Pharmaceuticals Ltd.와 로열티계약을 체결하고 있</SPAN>
<SPAN>습니다. 동 </SPAN>
<SPAN>계약에 의할 경우 당사가 공급한 제품을 사용하여 Intas Pharmaceuticals Ltd. 가 판매한 제품의 매출액에서 제반비용을 차감한 금액을 대상으로 5%의 로열티를 수령하도록 되어 있으며, 이러한 계약에 따라 당기 및 전기 중 인식한 로열티 수익은 각</SPAN>
<SPAN>각</SPAN>
<SPAN> </SPAN>
<SPAN>2,049,857천원 및</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>1,056,037천원</SPAN>
<SPAN>입니다.  </SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;(2) 기술료계약&cr;</SPAN>
<SPAN>당사는 2013년 7월 15일자로 Intas Pharmaceuticals Ltd.와 기술료계약을 체결하였습니다. 동 계약에 의할 경우 당사는 Intas Pharmaceuticals Ltd.으로부터 각 단계별로 총 USD 750,000의 기술료를 수령하기로 약정되어 있습니다. 동 계약에 따</SPAN>
<SPAN>라 </SPAN>
<SPAN></SPAN>
<SPAN>당기 및 전기에 인식한 금액은 없습니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(3) 금융기관과의 약정사항&cr;당사는 하나은행과 일반자금대출약정 50억원을 체결하고 있습니다. </SPAN>
<SPAN>&cr;&cr;(4) 제공하거나 제공받은 지급보증&cr;보고기간종료일 현재 당사의 차입금 등과 관련하여 대표이사로부터 지급보증 3.6억원을 제공받고 있으며, 이 외에 당사가 제공하거나 제공받은 지급보증의 내역은 없습니다&cr;&cr;(5) 소송사건&cr;보고기간종료일 현재 당사가 계류 중인 소송사건은 없습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>
<P>34. 특수관계자 거래</P>
<P>&cr;(1) 특수관계자 거래&cr;보고기간종료일 현재 당사의 차입금 등과 관련하여 대표이사로부터 지급보증(3.6억원)을 제공받고 있으며, 그 외의 특수관계자와의 자금거래를 포함한 거래내역 및 채권채무잔액은 없습니다.&cr;&cr;(2) 주요 경영진과의 거래&cr;당사의 주요경영진에는 당사 활동의 계획, 운영, 통제에 대한 중요한 권한 및 책임을 가진 이사 및 집행임원 등이 포함되어 있으며, 당기와 전기 중 주요 경영진에 대한 보상내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="597">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="597" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구  분</TH>
<TH WIDTH="194" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기</TH>
<TH WIDTH="193" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">급여</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">260,115</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">퇴직급여</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">23,361</TD>
<TD WIDTH="193" HEIGHT="30" ALIGN="RIGHT">33,333</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>

<P>&cr;
<SPAN USERMARK=" B">가. 재무제표 재작성 등 유의사항&cr;</SPAN>당사는 매출 및 연구개발비 기간귀속과 관련된 회계처리의 오류와 관련하여 2019년&cr;12월 31일로 종료되는 보고기간의 재무제표를 재작성하였습니다.&cr;&cr;
<SPAN USERMARK=" B">나. 대손충당금 설정현황 등</SPAN>&cr;(1) 대손충당금 설정내역
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총장부금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금설정율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2020년&cr;(제24기)</TD>
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="133" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,016,524,224</TD>
<TD WIDTH="132" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">12,332,929</TD>
<TD WIDTH="132" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">0.2%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2019년&cr;(제23기)</TD>
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="133" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,080,682,380</TD>
<TD WIDTH="132" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">34,484,476</TD>
<TD WIDTH="132" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1.7%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2018년&cr;(제22기)</TD>
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="133" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">740,079,220 </TD>
<TD WIDTH="132" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">155,134,519</TD>
<TD WIDTH="132" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">21.0%.</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 대손충당금 변동내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="194" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구  분</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제24기)</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제23기)</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제22기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기초금액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(34,484,476)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(155,134,519)</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">
<SPAN>(13,167,506)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">회계정책변경효과</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(153,902,027)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기환입액(설정액)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">22,151,547 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">120,650,043 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">13,867,691 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상각채권의 회수</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,932,677)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제각</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기말금액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(12,332,929)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(34,484,476)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(155,134,519)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(3) 매출채권 관련 대손충당금 설정 방침&cr;당사는 채권 발생일로부터 만기일이 도래하지 않은 채권은 정상채권으로, 만기일이 경과하였으나 회수하지 않은 채권은 연체채권으로 분류하고 있습니다. 한편 정상채권은 과거 3개년 간의 매출채권 경과기간별 평균미회수율을 측정하여 경과기간별 대손설정율을 산출하고 이를 설정대상 정상채권에 적용하여 손상차손을 인식하고 있으며 연체채권으로 분류하고 있는 사고거래처, 거래중지처 등은 100% 설정율을 적용하여 손상차손을 인식하고 있습니다.  &cr;&cr;
<SPAN USERMARK=" B">다. 재고자산 현황 등&cr;</SPAN>(1) 재고자산 보유현황
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="160" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제24기)</TH>
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제23기)</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제22기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER">원재료</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">42,462,162 </TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">258,975,570 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">83,663,897 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER">재공품</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">5,368,589 </TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">113,435,120 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">9,377,355 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER">제품</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">768,285,726 </TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">478,277,434 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">352,012,823 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">816,116,477 </TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">850,688,124 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">445,054,075 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">총자산대비 재고자산 구성비율</TD>
<TD WIDTH="153" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">4.59%</TD>
<TD WIDTH="153" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">5.04%</TD>
<TD WIDTH="152" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">7.71%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="70" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">재고자산회전율(회수)&cr;[연환산매출원가 ÷{(기초재고＋기말재고)÷2}]</TD>
<TD WIDTH="153" HEIGHT="70" ALIGN="RIGHT" VALIGN="MIDDLE">6.69회</TD>
<TD WIDTH="153" HEIGHT="70" ALIGN="RIGHT" VALIGN="MIDDLE">7.70회</TD>
<TD WIDTH="152" HEIGHT="70" ALIGN="RIGHT" VALIGN="MIDDLE">9.38회</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 재고자산의 실사내역&cr;1) 실사일자&cr;나) 2018년 기말 재고자산 실사 : 2019년 1월 7일&cr;다) 2019년 기말 재고자산 실사 : 2019년 12월 27일&cr;가) 2020년 기말 재고자산 실사 : 2020년 12월 29일&cr;&cr;2) 재고실사 시 전문가의 참여 또는 감사인의 입회여부&cr;당사 재고실사는 외부감사인의 입회 하에 실시되었습니다.&cr;가) 2018년 기말 : 한울회계법인 (지정감사인)&cr;나) 2019년 기말 : 다산회계법인&cr;다) 2020년 기말 : 정인회계법인 (지정감사인)&cr;&cr;(3) 재고자산 보유내역 및 평가내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(기준일 : 2020년 12월 31일)                                                                   (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="146" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="472" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="157" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손실충당금</TH>
<TH WIDTH="157" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">65,553,475</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(23,091,313)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">42,462,162</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">재공품</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">6,326,721</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(958,132)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">5,368,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제품</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">875,165,255</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(106,879,529)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">768,285,726</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">947,045,451</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(130,928,974)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">816,116,477</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK=" B">라. 수주계약 현황&cr;</SPAN>
<SPAN>본 보고서 Ⅱ. 사업의 내용의 5. 매출에 관한 사항 중 다. 수주현황 항목을 참조&cr;</SPAN>&cr;
<SPAN USERMARK=" B">마. 공정가치평가 내역&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>(1) 당기말 및 전기말 현재 공정가치로 후속 측정되지 않는 금융상품의 장부금액과 공정가치는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="222" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="220" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">금융자산:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,516,029</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">806,433</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">806,433</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  매출채권및기타채권</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,051,553</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,051,553</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,165,116</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,165,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  비유동기타채권</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">217,879</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">217,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금융자산 합계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">4,823,100</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">4,823,100</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,189,428</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,189,428</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">금융부채:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  매입채무및기타채무</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">173,456</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">279,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE">  차입부채</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,517,614</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,517,614</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,702,589</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,702,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금융부채 합계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,691,070</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,691,070</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,981,716</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,981,716</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>당사는 상기와 같이 금융자산 및 금융부채는 장부금액이 공정가치와 합리적인 근사치라고 판단하고 있습니다.&cr;&cr;</SPAN>(2) 공정가치 서열체계&cr;당사는 공정가치로 측정되는 금융상품에 대하여 공정가치 측정에 사용된 투입변수에따라 다음과 같은 공정가치 서열체계로 분류하고 있습니다.
</P>
<P>&cr;- '수준 1'은 동일한 자산이나 부채에 대한 활성시장의 (조정되지 않은) 공시가격을       사용하여 도출되는 공정가치입니다.&cr;-  '수준 2'는 직접적 또는 간접적으로 관측가능한, 자산이나 부채에 대한 투입변수를    사용하여 도출되는 공정가치입니다.&cr;- '수준 3'은 자산이나 부채에 대하여 관측가능한 시장정보에 근거하지 않은 투입변       수(관측불가능한 변수)를 사용하는 평가기법으로부터 도출되는 공정가치입니다.</P>
<P></P>
<PGBRK></PGBRK>
<P>당기말 및 전기말 현재 공정가치로 측정되거나 공정가치가 공시되는 금융상품의 공정가치 서열체계 구분은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="706" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="706" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준1</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준2</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준3</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="706" HEIGHT="30" COLSPAN="6"> 당기말: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">   파생금융부채</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">96,755</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">96,755</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">96,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="706" HEIGHT="30" COLSPAN="6">전기말 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">   파생금융부채</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">351,622</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">351,622</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">351,622</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;수준 3으로 인식되는 공정가치의 변동내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="660" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본으로 재분류</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5"> 당기말: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">351,622</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">254,867</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">96,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">전기말 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(351,622)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">351,622</TD>
</TR>
</TBODY>
</TABLE>
<P>당기 및 전기 중 수준 1과 수준 2 간의 유의적인 이동은 없습니다.&cr;&cr;(3) 가치평가기법 및 투입변수  &cr;당사는 공정가치 서열체계에서 수준3으로 분류되는 금융상품의 공정가치에 대하여 다음의 가치평가기법 및 투입변수를 사용하고 있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="233"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="660" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="242" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가치평가기법</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">투입변수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" COLSPAN="4" VALIGN="MIDDLE"> 당기말: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="53" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">96,755</TD>
<TD WIDTH="242" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">현금흐름할인법&cr;이항옵션모형</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">할인율&cr;기대주가변동성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="660" HEIGHT="30" COLSPAN="4" VALIGN="MIDDLE">전기말 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="53" VALIGN="MIDDLE">  파생금융부채</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">351,622</TD>
<TD WIDTH="242" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">현금흐름할인법&cr;이항옵션모형</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">할인율&cr;기대주가변동성</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">바. 채무증권 발행실적 등</SPAN>
</P>
<P></P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="897" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="595"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="604" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="2">(단위 : 천원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="899" BORDER="1">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="63"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="105" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="72" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">선바이오(주)</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20190513">2019.05.13</TU>
<TE WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">2,000,000</TE>
<TE WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_RATE">표면0%&cr;만기4%</TE>
<TE WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_LEV">KIS채권평가(주)</TE>
<TU WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20220513">2022.05.13</TU>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">2,000,000</TE>
<TE WIDTH="70" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="758" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="452"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20191231">2019.12.31</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="461" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="756" BORDER="1">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="146" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="84" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="84" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">2,000,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">2,000,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">2,000,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">2,000,000</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="739" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="433"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="442" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="741" BORDER="1">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="146" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="76" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="53" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>
<P USERMARK=" B">1. 예측 정보에 대한 주의사항</P>
<P>&cr;당사가 동 사업보고서에서 미래에 발생할 것으로 예상, 예측한 활동, 사건 또는현상은, 당해 공시서류 작성시점의 사건 및 재무성과에 대하여 회사의 견해를 반영한것입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다. 또한, 이러한 가정들에는예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래할 수 있는위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래할 수 있는 요인에는 회사 내부경영과 관련된 요인과 외부환경에 관한 요인이 포함되어 있으며, 이에 한하지 않습니다. 당사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 결론적으로, 동 사업보고서상에, 회사가 예상한 결과 또는 사항이 실현되거나 회사가 당초에 예상한 영향이 발생한다는 확신을 제공할 수 없습니다. 동 보고서에 기재된 예측정보는 동 보고서 작성시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측정보를 업데이트할 예정이 없음을 유의하시기 바랍니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">2. 경영진단의 개요&cr;</SPAN>
<SPAN>&cr;당사 이사회는 2020년 1월 1일부터 2020년 12월 31일까지 제 24기 사업연도의 회계 및 업무에 관하여 이사의 경영진단에 관한 의견을 아래와 같이 보고합니다.&cr;&cr;당사의 경영에 대한 전반적인 사항을 파악하기 위하여 장부와 관계 서류를 열람하고 재무제표 및 부속명세서에 대하여도 면밀히 검토하였습니다. 경영활동에 중대한 영향을 미칠 수 있는 사항에 대하여는 그 내용을 면밀히 검토하는 등 적정한 방법으로 회사경영에 대한 내용을 진단하였습니다.</SPAN>
</P>

<P>
<SPAN>&cr;당사는 2020년에 약 5,772백만원의 매출을 달성하였으며, PEG유도체 판매액인 제품매출액이 전체 매출액의 62%를 차지합니다. &cr;&cr;동기간 영업이익은 1,639백만원, 당기순이익은 1,202백만원입니다. 주당순이익은  105원입니다.&cr;&cr;기말 현재 자기자본은 약 8,836이며 자산총계는 약 17,772백만원입니다.&cr;&cr;</SPAN>
<SPAN>기말 현재 부채비율은 약 101%, 유동비율은 약 216%이며 재무구조는 양호합니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">3. 재무상태</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="617"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="626" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위:원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="130"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>과목</P>
</TH>

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제24기 </P>
</TH>

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제23기 </P>
</TH>

<TH ROWSPAN="3" WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증  감</P>
</TH>

<TH ROWSPAN="3" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증감율</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(2020년도) </P>
</TH>

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(2019년도) </P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회계처리 기준</P>
</TH>

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS </P>
</TH>

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[유동자산]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,399,359,177</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,829,128,765</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,570,230,412</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>당좌자산</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,583,242,700</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,978,440,641</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,604,802,059</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>재고자산</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">816,116,477</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">850,688,124</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-34,571,647</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[비유동자산]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,372,395,063</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,052,323,787</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-679,928,724</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-0.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>유형자산</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,361,800,741</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,053,580,196</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-691,779,455</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-0.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>투자자산</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,765,076,768</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,780,864,792</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-15,788,024</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>기타비유동자산</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">245,517,554</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">217,878,799</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,638,755</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>자산총계</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,771,754,240</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,881,452,552</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">890,301,688</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[유동부채]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,496,866,015</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,831,823,403</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-334,957,388</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-0.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[비유동부채]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,438,834,834</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,631,945,491</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-193,110,657</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>부채총계</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,935,700,849</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,463,768,894</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-528,068,045</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-0.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[자본금]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,835,270,000</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,835,270,000</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[자본잉여금]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000,810,945</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000,810,945</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[자본조정]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,660,349,775</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,443,764,775</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">216,585,000</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>[이익잉여금]</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">339,622,671</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-862,162,062</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,201,784,733</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-1.4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>자본총계</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,836,053,391</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,417,683,658</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,418,369,733</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>자기자본비율</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49.72</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43.94</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="139" VALIGN="MIDDLE" HEIGHT="30">
<P>부채비율</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101.13</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127.58</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">4. 영업실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="617"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="626" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위:원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="210"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제24기 </P>
</TH>

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제23기 </P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(2020년도) </P>
</TH>

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(2019년도) </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">
<P>매출액</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,458,528,590</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,547,189,952</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">
<P>매출원가</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,019,739,785</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,841,257,170</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">
<P>매출총이익</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,438,788,805</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,705,932,782</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">매출총이익률</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63.0</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56.6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">
<P>판매비와관리비</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,799,839,768</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,026,906,887</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">
<P>영업이익</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,638,949,037</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,679,025,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">영업이익률</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30.0</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25.6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">영업외수익</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">305,606,083</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">176,160,248</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">영업외비용</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742,655,046</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">393,441,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">법인세비용차감전계속사업이익</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,201,900,074</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">법인세등</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115,341</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">
<P>당기순이익</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,201,784,733</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,461,744,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">당기순이익률</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22.0</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22.3</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK=" 0X0000FF"></SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>
<P>1. 회계감사인의 명칭 및 감사의견(검토의견 포함한다. 이하 이 조에서 같다)을 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="999" BORDER="1">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="570"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="579" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="145" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제24기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="100" HEIGHT="145" ACODE="OPN_AUR1" VALIGN="MIDDLE">정인회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="145" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>

<TE WIDTH="579" HEIGHT="145" ACODE="OPN_EMP1" VALIGN="MIDDLE">
<SPAN USERMARK=" B"></SPAN>감사의견에는 영향을 미치지 않는 사항으로서&cr;이용자는 재무제표에 대한 주석 3에 주의를 기울여야 할 필요가 있습니다. &cr;재무제표에 대한 주석 3은 경영진이 코로나바이러스감염증-19(COVID-19)의 확산이&cr;기업의 생산 능력과 고객에 대한 주문 이행능력에 미칠 수 있는 영향과 관련한&cr;불확실성 및 이러한 사건이나 상황을 다루기위해취해진 조치와 계획을 설명합니다.&cr;우리의 의견은 이 사항으로부터 영향을 받지아니합니다.
<SPAN></SPAN>
</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="145" ACODE="OPN_POT1" VALIGN="MIDDLE">로열티 수익인식</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제23기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="100" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">다산회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE WIDTH="579" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="168" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제22기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="100" HEIGHT="168" ACODE="OPN_AUR3" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="168" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE WIDTH="579" HEIGHT="168" ACODE="OPN_EMP3" VALIGN="MIDDLE">감사의견에는 영향을 미치지 않는 사항으로서, 이용자는 재무제표에 대한 주석 34에주의를 기울여야 할 필요가 있습니다. 재무제표에 대한 주석 34에서 설명하는 바와 같이, 회사는 2018년 1월 1일을 최초적용일로 하여 기업회계기준서 제1109호 ‘금융상품’을 적용하였으며, 경과규정에 따라 회계변경의 누적효과는 당기의 기초이익잉여금에 반영하고 비교표시되는 전기재무제표를 재작성하지 않습니다. 새로운 기업회계기준서의 최초적용으로 당기초의 대손충당금이 153,902천원 증가하고 이익잉여금이 153,902천원 감소하였습니다.</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="168" ACODE="OPN_POT3" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>2. 감사용역 체결현황은 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="673" BORDER="1">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="106" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제24기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">정인회계법인</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">재무제표에 대한 외부감사</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">6,750천원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">710</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">6,750천원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">710</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="106" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제23기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE">다산회계법인</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE">재무제표에 대한 외부감사</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">4,000천원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">415</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">4,000천원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">414</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="106" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제22기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">한울회계법인</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE">재무제표에 대한 외부감사</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">4,000천원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">415</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">4,000천원</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">415</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>3. 회계감사인과의 비감사용역 계약체결 현황은 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="636" BORDER="1">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGL_YEAR1" VALIGN="MIDDLE">제24기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">2020.02.10</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">법인세 세무조정</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">5백만원</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">다산회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGL_YEAR2" VALIGN="MIDDLE">제23기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">2019.02.14</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">법인세 세무조정</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">5백만원</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">다산회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGL_YEAR3" VALIGN="MIDDLE">제22기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2018.04.30</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">법인세 세무조정</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">2백만원</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">호연회계법인</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>
<P>4. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항에 대해 내부감사기구가 회계감사인과 논의한 결과를 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="617" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="232"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="241" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20210310" VALIGN="MIDDLE">2021년 03월 10일</TU>
<TE ALIGN="CENTER" WIDTH="117" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">내부감사, 업무수행이사</TE>
<TE ALIGN="CENTER" WIDTH="74" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">대면보고</TE>
<TE ALIGN="CENTER" WIDTH="241" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE">주요 회계이슈(수익인식) 논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="145" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="DIS_DATE" AUNITVALUE="20210324" VALIGN="MIDDLE">2021년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="117" HEIGHT="145" ACODE="DIS_ATT" VALIGN="MIDDLE">내부감사, 업무수행이사</TE>
<TE ALIGN="CENTER" WIDTH="74" HEIGHT="145" ACODE="DIS_WAY" VALIGN="MIDDLE">대면보고</TE>
<TE ALIGN="CENTER" WIDTH="241" HEIGHT="145" ACODE="DIS_CONT" VALIGN="MIDDLE">이슈 관련 진행상황 및 감사보고서 일정 논의(COVID_19에 기인한 사업보고서 발행 지연에 대한 제재면제)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20210504" VALIGN="MIDDLE">2021년 05월 04일</TU>
<TE ALIGN="CENTER" WIDTH="117" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">내부감사, 업무수행이사</TE>
<TE ALIGN="CENTER" WIDTH="74" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">서면보고</TE>
<TE ALIGN="CENTER" WIDTH="241" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE">외부감사 종결보고</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">50_조정협의회내용및재무제표불일치정보</FILENAME>
<P>조정협의회 주요 협의내용</P>

<TABLE-GROUP ACLASS="ADJ_DIS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="623" BORDER="1">

<COLGROUP>
<COL WIDTH="26"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="474"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="483" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내 용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="30" VALIGN="MIDDLE" AUPDATECONT="N" COLSPAN="2">개최 일자</TD>
<TU ALIGN="CENTER" WIDTH="483" HEIGHT="30" AUNIT="ADJ_DATE" AUNITVALUE="20210223" VALIGN="MIDDLE">2021년 02월 23일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="35" HEIGHT="90" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">참&cr;석&cr;자</TD>
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE" AUPDATECONT="N">회사</TD>
<TE ALIGN="CENTER" WIDTH="483" HEIGHT="30" ACODE="ADJ_CPY" VALIGN="MIDDLE">선바이오(주)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE" AUPDATECONT="N">전기 감사인</TD>
<TE ALIGN="CENTER" WIDTH="483" HEIGHT="30" ACODE="ADJ_PRE" VALIGN="MIDDLE">다산회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE" AUPDATECONT="N">당기 감사인</TD>
<TE ALIGN="CENTER" WIDTH="483" HEIGHT="30" ACODE="ADJ_NOW" VALIGN="MIDDLE">정인회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="30" VALIGN="MIDDLE" AUPDATECONT="N" COLSPAN="2">협의대상</TD>
<TE ALIGN="CENTER" WIDTH="483" HEIGHT="30" ACODE="ADJ_OBJ" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="76" VALIGN="MIDDLE" AUPDATECONT="N" COLSPAN="2">주요 협의내용 및&cr;의견 불합치 이유</TD>
<TE WIDTH="483" HEIGHT="76" ACODE="ADJ_RSN" VALIGN="MIDDLE">(1) 주식매수선택권 평가시점의 종가 입력 오류로 인해 평가금액 오류 발생, 당기손익 영향 없으나 전기 자본항목의 수정에 대한 의견 불일치&cr;(2) 기술료수입(로열티수익)의 기간귀속에 대한 의견불일치</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 당사의 전ㆍ당기 감사인은 한국공인회계사회에 설치된 전ㆍ당기 감사인간 의견불일치 조정협의회를 진행하지 않았습니다. 상기 개최일자는 의견 불일치가 제시 된 일자를 기재하였습니다.&cr;주2) 당기 감사인과 전기 감사인은 당사(유선 및 이메일)를 통해 전기 재무제표에 대한 협의를 진행하였으나 의견 불합치로 당기 비교표시 재무제표의 전기 재무제표 수정사항이 아래와 같이 발생하였습니다.&cr;</P>
<P>전ㆍ당기 재무제표 불일치에 대한 세부정보</P>

<TABLE-GROUP ACLASS="FIN_DISC" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="597" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="297" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재무제표명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계정과목명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기금액&cr;(A)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기 비교&cr;표시금액(B)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">불일치 금액&cr;(B-A)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="FIN_FNAM" VALIGN="MIDDLE">재무상태표</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="FIN_ANAM" VALIGN="MIDDLE">매출채권 및 기타채권</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_PRE" VALIGN="MIDDLE">1,403,226</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_CMP" VALIGN="MIDDLE">2,165,116</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_BTN" VALIGN="MIDDLE">761,890</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="FIN_FNAM" VALIGN="MIDDLE">재무상태표</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="FIN_ANAM" VALIGN="MIDDLE">주식발행초과금</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_PRE" VALIGN="MIDDLE">2,987,816</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_CMP" VALIGN="MIDDLE">3,000,811</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_BTN" VALIGN="MIDDLE">12,995</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="FIN_FNAM" VALIGN="MIDDLE">재무상태표</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="FIN_ANAM" VALIGN="MIDDLE">주식매수선택권</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_PRE" VALIGN="MIDDLE">1,640,609</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_CMP" VALIGN="MIDDLE">1,668,720</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_BTN" VALIGN="MIDDLE">28,111</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="FIN_FNAM" VALIGN="MIDDLE">재무상태표</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="FIN_ANAM" VALIGN="MIDDLE">미처리결손금</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_PRE" VALIGN="MIDDLE">-1,638,825</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_CMP" VALIGN="MIDDLE">-918,041</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_BTN" VALIGN="MIDDLE">720,784</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="FIN_FNAM" VALIGN="MIDDLE">손익계산서</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="FIN_ANAM" VALIGN="MIDDLE">매출액</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_PRE" VALIGN="MIDDLE">5,771,750</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_CMP" VALIGN="MIDDLE">6,547,190</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="FIN_BTN" VALIGN="MIDDLE">775,440</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>

<P>&cr;
<SPAN USERMARK=" B">가. 이사회의 구성 개요</SPAN>
</P>
<P>당사는 보고서 작성 기준일 현재 대표이사 1인을 포함한 총 3명의 이사(사내이사 1인과 사외이사 2인)로 이사회가 구성되어 있습니다. &cr;&cr;이사회는 주주총회에서 선임된 등기이사로 구성하고 상법 또는 정관에 정하여진 사항, 주주총회로부터 위임받은 사항, 회사 경영의 기본방침 및 업무집행에 관한 중요사항을 의결하며 이사의 직무집행을 감독하고 있습니다.&cr;&cr;(1) 사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>* </P>
<P></P>
<P USERMARK=" B">나. 중요의결사항</P>

<TABLE ACLASS="NORMAL" WIDTH="1167" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="387"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회차</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="396" HEIGHT="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의안내용</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가결&cr;여부</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사내이사의 성명</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사외이사의 성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감사의 성명</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">노 광&cr;(출석율: 100%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김판균&cr;(출석율: 100%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김동일&cr;(출석율: 100%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주우식&cr;(출석율: 75%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정유근</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">찬반여부</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">찬반여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">찬반여부</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">2020-02-03</TD>
<TD VALIGN="MIDDLE" WIDTH="396" HEIGHT="30">외부감사 전 재무제표 결산 승인의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30">가</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">불참</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="145">2</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="145">2020-03-04</TD>
<TD VALIGN="MIDDLE" WIDTH="396" HEIGHT="145">[제1호의안] 제23기(2019년도) 정기주주총회 소집의 건&cr; 부의안건 (1) 제1호 의안 : 제23기 재무제표 승인의 건&cr;              (2) 제2호 의안 : 이사 보수한도 승인의 건&cr;              (3) 제3호 의안 : 감사 보수한도 승인의 건&cr;[제2호의안] 전자투표 채택의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="145">가</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="145">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="145">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="145">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="145">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="145">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">3</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">2020-12-23</TD>
<TD VALIGN="MIDDLE" WIDTH="396" HEIGHT="30">준비금 자본 전입(무상증자)의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30">가</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53">4</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">2020-12-24</TD>
<TD VALIGN="MIDDLE" WIDTH="396" HEIGHT="53">중국 파마솔루션(PharmaSolution)과 MucoPEG 구강건조증치료제의 기술이전 계약체결의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="53">가</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="53">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53">참석</TD>
</TR>
</TBODY>
</TABLE>

<P>* 김판균 사내이사는 2020년 3월 31일 사임하였으며, 임기 중의 출석율을 기재하였습니다.&cr;&cr;
<SPAN USERMARK=" B">다. 이사회내 위원회&cr;</SPAN>당사는 사업보고기준일 현재 이사회 내에 위원회가 설치되지 않았습니다.&cr;&cr;
<SPAN USERMARK=" B">라. 이사의 독립성&cr;</SPAN>당사는 사외이사 후보 추천위원회를 설치하고 있지 않습니다. 다만 당사의 경영 자문및 투명경영을 위해 주주총회의 의결에 따라 최대주주등과의 이해관계와 결격요건이 없는 사외이사 2인을 두고 있습니다. &cr;&cr;□ 사외이사 현황
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="402"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="43"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="411" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요경력</P>
</TH>

<TH WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>최대주주등과의 &cr;이해관계</P>
</TH>

<TH WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>결격요건&cr;여부</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>김동일</P>
<P>(58.08.04)</P>
</TD>

<TD WIDTH="411" VALIGN="MIDDLE" HEIGHT="214">
<P>(1983.02) 서울대학교 대학원 공업화학과 (공학석사)</P>
<P>(1986.02) 미국 M.I.T., Department of Applied Biological Sciences (공학석사) </P>
<P>(1989.05) 미국 Rutgers 대학교, Department of Chemical and Biochemical Engineering (공학박사)</P>
<P>(1981.12∼1984.05) (주)녹십자 종합연구소, 연구원</P>
<P>(1989.06∼1991.08) (재)목암생명공학연구소, 선임연구원</P>
<P>(1991.09∼) 현재 인하대학교 공과대학 생명공학과, 교수</P>
<P>(2007.03∼) 현재 (주)셀트리온, 사외이사</P>
</TD>

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>타인</P>
</TD>

<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>해당사항</P>
<P>없음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">주우식&cr;(59.06.17)</TD>

<TD WIDTH="411" VALIGN="MIDDLE" HEIGHT="214">
<P>(1980) 제24회 행정고시 합격</P>
<P>(1982) 한국은행 행원</P>
<P>(1994~1996) IMF(워싱턴) 이코노미스트</P>
<P>(1980~1999) 재정경제부 경제정책국 과장</P>
<P>(1999~2012) 삼성전자, 삼성증권 부사장</P>
<P>(2012) KDB 금융그룹 지주 수석 부사장</P>
<P>(2013~2015) 전주페이퍼 대표이사 사장</P>
<P>(2015~2017) 삼정 KPMG 부회장</P>
<P>(2018~현재) 옐로씨매니지먼트(사모펀드) 회장</P>
</TD>

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>타인</P>
</TD>

<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>해당사항</P>
<P>없음</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">마. 사외이사의 전문성</SPAN>&cr;당사는 사업보고기준일 현재 사외이사의 직무수행을 보조하기 위한 별도의 지원조직이 없으며, 사외이사를 대상으로 교육을 실시하거나 위탁교육 등 외부기관이 제공하는 교육을 이수하도록 한 바 없습니다.&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">40_02_사외이사_교육_미실시내역</FILENAME>
<P USERMARK=" B">바. 사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ODRT_EDU_NOT_DTL">해당사항 없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 감사기구에 관한 사항&cr;</SPAN>당사는 감사위원회는 설치하지 않았으며, 현재 비상근 감사 1명으로 구성되어 주주총회를 통하여 이를 선임합니다.&cr;&cr;(1) 감사의 설치와 직무
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="465"></COL>
<COL WIDTH="41"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="474" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내용</P>
</TH>

<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="260">
<P>제39조</P>
<P>(감사의 수와 선임)</P>
</TD>

<TD WIDTH="474" VALIGN="MIDDLE" HEIGHT="260">
<P>①이 회사의 감사는 1명이상 2인 이내로 한다. </P>
<P>②감사는 주주총회에서 선임하며, 감사의 선임을 위한 의안은 이사의 선임을 위한 의안과는 구분하여 의결하여야 한다.</P>
<P>③감사의 선임은 출석한 주주의 의결권의 과반수로 하되 발행주식총수의 4분의 1이상의 수로 하여야 한다. 그러나 의결권있는 발행주식총수의 100분의 3을 초과하는 수의 주식을 가진 주주는 그 초과하는 주식에 관하여 제1항의 감사의 선임에 있어서는 의결권을 행사하지 못한다. 다만, 소유주식수의 산정에 있어 최대주주와 그 특수관계인, 최대주주 또는 그 특수관계인의 계산으로 주식을 보유하는 자, 최대주주 또는 그 특수관계인에게 의결권을 위임한 자가 소유하는 의결권있는 주식의 수는 합산한다.</P>
</TD>

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="260">
<P>정관</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제40조</P>
<P>(감사의 임기)</P>
</TD>

<TD WIDTH="474" VALIGN="MIDDLE" HEIGHT="53">
<P>② 감사의 임기는 취임 후 3년 내의 최종의 결산기에 관한 정기주주총회 종결 시까지로 한다.</P>
</TD>

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>정관</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>제41조</P>
<P>(감사의 보선)</P>
</TD>

<TD WIDTH="474" VALIGN="MIDDLE" HEIGHT="76">
<P>감사 중 결원이 생긴 때에는 주주총회에서 이를 선임한다. 그러나 이 정관 제39조에서 정하는 원수를 결하지 아니하고 업무수행 상 지장이 없는 경우에는 그러하지 아니한다.</P>
</TD>

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>정관</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="329">
<P>제41조의2</P>
<P>(감사의 직무)</P>
</TD>

<TD WIDTH="474" VALIGN="MIDDLE" HEIGHT="329">
<P>①감사는 이 회사의 회계와 업무를 감사한다.</P>
<P>②감사는 이사회에 출석하여 의견을 진술할 수 있다.</P>
<P>③감사는 필요하면 회의의 목적사항과 소집이유를 서면에 적어 &cr;이사(소집권자가 있는 경우에는 소집권자를 말한다. 이하 같다.)에게 제출하여 이사회 소집을 청구할 수 있다. </P>
<P>④제3항의 청구를 하였는데도 이사가 지체 없이 이사회를 소집하지 아니하면 그 청구한 감사가 이사회를 소집할 수 있다. </P>
<P>⑤감사는 회의의 목적사항과 소집의 이유를 기재한 서면을 이사회에 제출하여 임시총회의 소집을 청구할 수 있다.</P>
<P>⑥감사는 그 직무를 수행하기 위하여 필요한 때에는 자회사에 대하여 영업의 보고를 요구할 수 있다. 이 경우 자회사가 지체없이 보고를 하지 아니할 때 또는 그 보고의 내용을 확인할 필요가 있는 때에는 자회사의 업무와 재산상태를 조사할 수 있다.</P>
<P>⑦감사는 회사의 비용으로 전문가의 도움을 구할 수 있다.</P>
</TD>

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="329">
<P>정관</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 감사위원회(감사)의 감사업무에 필요한 경영정보접근을 위한 내부장치마련 여부</P>
<P>당사 정관은 감사업무에 필요한 경영정보접근을 위하여 다음과 같이 규정하고 있습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="467"></COL>
<COL WIDTH="36"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="476" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내용</P>
</TH>

<TH WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>제41조의 2</P>
<P>(감사의 직무)</P>
</TD>

<TD WIDTH="476" VALIGN="MIDDLE" HEIGHT="99">
<P>⑥감사는 그 직무를 수행하기 위하여 필요한 때에는 자회사에 대하여 영업의 보고를 요구할 수 있다. 이 경우 자회사가 지체 없이 보고를 하지 아니할 때 또는 그 보고의 내용을 확인할 필요가 있을 때에는 자회사의 업무와 재산상태를 조사할 수 있다.</P>
</TD>

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>정관</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">나. 감사의 인적사항 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="325"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성 명</P>
</TH>

<TH WIDTH="334" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 경력</P>
</TH>

<TH WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>결격요건 여부</P>
</TH>

<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비 고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>정유근&cr;(57.09.03)</P>
</TD>
<TD WIDTH="334" HEIGHT="168" VALIGN="MIDDLE">-서울대 경영대학 졸업&cr;-삼성물산&cr;-삼성전자 근무&cr;-세무사 시험 합격&cr;-대원세무법인&cr;- 현 신영세무법인 세무사, 한국세무사회 상담    위원, 선바이오(주) 감사</TD>

<TD WIDTH="112" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>해당사항없음</P>
</TD>

<TD WIDTH="93" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>비상근/등기</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">다. 감사의 독립성&cr;</SPAN>당사는 사업보고기준일 현재 정관에 감사에 관한 규정을 두어 감사의 권한, 책임, 운영방안 등을 규정하고 있습니다. &cr;
</P>

<P>&cr;
<SPAN USERMARK=" B">라. 감사의 주요활동 내역</SPAN>
</P>
<P>VI. 1. 나. 이사회 중요의결사항을 참조하기 바랍니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_04_감사_교육_미실시내역</FILENAME>
<P USERMARK=" B">마. 감사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_EDU_NOT_DTL">해당사항없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_02_감사_지원조직_현황</FILENAME>
<P USERMARK=" B">바. 감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="623" BORDER="1">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADT_OGN_NM">경영지원부</TE>
<TE WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADT_OGN_CNT">2</TE>
<TE WIDTH="206" VALIGN="MIDDLE" HEIGHT="76" ACODE="ADT_OGN_PST" ALIGN="CENTER">차장1명, 과장1명&cr;(평균 10.1년)</TE>
<TE WIDTH="209" VALIGN="MIDDLE" HEIGHT="76" ACODE="ADT_OGN_DTL">재무제표, 경영전반에 관한 감사직무 수행지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>

<P>&cr;
<SPAN USERMARK=" B">사. 준법지원인에 관한 사항&cr;</SPAN>당사는 사업보고서 작성기준일 현재 선임된 준법지원인이 없습니다.&cr;
</P>
</LIBRARY>
</INSERTION>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 투표제도&cr;</SPAN>(1) 집중투표제의 채택여부&cr;보고서 작성일 현재 집중투표제를 채택하고 있지 않습니다.&cr;&cr;(2) 서면투표제 또는 전자투표제의 채택여부&cr;당사는 아래 정관 규정에 따라 서면투표제를 채택하고 있으며, 2020년 3월 4일 의결권 행사에 있어 주주의 편의를 제고하기 위하여 「상법」제368조의4(전자적 방법에 의한 의결권의 행사)에 따라 전자투표제를 채택하였고, 이에 2020년 3월 23일 개최된 제23기 주주총회부터 전자투표제를 시행하였습니다.&cr;
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="452"></COL>
<COL WIDTH="35"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="461" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내용</P>
</TH>

<TH WIDTH="44" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="76">
<P>제26조(의결권의 대리행사)</P>
</TD>

<TD WIDTH="461" VALIGN="MIDDLE" HEIGHT="76">
<P>①주주는 대리인으로 하여금 그 의결권을 행사하게 할 수 있다.</P>
<P>②제1항의 대리인은 주주총회 개시전에 그 대리권을 증명하는 서면(위임장)을 제출하여야 한다.</P>
</TD>

<TD WIDTH="44" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>정관</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">나. 소수주주권의 행사여부</SPAN>
</P>
<P>당사는 최근 3 사업연도 까지 소수주주권이 행사된 사실이 없습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">다. 경영권 경쟁&cr;</SPAN>당사는 사업보고대상 기간 중 경영지배권에 관하여 경쟁한 사실이 없습니다.
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">가. 최대주주 및 특수관계인의 주식소유 현황</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="682" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="371" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="685" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="330" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">노광</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="53" ACODE="SH5_RET" VALIGN="MIDDLE">최대주주 및 대표이사</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="53" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="53" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">  2,503,040 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="53" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   32.63</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="53" ACODE="SH5_END_CNT" VALIGN="MIDDLE">  2,111,947 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="53" ACODE="SH5_END_RT" VALIGN="MIDDLE">   27.53 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노완</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">제</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">    117,600 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    1.53 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">   118,800 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">   1.55 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">조학수</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">사촌</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     90,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    1.17 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     70,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.91 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노흥덕</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     74,300 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.97 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     74,300 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.97 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노찬</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">형</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     46,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">  0.60 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     44,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.57 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노수덕</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     15,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">     0.20</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       5,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.07 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">조동환</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">매형</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     12,424 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">     0.16</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       6,300 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.08 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노성두</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">제</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     31,200 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">     0.41</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     31,200 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.41 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">이티에스소프트(주)</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">제의 회사</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     40,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.52 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     40,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.52 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">황은숙</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">제수</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     39,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.51 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     39,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.51 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노순남</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">누이</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     17,938 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.23 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     10,294 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.13 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">백기황</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌누이 남편</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     20,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.26 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     20,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.26 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">김영옥</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">처의 올케</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     20,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.26 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     20,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.26 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">전상룡</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">동서</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     15,900 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.21 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     11,826 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.15 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노경애</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌누이</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     11,500 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">     0.15</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     11,500 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.15 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김경숙</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">처의 누이</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     12,782 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.17 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     12,782 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.17 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">박상갑</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">처 누이남편</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     11,500 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.15 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     11,500 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.15 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김능율</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">동서</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     10,340 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.13 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     10,340 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.13 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">정춘자</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">모</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       5,254 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.07 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       3,854 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.05 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">신명희</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">제의 처</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       8,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.10 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       8,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.10 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">김동일</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사외이사</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       5,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.07 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       5,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.07 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">박재옥</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 처</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       1,576 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.02 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       1,576 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.02 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노태현</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 자녀</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     10,888 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.14 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     10,888 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.14 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">선바이오(주)</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">자사주</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       7,997 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.10 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       7,997 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.10 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">박효경</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">고종사촌</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     24,402 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.32 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     24,402 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.32 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">김선기</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 처</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     10,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.13 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       9,180 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.12 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노선애</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     11,965 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.16 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     11,965 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.16 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">노문정</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 자녀</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       1,500 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">  0.02 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       1,500 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.02 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">김태형</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">처 조카</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">         880 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.01 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">         880 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.01 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">김태오</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">처 조카</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">         880 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.01 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">         880 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.01 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">김준</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 남편</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       9,162 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.12 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     12,582 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.16 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">백성현</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 자녀</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       4,399 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">   0.06 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       4,399 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.06 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">백준현</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">사촌의 자녀</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">       4,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">    0.05 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">       4,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.05 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="35" ACODE="SH5_NM_T" VALIGN="MIDDLE">KIM SUN SOOK</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="35" ACODE="SH5_RET" VALIGN="MIDDLE">배우자</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="35" ACODE="STK_KND">
<P>보통주</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="35" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">     38,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">     0.50</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="35" ACODE="SH5_END_CNT" VALIGN="MIDDLE">     38,000 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="35" ACODE="SH5_END_RT" VALIGN="MIDDLE">    0.50 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="145" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">박재순</TE>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">관계회사 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">8,890</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.12</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">8,890</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.12</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="249" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="58" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">  3,241,317 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">42.26 </TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">  2,802,872 </TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">36.54 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="58" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>(1) 최대주주의 주요경력 및 개요</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1005">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성별</TH>
<TH WIDTH="78" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">출생년월</TH>
<TH WIDTH="78" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위</TH>
<TH WIDTH="78" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등기임원&cr;여부</TH>
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상근&cr;여부</TH>
<TH WIDTH="78" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담당&cr;업무</TH>
<TH WIDTH="198" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
<TH WIDTH="167" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수</TH>
<TH WIDTH="92" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재직기간</TH>
<TH WIDTH="92" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의결권&cr;있는 주식</TH>
<TH WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">노광</TD>
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">남</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">1957.10</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">등기임원</TD>
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">상근</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">회사총괄</TD>
<TD WIDTH="198" HEIGHT="99" VALIGN="MIDDLE">-서울대 졸업&cr;-Rutgers Univ. 박사&cr;-Enzon Pharma 연구부장&cr;-현 선바이오(주) 대표이사</TD>
<TD WIDTH="84" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">2,111,947</TD>
<TD WIDTH="83" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">23년 5개월</TD>
<TD WIDTH="92" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2021.07.10</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P>(2) 최대주주의 최대주주(법인 또는 단체)의 개요&cr;&cr;본 보고서 작성기준일 현재 해당사항 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P>(3) 최대주주의 변동내역&cr;&cr;본 보고서 작성기준일 현재 해당사항 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">나. 주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">이수화학</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">403,360</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">5.26</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">-</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-  </TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">[ 소액주주현황 ]</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="49"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNT">1,472</TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNTT">1,513</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_RT">97.29</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNT">3,811,017</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNTT">7,670,540</TE>
<TE WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_RT">49.68</TE>
<TE WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P USERMARK=" B">다. 주식사무</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="508"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="517" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내 용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="605">정관상 &cr;신주인수권</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="605">
<P>제11조(신주인수권) ①이 회사의 주주는 신주발행에 있어서 그가 소유한 주식수에 비례하여 신주의 배정을 받을 권리를 가진다.</P>
<P>②제1항의 규정에 불구하고 다음 각호의 경우에는 주주외의 자에게 신주를 배정할 수 있다.</P>
<P>1. 일반공모의 방식으로 신주를 발행하는 경우</P>
<P>2. 주주우선공모의 방식으로 신주를 발행하는 경우</P>
<P>3. 발행하는 주식총수의 100분의 20범위 내에서 우리사주조합원에게 신주를 우선배정하는 경우</P>
<P>4. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 주식예탁증서(DR)발행에 따라 신주를 발행하는 경우</P>
<P>5. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 신기술의 도입, 재무구조의 개선 등 회사의 경영상 목적을 달성하기 위하여 국내외 법인 또는 제 3자에게 신주를 발행하는 경우</P>
<P>6. 현물출자, 출자전환 기타 채권과 신주납입 대금을 상계하는 방법으로 발행하는 경우</P>
<P>7. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 사업상 중요한 기술도입, 연구개발, 생산·판매·자본제휴를 위하여 그 상대방에게 신주를 발행하는 경우</P>
<P>8. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 긴급한 자금조달을 위하여 국내외 금융기관 또는 기관투자자에게 신주를 발행하는 경우</P>
<P>9. 주권을 한국거래소에 상장하기 위하여 신주를 모집하거나 인수인에게 인수하게 하는 경우</P>
<P>10. 증권 인수업무 등에 관한 규정 제 10조의 2(신주인수권)에 의거하여 신주를 발행하는 경우</P>
<P>③주주가 신주인수권을 포기 또는 상실하거나 신주배정에서 단주가 발생하는 경우에 그 처리방법은 이사회의 결의로 정한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">결산일</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">12월 31일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">정기주주총회</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">매사업년도 종료후 3월 이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">주주명부&cr;폐쇄시기</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">매사업년도 1월 1일부터 1월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">주권의&cr;종류</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">1주권, 5주권, 10주권, 50주권, 100주권, 500주권, 1000주권, 10000주권의 8종</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">명의개서&cr;대리인</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">한국예탁결제원 (☎ 1577-6600) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주주의 특전</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">해당사항 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">공고방법</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="76">이 회사의 공고는 회사 인터넷 홈페이지(www.sunbio.com)에 한다. 다만, 전산장애 또는 그 밖의 부득이한 사유로 인터넷 홈페이지에 공고를 할 수 없는 때에는 서울시에서 발행되는 매일경제신문에 게재한다. </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P USERMARK=" B">라. 주가 및 주식거래실적 (KRX코넥스시장)&cr;&cr;
<SPAN USERMARK=" !B">보고서 작성일로부터 최근 6개월간 주가 및 거래량은 아래와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="617"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="626" HEIGHT="30">(단위:원, 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" VALIGN="MIDDLE" COLSPAN="2" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"></TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;7월</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;8월</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;9월</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;10월</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;11월</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년&cr;12월</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="3" ALIGN="CENTER" WIDTH="63" HEIGHT="90">주가&cr;(원)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">최고</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">14,400 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">18,800 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">19,300 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">    16,900 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">16,750 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="85" HEIGHT="30">21,850</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">최저</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">9,940 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">    12,400 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">15,650 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">    14,500 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">13,450 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="85" HEIGHT="30">15,850</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">평균</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">11,143 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">    14,125 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">17,640 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">    15,969 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">14,869 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="85" HEIGHT="30">18,217</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="3" ALIGN="CENTER" WIDTH="63" HEIGHT="90">거래량&cr;(주)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">최고</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">55,115 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">51,993 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">23,348 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">9,783 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">70,171 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="85" HEIGHT="30">92,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">최저</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">1,666 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">4,522 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">968 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">1,316 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">    2,033 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="85" HEIGHT="30">3,297</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">월간</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">294,325 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">339,810 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">157,069 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30"> 74,737 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="86" HEIGHT="30">246,106 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="85" HEIGHT="30">509,762</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P USERMARK=" B">가. 임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1445" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="1096"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1105" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1448" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="479"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="488" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">노광</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="195710" VALIGN="MIDDLE">1957.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">회사총괄</TE>
<TE WIDTH="488" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">-서울대 졸업&cr;-Rutgers Univ. 박사&cr;-Enzon Pharma 연구부장&cr;-현 선바이오(주) 대표이사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">2,111,947</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">본인</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">23년 5개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20210710" VALIGN="MIDDLE">2021.07.10</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">김동일</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="195808" VALIGN="MIDDLE">1958.08</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사</TE>
<TE WIDTH="488" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">-Rutgers Univ. 박사&cr;-녹십사,목암생명공학연구소 연구소&cr;-현 인하대 교수, (주)셀트리온, 선바이오(주) 사외이사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">5,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">타인</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">5년 9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="20210321" VALIGN="MIDDLE">2021.03.21</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="171" ACODE="SH5_NM_T" VALIGN="MIDDLE">주우식</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="171" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="171" AUNIT="SH5_BIH" AUNITVALUE="195906" VALIGN="MIDDLE">1959.06</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="171" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="171" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="171" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="171" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사</TE>

<TE WIDTH="488" HEIGHT="171" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">-서울대 법학과 졸업 / Cornel Univ.경제학 박사&cr;-제 24회 행정고시 합격 / -한국은행 행원</P>
<P USERMARK="F-GL11">- IMF(워싱턴) 이코노미스트 / -재정경제부 경제정책국 과장</P>
<P USERMARK="F-GL11">-삼성전자, 삼성증권 부사장 / -KDB 금융그룹 지주 수석 부사장</P>
<P USERMARK="F-GL11">-전주페이퍼 대표이사 사장 / -삼정 KPMG 부회장</P>
<P USERMARK="F-GL11">-현 옐로씨매니지먼트(사모펀드) 회장</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="171" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="171" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="171" ACODE="SH5_RLTN" VALIGN="MIDDLE">타인</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="171" ACODE="SH5_PER" VALIGN="MIDDLE">1년 11개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="171" AUNIT="SH5_FIH" AUNITVALUE="20220103" VALIGN="MIDDLE">2022.01.03</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">정유근</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="195709" VALIGN="MIDDLE">1957.09</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">감사</TE>
<TE WIDTH="488" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">-서울대 경영대학 졸업&cr;-삼성물산 / -삼성전자 근무&cr;-세무사 시험 합격 / -대원세무법인&cr;-현 신영세무법인 세무사, 한국세무사회 상담위원, 선바이오(주) 감사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">타인</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2년 9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20210321" VALIGN="MIDDLE">2021.03.21</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">이성훈</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="195704" VALIGN="MIDDLE">1957.04</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">QA</TE>
<TE WIDTH="488" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">-한양대 졸업&cr;-삼일회계법인 MCS본부이사&cr;-한국IBM 컨설팅 Principal, SO executive, QA-RM 담당&cr;-현 선바이오(주) 사내이사, QA담당</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">타인</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">4년 5개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20220705" VALIGN="MIDDLE">2022.07.05</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">51_등기임원후보자및해임대상자</FILENAME>
<P USERMARK=" B">나. 등기임원 선임 후보자 및 해임 대상자 현황</P>

<TABLE-GROUP ACLASS="PSN_MBER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="888" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="629"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="170" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20210329">2021년 03월 29일</TU>
<TD VALIGN="BOTTOM" WIDTH="638" HEIGHT="30" AUPDATECONT="N"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="891" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="367"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사외이사&cr;후보자&cr;해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="376" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선ㆍ해임&cr;예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="157" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="157" ACODE="PSN_NAM" VALIGN="MIDDLE">이성훈</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="157" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="157" AUNIT="PSN_BIH" AUNITVALUE="195704" VALIGN="MIDDLE">1957.04</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="157" ACODE="PSN_DIR" VALIGN="MIDDLE">부</TE>

<TE WIDTH="376" HEIGHT="157" ACODE="PSN_CAR" VALIGN="MIDDLE">
<P USERMARK="F-GL10">- 한양대학교 공과대학 공업경영학과 졸업</P>
<P USERMARK="F-GL10">- 대우전자 MIS실 제조Process analyst, 해외공장 MIS실 담당</P>
<P USERMARK="F-GL10">- 대우정보시스템즈 컨설팅/ERP사업부, 사업부장</P>
<P USERMARK="F-GL10">- 삼일회계법인 MCS본부이사</P>
<P USERMARK="F-GL10">- 한국IBM 컨설팅 Principal, SO executive QA-RM 담당</P>
<P USERMARK="F-GL10">- 2016~현재 선바이오(주) QA담당</P>
</TE>
<TU ALIGN="CENTER" WIDTH="96" HEIGHT="157" AUNIT="PSN_DAT" AUNITVALUE="20210329" VALIGN="MIDDLE">2021.03.29</TU>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="157" ACODE="PSN_RSP" VALIGN="MIDDLE">타인</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="207" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="207" ACODE="PSN_NAM" VALIGN="MIDDLE">안응호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="207" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="207" AUNIT="PSN_BIH" AUNITVALUE="195510" VALIGN="MIDDLE">1955.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="207" ACODE="PSN_DIR" VALIGN="MIDDLE">부</TE>

<TE WIDTH="376" HEIGHT="207" ACODE="PSN_CAR" VALIGN="MIDDLE">
<P USERMARK="F-GL10">- Rutgers-the State University of New Jersey&cr;   박사학위 취득 (경제학박사)</P>
<P USERMARK="F-GL10">- Rutgers대학교 경제학과 조교&cr;- Rutgers대학교 Visiting Part-time Lecturer &cr;- 한국수출입은행&cr;- 한국외국어대학교 (겸임교수)&cr;- 경인여자대학교 (교수)&cr;- 2021~현재 선바이오(주) CFO</P>
</TE>
<TU ALIGN="CENTER" WIDTH="96" HEIGHT="207" AUNIT="PSN_DAT" AUNITVALUE="20210329" VALIGN="MIDDLE">2021.03.29</TU>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="207" ACODE="PSN_RSP" VALIGN="MIDDLE">타인</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="PSN_APP" AUNITVALUE="N" VALIGN="MIDDLE">해임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="70" ACODE="PSN_NAM" VALIGN="MIDDLE">김동일</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="PSN_BIH" AUNITVALUE="195808" VALIGN="MIDDLE">1958.08</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="70" ACODE="PSN_DIR" VALIGN="MIDDLE">-</TE>
<TE WIDTH="376" HEIGHT="70" ACODE="PSN_CAR" VALIGN="MIDDLE" USERMARK="F-10">-Rutgers Univ. 박사&cr;-녹십사,목암생명공학연구소 연구소&cr;-현 인하대 교수, (주)셀트리온, 선바이오(주) 사외이사</TE>
<TU ALIGN="CENTER" WIDTH="96" HEIGHT="70" AUNIT="PSN_DAT" AUNITVALUE="20210329" VALIGN="MIDDLE">2021.03.29</TU>
<TE ALIGN="CENTER" WIDTH="104" HEIGHT="70" ACODE="PSN_RSP" VALIGN="MIDDLE">타인</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P USERMARK=" B">다. 직원 등 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="854" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="496" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="854" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="343" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">선바이오</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">14</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">14</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">7년9개월</TE>
<TE ALIGN="RIGHT" WIDTH="76" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">565,005</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">40,357</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">선바이오</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">10</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">10</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">9년4개월</TE>
<TE ALIGN="RIGHT" WIDTH="76" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">387,776</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">38,778</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">24</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">24</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="76" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">952,781</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>

<P USERMARK="F-11">
<SPAN USERMARK="F-12">* 직원 현황은 등기임원은 제외되었고, 미등기임원은 포함이 되었습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P USERMARK=" B">라. 미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="617" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="250"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="259" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="617" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">1</TE>
<TE WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">50,410</TE>
<TE WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">50,410</TE>
<TE WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">가. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">4</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">500,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">미등기임원 제외</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">50,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 보수지급금액</P>
<P USERMARK=" B">나-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">5</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">182,072</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">36,414</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">176,872</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">88,436</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">4,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">2,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM">1,200</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC">1,200</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">가. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="86"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>※ 개인별 보수총액이 5억원을 초과하는 이사ㆍ감사가 없습니다.&cr;</P>
<P USERMARK=" B">나. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 천원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">가. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 천원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">14_주식매수선택권의부여및행사현황</FILENAME>
<P><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="232"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">등기이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사외이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_NUM">2</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_SUMT">178,185</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_NUM">1</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">5</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUMT">178,185</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P><표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1030" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="636"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="645" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1031" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여&cr;받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초&cr;부여&cr;수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말&cr;미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사&cr;가격</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">김판균</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20160329">2016.03.29</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">40,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2018.03.29~2021.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">28,700</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">15명 </TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20160329">2016.03.29</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">60,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">55,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2018.03.29~2021.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">28,700</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">이OO</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20160808">2016.08.08</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">10,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2018.08.08~2021.08.07</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">28,100</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">2명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20160808">2016.08.08</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2018.08.08~2021.08.07</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">28,100</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">김판균</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20170317">2017.03.17</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">1,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">9,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2019.03.17~2022.03.21</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">16,130</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">이OO</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20170317">2017.03.17</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2019.03.17~2022.03.21</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">16,130</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">18명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20170317">2017.03.17</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">48,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">13,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">6,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">28,400</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2019.03.17~2022.03.21</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">16,130</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">6명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180321">2018.03.21</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">10,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2020.03.21~2023.03.20</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">18,818</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">주우식</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190325">2019.03.25</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">30,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2021.03.25~2026.03.24</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">29,660</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_NM">5명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190325">2019.03.25</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACODE="SH5_PER">2021.03.25~2026.03.24</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">29,660</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P>&cr;본 보고서 작성기준일 현재 해당사항 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P>&cr;본 보고서 작성기준일 현재 해당사항 없습니다.&cr;</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>

<P>&cr;
<SPAN USERMARK=" B">1. 공시사항의 진행ㆍ변경상황 &cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">2. 주주총회 의사록 요약&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="659">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="381"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주총일자</TH>
<TH WIDTH="390" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">안건</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결의내용</TH>
<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">제23기&cr;정기주주총회&cr;(2020.03.23)</TD>
<TD WIDTH="390" HEIGHT="122" VALIGN="MIDDLE">[제1호의안] 제23기(2019년도) 정기주주총회 소집의 건&cr; 부의안건 (1) 제1호 의안 : 제23기 재무제표 승인의 건&cr;              (2) 제2호 의안 : 이사 보수한도 승인의 건&cr;              (3) 제3호 의안 : 감사 보수한도 승인의 건&cr;[제2호의안] 전자투표 채택의 건</TD>
<TD WIDTH="113" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">원안대로 가결</TD>
<TD WIDTH="48" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">3. 중요한 소송사건&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">4. 견질 또는 담보용 어음ㆍ수표현황&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">5. 채무보증 현황&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">6. 채무인수약정 현황&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">7. 그 밖의 우발채무 등&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">8. 자본으로 인정되는 채무증권의 발행&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">9. 제재현황&cr;</SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">10. 작성기준일 이후 발생한 주요사항</SPAN>&cr;
<SPAN>가. 무상증자&cr;당사는 2020년 12월 23일 주식발행초과금을 재원으로 1주당 0.5주를 배정하는 무상증자를 결의하였으며, 2021년 1월 29일자로 신주가 상장되었습니다. 이로인해 당사의 발행주식 총수는 11,501,811주로 변경되었습니다.&cr;&cr;나. 유형자산 양도&cr;당사는 자산운용의 효율성 강화 및 현금유동성 확보에 따른 재무구조개선을 목적으로, 당기말 현재 보유하고 있는 투자부동산 전체(경기도 군포시 산본로 94소재의 토지 및 건물)에 대해 2021년 2월 10일 (주)삼경엠에스와 매매계약을 체결하였습니다. &cr;&cr;나. 주식매수선택권 행사&cr;당사는 2021년 3월 23일 주식매수선택권 45,870주가 행사되었으며, 이로인해 당사의 발행주식 총수는 11,547,681주로 변경되었습니다.&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">19_사모자금의사용내역</FILENAME>

<P>
<SPAN USERMARK=" B">11. 직접금융 자금의 사용&cr;</SPAN>&cr;가. 공모자금 사용내역&cr;
<SPAN USERMARK=" B"></SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;나. 사모자금의 사용내역
</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="863" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="554"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="563" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="863" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="56" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="252" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="252" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">전환사채</TE>
<TE ALIGN="CENTER" WIDTH="56" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20190513">2019.05.13</TU>
<TE ALIGN="RIGHT" WIDTH="168" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">시설자금, 운영자금 등</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">2,000,000</TE>
<TE ALIGN="CENTER" WIDTH="168" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">시설자금, 운영자금 등</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">2,000,000</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P USERMARK=" B">12. 중소기업검토기준표</P>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">중소기업검토기준표_1.jpg</IMG>
<IMG-CAPTION ATOC="N">중소기업검토기준표</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">13. 보호예수 현황&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>본 보고서 작성기준일 현재 해당사항 없습니다.&cr;&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>해당사항없음</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P>해당사항없음</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>